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A B S T R A C T
Background
Fluoride mouthrinses have been used extensively as a caries-preventive intervention in school-based programmes and by individuals at
home. This is an update of the Cochrane review of fluoride mouthrinses for preventing dental caries in children and adolescents that
was first published in 2003.
Objectives
The primary objective is to determine the effectiveness and safety of fluoride mouthrinses in preventing dental caries in the child and
adolescent population.
The secondary objective is to examine whether the effect of fluoride rinses is influenced by:
• initial level of caries severity;
• background exposure to fluoride in water (or salt), toothpastes or reported fluoride sources other than the study option(s); or
• fluoride concentration (ppm F) or frequency of use (times per year).
Search methods
We searched the following electronic databases: CochraneOral Health’s Trials Register (whole database, to 22 April 2016), theCochrane
Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2016, Issue 3), MEDLINE Ovid (1946 to 22 April 2016),
Embase Ovid (1980 to 22 April 2016), CINAHL EBSCO (the Cumulative Index to Nursing and Allied Health Literature, 1937 to
22 April 2016), LILACS BIREME (Latin American and Caribbean Health Science Information Database, 1982 to 22 April 2016),
BBO BIREME (Bibliografia Brasileira de Odontologia; from 1986 to 22 April 2016), Proquest Dissertations and Theses (1861 to 22
April 2016) and Web of Science Conference Proceedings (1990 to 22 April 2016). We undertook a search for ongoing trials on the US
National Institutes of Health Trials Register (http://clinicaltrials.gov) and the World Health Organization International Clinical Trials
Registry Platform. We placed no restrictions on language or date of publication when searching electronic databases. We also searched
reference lists of articles and contacted selected authors and manufacturers.
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Selection criteria
Randomised or quasi-randomised controlled trials where blind outcome assessment was stated or indicated, comparing fluoride
mouthrinse with placebo or no treatment in children up to 16 years of age. Study duration had to be at least one year. The main
outcome was caries increment measured by the change in decayed, missing and filled tooth surfaces in permanent teeth (D(M)FS).
Data collection and analysis
At least two review authors independently performed study selection, data extraction and risk of bias assessment. We contacted study
authors for additional information when required. The primary measure of effect was the prevented fraction (PF), that is, the difference
in mean caries increments between treatment and control groups expressed as a percentage of the mean increment in the control group.
We conducted random-effects meta-analyses where data could be pooled. We examined potential sources of heterogeneity in random-
effects metaregression analyses. We collected adverse effects information from the included trials.
Main results
In this review, we included 37 trials involving 15,813 children and adolescents. All trials tested supervised use of fluoride mouthrinse
in schools, with two studies also including home use. Almost all children received a fluoride rinse formulated with sodium fluoride
(NaF), mostly on either a daily or weekly/fortnightly basis and at two main strengths, 230 or 900 ppm F, respectively. Most studies
(28) were at high risk of bias, and nine were at unclear risk of bias.
From the 35 trials (15,305 participants) that contributed data on permanent tooth surface for meta-analysis, the D(M)FS pooled PF
was 27% (95% confidence interval (CI), 23% to 30%; I2 = 42%) (moderate quality evidence). We found no significant association
between estimates of D(M)FS prevented fractions and baseline caries severity, background exposure to fluorides, rinsing frequency
or fluoride concentration in metaregression analyses. A funnel plot of the 35 studies in the D(M)FS PF meta-analysis indicated no
relationship between prevented fraction and study precision (no evidence of reporting bias). The pooled estimate of D(M)FT PF was
23% (95% CI, 18% to 29%; I² = 54%), from the 13 trials that contributed data for the permanent teeth meta-analysis (moderate
quality evidence).
We found limited information concerning possible adverse effects or acceptability of the treatment regimen in the included trials. Three
trials incompletely reported data on tooth staining, and one trial incompletely reported information on mucosal irritation/allergic
reaction. None of the trials reported on acute adverse symptoms during treatment.
Authors’ conclusions
This review found that supervised regular use of fluoride mouthrinse by children and adolescents is associated with a large reduction
in caries increment in permanent teeth. We are moderately certain of the size of the effect. Most of the evidence evaluated use of
fluoride mouthrinse supervised in a school setting, but the findings may be applicable to children in other settings with supervised or
unsupervised rinsing, although the size of the caries-preventive effect is less clear. Any future research on fluoride mouthrinses should
focus on head-to-head comparisons between different fluoride rinse features or fluoride rinses against other preventive strategies, and
should evaluate adverse effects and acceptability.
P L A I N L A N G U A G E S U M M A R Y
Fluoride mouthrinses for preventing dental caries in children and adolescents
Review question
How effective and safe is the use of fluoride mouthrinse for preventing tooth decay (dental caries) in children and adolescents compared
with placebo (a mouthrinse without the active ingredient fluoride) or no treatment?
Background
Tooth decay is a health problem worldwide, affecting the vast majority of adults and children. Levels of tooth decay vary between and
within countries, but children in lower socioeconomic groups (measured by income, education and employment) tend to have more
tooth decay. Untreated tooth decay can cause progressive destruction of the tops of teeth (crowns), often accompanied by severe pain.
Repair and replacement of decayed teeth is costly in terms of time and money and is a major drain on the resources of healthcare
systems.
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Preventing tooth decay in children and adolescents is regarded as a priority for dental services and is considered more cost-effective
than treatment. Use of fluoride, a mineral that prevents tooth decay, is widespread. As well as occurring naturally, fluoride is added to
the water supply in some areas, and is used in most toothpastes and in other products that are available to varying degrees worldwide.
As an extra preventive measure, fluoride can be applied directly to teeth as mouthrinses, lozenges, varnishes and gels.
Fluoride mouthrinse has frequently been used under supervision in school-based programmes to prevent tooth decay. Supervised
(depending on the age of the child) or unsupervised fluoride mouthrinse needs to be used regularly to have an effect. Recommended
procedure involves rinsing the mouth one to two minutes per day with a less concentrated solution containing fluoride, or once a week
or once every two weeks with a more concentrated solution. Because of the risk of swallowing too much fluoride, fluoride mouthrinses
are not recommended for children younger than six years of age.
This review updates the Cochrane review of fluoride mouthrinses for preventing tooth decay in children and adolescents that was first
published in 2003. We assessed existing research for Cochrane Oral Health, and evidence is current up to 22 April 2016.
Study characteristics
We included 37 studies in which more than 15,000 children (aged six to 14 years) were treated with fluoride mouthrinse or placebo
(a mouthrinse with no active ingredient) or received no treatment. All studies assessed supervised use of fluoride mouthrinse in school
settings, with two studies also including home use. Most children received a sodium fluoride (NaF) solution, given at 230 parts per
million of fluoride (ppm F) daily or a higher concentration of 900 ppm F weekly or fortnightly. Studies lasted from two to three years.
Reports were published between 1965 and 2005, and studies took place in several countries.
Key results
This review update confirmed that supervised regular use of fluoride mouthrinse can reduce tooth decay in children and adolescents.
Combined results of 35 trials showed that, on average, there is a 27% reduction in decayed,missing and filled tooth surfaces in permanent
teeth with fluoride mouthrinse compared with placebo or no mouthrinse. This benefit is likely to be present even if children use fluoride
toothpaste or live in water-fluoridated areas. Combined results of 13 trials found an average 23% reduction in decayed, missing and
filled teeth (rather than tooth surfaces) in permanent teeth with fluoride mouthrinse compared with placebo or no mouthrinse. No
trials have looked at the effect of fluoride rinse on baby teeth. We found little information about unwanted side effects or about how
well children were able to cope with the use of mouthrinses.
Conclusion
Regular use of fluoride mouthrinse under supervision results in a large reduction in tooth decay in children’s permanent teeth. We
found little information about potential adverse effects and acceptability.
Quality of the evidence
Available evidence for permanent teeth is of moderate quality. This means we are moderately confident in the size of the effect. Very
little evidence is available to assess adverse effects.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Fluoride mouthrinse compared with placebo or no treatment for preventing caries in children and adolescents
Patient or population: children and adolescents
Setting: community (schools)
Intervention: f luoride mouthrinse (primarily supervised use in school sett ing)
Comparison: placebo or no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with placebo or
no treatment (assumed
risk)
Risk with flu-
oride mouthrinse (cor-
responding risk)
Changes in caries on
the surfaces of perma-
nent teeth measured by
D(M)FS increment -
nearest to 3 years
Mean increment ranged
across control groups
f rom 0.74 to 21.05, me-
dian 5.6
The corresponding
mean increment in the
intervent ion group is 3.
80 (95%CI 3.64 to 4.00)
PFa 0.27
(0.23 to 0.30)
15305
(35 RCTs)
⊕⊕⊕©
moderateb
Large ef fect:
D(M)FS PF 27% (23% to
30%)
Changes in caries on
the permanent teeth
measured by
D(M)FT increment -
nearest to 3 years
Mean increment ranged
across control groups
f rom 0.72 to 8.41, me-
dian 3.2
The corresponding
mean increment in the
intervent ion group is 2.
46 (95%CI 2.27 to 2.62)
PFa 0.23
(0.18 to 0.29)
5105
(13 RCTs)
⊕⊕⊕©
moderateb
Moderate to large ef -
fect:
D(M)FT PF 23% (18% to
29%)
Unacceptability of
treatment as measured
by leaving study early
149 per 1000 198 per 1000
(92 to 422)
RR 1.33
(0.62 to 2.83)
1700
(4 RCTs)
⊕©©©
very lowb,c,d
Tooth staining Study 1: ‘‘signif icant dif -
ference’’ in stain score
(f rom the control) in the
group using an amine
f luoride mouthrinse:
‘‘non-signif icant dif f er-
Study 1: 525
Study 2: 743
Study 3: 726
⊕©©©
very lowe
We know lit t le about the
risk of tooth staining
owing to incomplete re-
port ing
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ence’’ (f rom the con-
trol) in the group using
sodium f luoride
In 2 tri-
als where stannous f lu-
oride mouthrinsing was
tested against placebo
rinsing:
Study 2: ‘‘approximately
six children had tena-
cious staining that re-
quired a rubber cup pro-
phylaxis carried out ’’
- no indicat ion as to
which groups these
children belonged
Study 3: ‘‘some amount
of yellow pigmentat ion,
somewhat more not ice-
able in the children in
the test group’’
Signs of acute toxic-
ity during applicat ion of
treatment (such as nau-
sea/ gagging/ vomit ing)
Not reported in any studies No data on signs of
acute toxicity
Mucosal irritat ion/ oral
sof t t issue allergic re-
act ion
‘‘no cases of mucosal hypersensit ivity af ter periodical examinat ions of
every subject ’’ - reported in 1 study
434
(1 RCT)
⊕©©©
very lowe
We know very lit t le
about the risk of mu-
cosal irritat ion/ allergic
react ion owing to lack
of report ing
* The basis for the assumed risk, the risk in the placebo or no treatment group, was the range and median in the control groups of the studies included in the review.
Thecorresponding risk, the risk in the intervention group (and its 95% confidence interval), is based on the assumed risk in the comparison group and the relative effect of
the intervent ion (and its 95% CI)
CI = conf idence interval; D(M)FS = decayed (missing) and f illed permanent surfaces; D(M)FT = decayed (missing) and f illed permanent teeth; PF = prevented f ract ion; RR =
risk rat io5
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aPF = 1 - (mean increment in control group/ mean increment in treatment group) (expressed as percentages). PF values
between 1% and 10% are considered to be a small ef fect; between 10% and 20%, a moderate ef fect; above 20% a large or
substant ial ef fect.
bAll studies were at unclear or high risk of bias. Trials had unclear or high risk of bias in sequence generat ion and allocat ion
concealment. Most studies had supervised mouthrinsing conducted in the school sett ing - this was considered for indirectness
but downgrading considered unnecessary.
cWide conf idence interval - small number of part icipants analysed.
dHigh unexplained heterogeneity observed.
eIncomplete information f rom one to three trials with unclear or high risk of bias. Outcome downgraded for concerns of risk
of bias and serious imprecision.
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B A C K G R O U N D
Description of the condition
Dental caries is the most prevalent chronic disease, afflicting a
significant proportion of the world population, including around
60% to 90% of school-aged children and the vast majority of
adults (Marcenes 2013; Petersen 2004). Dental caries levels vary
considerably between and within countries, but children in lower
socioeconomic status (SES) groups have higher caries levels than
those in upper SES groups, and in high-income countries the
association between socioeconomic position and caries might be
stronger (Chen 1995; Reisine 2001; Schwendicke 2015). Un-
treated caries causes progressive destruction of the crowns of the
teeth, often accompanied by severe pain and suffering, especially
in children, where it can result in poorer quality of life and gen-
eral health (Sheiham 2005). Untreated caries in permanent teeth
was the most prevalent condition among all those evaluated in
the Global Burden of Disease (GBD) 2010 study, affecting 35%
of the global population, or 2.4 billion people; untreated caries
in deciduous teeth was the 10th most prevalent condition, af-
fecting 9% of the population, or 621 million children worldwide
(Kassebaum 2015). Repair and replacement of carious teeth is ex-
cessively time consuming and costly, representing a major drain
of resources for healthcare systems. On a population basis, dental
caries is the fourth most expensive chronic disease to treat accord-
ing to the World Health Organization (Petersen 2008).
Dental caries occurs because of demineralisation of tooth struc-
ture by organic acids formed by oral bacteria present in dental
plaque through the anaerobic metabolism of dietary sugars. The
causal role of sugars in caries is well established (Sheiham 2001).
Most caries lesions in children’s permanent teeth progress rela-
tively slowly, with an average lesion taking three years to progress
through tooth enamel to dentine (Mejare 1998). The dental caries
process is influenced by the susceptibility of the tooth surface, the
bacterial profile, the quantity and quality of saliva and the presence
of fluoride, which promotes remineralisation and inhibits dem-
ineralisation of the tooth structure.
Description of the intervention
Fluoride mouthrinses have been used extensively for the past 40
years to prevent dental caries in children. The use of rinses was es-
pecially widespread in school-based programmes in countries ex-
periencing high caries prevalence in the 1970s and 1980s. Doubts
about the effectiveness of fluoride mouthrinse as a population
strategy began in the mid-1980s, in view of the decline in den-
tal caries, and their presumed cost-effectiveness was challenged
(Disney 1990; Stamm 1984). The current view is that fluoride
mouthrinsing programmes are appropriate only for children at
high risk of caries (FDI 2002). The fluoride compound most
commonly used in mouthrinse is sodium fluoride. Supervised,
school-based, weekly rinsing programmes using 900 ppm fluoride
(F) solutions of 0.2% sodium fluoride have been popular in the
United States in non-fluoridated communities (Horowitz 1996).
In Scandinavian countries and in several other countries, such pro-
grammes have been discontinued on the basis of the above-noted
caries decline and widespread use of fluoride toothpastes (Seppa
1989; Twetman 2004). Mouthrinse solutions of 0.05% sodium
fluoride, containing 230 ppm F, are available commercially for
daily home use in some countries. Rinses containing 100 ppm
F are also available for over-the-counter (OTC) sale and are rec-
ommended for twice-daily use. Fluoride mouthrinses have thus
moved frombeing a toolmainly advocated in the public health set-
ting; through the force of commercial marketing, they have gained
greater prominence in the personal dental products market. By
virtue of the widespread use of other oral mouthrinse products,
from simple breath fresheners to products formulated to counter
inflammatory periodontal (gum) diseases, it has been argued that
the procedure could in fact be cost-effective if those already using
non-fluoride mouthrinses convert to using fluoride rinses (Stamm
1993).
Although the procedure is not recommended for children younger
than six years of age because of the risk of acute and chronic flu-
oride ingestion, data have implicated use of fluoride mouthrinse
by preschool children as a risk factor for dental fluorosis (enamel
defects caused by chronic ingestion of excessive amounts of fluo-
ride during the period of tooth formation) because some young
children might swallow substantial amounts (Ripa 1991; Stookey
1994). Accidental swallowing of the usual 10 mL rinse volume
of a 0.05% (230 ppm F) NaF solution daily by a child of five
or six years of age will result in ingestion of 2.3 mg of fluoride
(the average dosage ingested would be twice the optimum level in
a fluoridated area). Although this dose is far below the probable
toxic dose (PTD) of fluoride, estimated to be 5mg/kg body weight
(Whitford 1992), or approximately 100 mg of fluoride for a child
of five or six years (20 kg), this amount would be available in just
434 mL of the standard daily rinsing solution.
A large number of clinical trials have extensively investigated the
effect of fluoride mouthrinses on the incidence of caries in chil-
dren during the past five decades. Besides sodium fluoride solu-
tions,mouthrinses containing other fluoride compounds in several
concentrations and rinsing frequencies have been tested. Numer-
ous articles and textbook chapters have reviewed evidence from
these primary studies on the effectiveness of fluoride mouthrinses
(Birkeland 1978; Bohannan 1985; Leverett 1989; Petersson 1993;
Ripa 1991; Ripa 1992; Torell 1974). In one review article from
the mid-1980s, review authors used a meta-analytical approach to
synthesise the results of US fluoride mouthrinse studies carried out
in fluoride-deficient communities (Stamm 1984). Two systematic
reviews on the caries-inhibiting effect of fluoridemouthrinses have
been published more recently (Twetman 2004; Weyant 2013).
It is evident from these reviews and meta-analyses that fluoride
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mouthrinses are caries-inhibitory treatments. However, the au-
thors of these reviews failed to conduct a comprehensive search for
individual trials or to formally evaluate the risk of bias in included
trials, despite obvious drawbacks in the design and methods of the
included trials.
How the intervention might work
The most important anti-caries effect of fluoride present in dental
plaque and saliva is considered to result from its local action on
the tooth/plaque interface, through promotion of remineralisa-
tion of early caries lesions and reduction in tooth enamel solubility
(Featherstone 1988). Enamel demineralisation is markedly inhib-
ited if fluoride is present at the time of the acid challenge because,
as cariogenic bacteria metabolise carbohydrates and produce acid,
fluoride diffuses with the acid from dental plaque into the enamel
in response to lowered pH, and acts at the enamel crystal surface
to reduce mineral loss. When pH rises following enamel deminer-
alisation, released fluoride and fluoride present in the saliva can
combine with dissolved calcium and phosphate ions to precipi-
tate or grow fluorapatite-like crystalline material within the tooth,
thereby establishing an improved enamel crystal structure. Thus,
fluoride enhances this mineral gain and provides a material that
is more resistant to subsequent acid attack (Ten Cate 1999). This
occurs with all forms and concentrations of topical fluoride, al-
though to a variable extent. With high-concentration topical flu-
oride vehicles (such as varnishes and gels), calcium fluoride is pre-
cipitated on the enamel surface and in the plaque. This calcium
fluoride acts as a fluoride reservoir, which is released when the oral
pH falls, and the amount of fluoride deposited in the subsurface
lesion is greater after topical application with such high-concen-
tration fluoride vehicles (Horowitz 1996; Ogaard 1994; Ogaard
2001). Regular use of fluoride toothpaste or mouthrinse results
in sustained elevated fluoride concentrations in oral fluids during
the demineralisation-remineralisation cycle, as small amounts are
maintained constantly in the mouth (Clarkson 1996).
Why it is important to do this review
The Cochrane Oral Health Group undertook an extensive pri-
oritisation exercise in 2014 to identify a core portfolio of titles
that were the most clinically important ones to maintain in The
Cochrane Library (Worthington 2015). The paediatric expert panel
identified this review as a priority title (Cochrane OHG priority
review portfolio).
Prevention of dental caries in children and adolescents is gener-
ally regarded as a priority for dental services and is considered
more cost-effective than treatment (Burt 1998). Fluoride ther-
apy has been the centrepiece of caries-preventive strategies since
water fluoridation schemes were introduced over six decades ago
(Murray 1991), when caries was highly prevalent and severe, and
when even modest prevention activities led to considerable reduc-
tion in disease levels. Over the past 30 years, with the substan-
tial decline in dental caries rates in many western countries, the
increase in dental fluorosis levels in some countries and intensive
research on the mechanism of action of fluoride highlighting the
primary importance of its topical effect, greater attention has been
paid to the appropriate use of other fluoride-based interventions
(Featherstone 1988; Featherstone 1999; Glass 1982; Marthaler
1996; O’Mullane 1994; Ripa 1991).
Use of topically applied fluoride products in particular, which
are much more concentrated than the fluoride in drinking water,
has increased over recent decades. By definition, the term ’topi-
cally applied fluoride’ is used to describe those delivery systems
that provide fluoride to exposed surfaces of the dentition, at el-
evated concentrations, for a local protective effect, and therefore
are not intended for ingestion. Fluoride-containing toothpastes
(dentifrices), mouthrinses, gels and varnishes are the modalities
most commonly used at present, alone or in combination. Vari-
ous products are marketed in different countries, and a variety of
caries-preventive programmes based on these products have been
implemented. Toothpastes are by far the most widespread form
of fluoride usage (Murray 1991a; Ripa 1991); although reasons
for the decline in prevalence of dental caries in children from dif-
ferent countries have been the topic of much debate (De Liefde
1998; Krasse 1996;Marthaler 1996;Marthaler 2004;Nadanovsky
1995), this event has been attributed mainly to the gradual in-
crease in, and regular home use of, fluoride in toothpaste (Bratthall
1996; Glass 1982; Marthaler 1994; O’Mullane 1994; Ripa 1991;
Rolla 1991).
At the same time, the lower caries prevalence in many countries
now and the widespread availability of fluoride from multiple
sources have raised the question of whether topically applied fluo-
rides are still effective in reducing caries, and whether they are safe,
mainly in terms of the potential risk of fluorosis (mottled enamel).
This is particularly important, as nearly all child populations in
high-income countries are exposed to some source of fluoride, no-
tably in toothpaste, and adverse effects may be rare (such as acute
fluoride toxicity) or more subtle (such as mild dental fluorosis)
(Marthaler 2004; Murray 1991a).
Traditional narrative reviews have extensively reviewed evidence
on the effects of topically applied fluoride products on prevention
of dental caries in children. Several systematic reviews focusing
on evaluation of specific fluoride active agents within specific de-
livery systems have used a quantitative meta-analytical approach
to synthesise trial results (Ammari 2003; Bartizek 2001; Chaves
2002; Clark 1985; Helfenstein 1994; Johnson 1993; Petersson
2004; Stamm 1984; Stamm 1995; Steiner 2004; Strohmenger
2001; Twetman 2004; Van Rijkom 1998; Weyant 2013). How-
ever, no systematic investigation has been conducted to evaluate
and compare effects of the main modalities of topically applied
fluoride treatments and to examine formally the main factors that
may influence their effectiveness.
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This review, which is one in a series of Cochrane systematic re-
views of topical fluoride interventions, assesses the effectiveness of
fluoride rinses for prevention of dental caries in children (Marinho
2003a;Marinho 2003b;Marinho 2004;Marinho 2004a;Marinho
2013; Marinho 2015). This is an update of the review first pub-
lished in 2003, which showed clear evidence of a caries-inhibiting
effect of fluoride mouthrinse in the permanent teeth of children
(Marinho 2003). It is generally recognised that blinding is partic-
ularly important when outcome measures require specific criteria
to improve objectivity in measurement, as in assessment of dental
caries. Of note in this series of topical fluoride reviews is that lack
of blinding in the main outcome assessment (caries increment)
or lack of any indication of blind outcome assessment remains
an exclusion criterion - that is, we have excluded studies if open
outcome assessment is reported, or if blind outcome assessment is
not reported and is unlikely to have been used.
O B J E C T I V E S
The primary objective is to determine the effectiveness and safety
of fluoride mouthrinses in preventing dental caries in the child/
adolescent population.
The secondary objective is to examine whether the effect of fluo-
ride rinses is influenced by:
• initial level of caries severity;
• background exposure to fluoride in water (or salt),
toothpastes or reported fluoride sources other than the study
option(s); or
• fluoride concentration (ppm F) or frequency of use (times
per year).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised or quasi-randomised controlled trials
where ’blind outcome assessment’ was stated or indicated (e.g.
caries examinations performed independently of previous results,
radiographic examinations registered separately from clinical ex-
aminations/added later, examiners clearly not involved in giving
treatment, use of placebo described), and in which the length of
follow-up was at least one year/school year. We included cluster-
randomised trials, except when only one cluster was assigned to
each study group .
We excluded randomised or quasi-randomised controlled trials
with open outcome assessment or no indication of blind assess-
ment of outcome (blind assessment was considered unlikely if the
following were not described: a caries examination performed in-
dependently of previous results, X-rays registered independently
of clinical examination, examiners clearly not involved in giving
treatment and use of placebo), or lasting less than one year/school
year, or where random or quasi-random allocation was not used
or indicated. We also excluded split-mouth studies as they are un-
suitable for fluoride mouthrinse owing to unavoidable contami-
nation.
Types of participants
Children or adolescents aged 16 or younger at the start of the study
(irrespective of initial level of dental caries, background exposure
to fluorides, dental treatment level, nationality, setting where in-
tervention was received or time when it started).
We excluded studies where participants were selected on the basis
of special (general or oral) health conditions.
Types of interventions
Intervention: topical fluoride in the form of a mouthrinse that
is swished and expectorated, not swallowed. We included fluoride
mouthrinses irrespective of formulation, concentration (ppm F),
volume, duration or frequency of application, or application tech-
nique of application.
Comparison: placebo or no treatment.
Therefore, the following comparison is of interest: fluoride mouth
rinse versus placebo or no treatment.
We excluded studies where the intervention consisted of use of
any other caries-preventive agent or procedure (e.g. other fluo-
ride-based measures, chlorhexidine, sealants, oral hygiene inter-
ventions, xylitol chewing gums), in addition to fluoride rinse.
Types of outcome measures
The primary outcome measure in this review is caries increment,
as measured by change from baseline in the number of decayed
(missing) and filled permanent tooth surfaces (D(M)FS), or in the
number of decayed (extracted/missing) and filled primary tooth
surfaces (d(e/m)fs) or both (and change in the number of perma-
nent or primary teeth (D(M)FT/d(e/m)ft). Dental caries is de-
fined here as clinically and radiographically recorded at the dentin
level of diagnosis. If caries data were reported only with dentin
and enamel lesions combined, this was used in the analysis. (See
Data collection and analysis for different ways of recording caries
and reporting D(M)FT/S and d(m)ft/s scores in permanent and
primary dentitions in clinical trials of caries preventive interven-
tions, and for ways in which data were selected for analysis.)
We excluded studies reporting no dental caries data, reporting only
on plaque/gingivitis/gingival bleeding, calculus, dentin hypersen-
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sitivity or fluoride physiological outcome measures (fluoride up-
take by enamel or dentin, salivary secretion levels, etc).
Primary outcomes
• Caries increment in permanent tooth surfaces (D(M)FS),
reported as change from baseline (and D(M)FT, whenever
reported)
• Caries increment in primary tooth surfaces (d(e)fs),
reported as change from baseline (and d(e)ft, whenever reported)
Secondary outcomes
• Development of new caries, reported as change in the
proportion of children developing new caries
• Children not remaining caries-free, reported as a change in
the proportion
• Tooth staining, measured as change in the proportion of
children
• Signs of acute toxicity during application of treatment
(such as nausea/gagging/vomiting)
• Mucosal irritation/oral soft tissue allergic reaction
• Dropouts or withdrawals during the trial (as an indirect
measure of treatment acceptability)
Search methods for identification of studies
To identify trials for inclusion in this review, we developed detailed
search strategies for each database searched. These were based on
the search strategy developed forMEDLINE Ovid but revised ap-
propriately for each database. The search strategy used a combina-
tion of controlled vocabulary and free text terms and was linked
with the Cochrane Highly Sensitive Search Strategy (CHSSS)
for identifying randomised trials (RCTs) in MEDLINE: sensitiv-
ity maximising version (2008 revision) as referenced in Chapter
6.4.11.1 and detailed in Box 6.4.c of the Cochrane Handbook for
Systematic Reviews of Interventions version 5.1.0 (updated March
2011) (Higgins 2011). We have provided details of the current
MEDLINE search strategy in Appendix 3. The search of Embase
was linked to Cochrane Oral Health’s filter for identifying RCTs.
Electronic searches
We searched the following electronic databases:
• Cochrane Oral Health’s Trials Register (searched 22 April
2016) (see Appendix 1);
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 3) in the Cochrane Library (searched
22 April 2016) (see Appendix 2);
• MEDLINE Ovid (1946 to 22 April 2016) (see Appendix
3);
• Embase Ovid (1980 to 22 April 2016) (see Appendix 4);
• CINAHL EBSCO (Cumulative Index to Nursing and
Allied Health Literature; 1937 to 22 April 2016)(see Appendix
5);
• LILACS BIREME (Latin American Caribbean Health
Sciences Literature; 1980 to 22 April 2016) (see Appendix 6);
• BBO BIREME (Brazilian Bibliography of Odontology;
1980 to 22 April 2016) (see Appendix 6);
• Proquest Dissertations and Theses (1861 to 22 April 2016)
(see Appendix 7); and
• Web of Science Conference Proceedings (1990 to 22 April
2016) (see Appendix 8).
We placed no restrictions on the language or date of publication
when searching electronic databases.
For ongoing trials, we searched the following trial registries (see
Appendix 9 for details of search terms):
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (http://clinicaltrials.gov/; searched 22 April
2016);
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch; searched 22 April
2016).
Searching other resources
Reference searching
We scanned all eligible trial reports retrieved from the searches,
meta-analytical reports and systematic reviews/review articles for
relevant references. For the original version of this review, review
authors had also checked reference lists of relevant chapters from
preventive dentistry textbooks on topically applied fluoride inter-
ventions for relevant references (Ekstrand 1988; Fejerskov 1996;
Murray 1991c).
Handsearching
Review authors carried out some handsearching for the original
version of this review, using journals identified as having the high-
est yield of eligible RCTs and controlled clinical trials (CCTs). We
handsearched the following journals:
• Community Dentistry and Oral Epidemiology (1990 to
2000);
• British Dental Journal (1999 to 2000);
• Caries Research (1999 to 2000);
• Journal of the American Dental Association (1999 to 2000);
• Journal of Dental Research (1999 to 2000);
• Journal of Public Health Dentistry (1999 to 2000); and
• European Journal of Oral Sciences (1999 to 2000).
For the update of this review, we did not undertake any hand-
searching.
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Personal contact
For the original review, we contacted experts in the field of pre-
ventive dentistry to identify any unpublished trials or trial reports
that may not have been indexed by the major databases. We sent
a letter to the author(s) of each included study published during
the 1980s and 1990s to request information on possible unpub-
lished trials eligible for inclusion. All authors of trials who had
been contacted to clarify reported information to enable assess-
ment of eligibility or obtain missing data were also asked for un-
published trials. In addition, on the basis of information extracted
mainly from included trials, we created a list of manufacturers of
fluoride rinses for locating unpublished trials, and we contacted
six fluoride rinse manufacturers in October 2000. We requested
information on any unpublished trials from GABA AG, Johnson
& Johnson, Oral-B Laboratories, Colgate Oral Pharmaceuticals,
Procter & Gamble and Warner Lambert. GABA provided a list
of 409 records obtained through a search performed in GALI-
DENT (Database of GABA Library in Dentistry) using the key-
word ’amine fluoride’; we incorporated in this update the search
results from this list of records from GABA.
Data collection and analysis
Selection of studies
At least two review authors performed screening for eligibility in-
dependently for all reports identified from all searches performed.
We considered it essential to identify all reports related to the same
study. When a trial report thought to be potentially relevant was
written in a language not known to the review authors, it was trans-
lated and the inclusion criteria form completed by a review author
with reference to the translator. We attempted to contact authors
of trials that could not be classified to ascertain whether inclusion
criteria were met. We noted trials not fulfilling the inclusion cri-
teria and our reasons for excluding them in the Characteristics of
excluded studies table.
Data extraction and management
At least two review authors extracted data from all included stud-
ies in duplicate using a predesigned pilot-tested data extraction
form. We extracted numerical data presented only in graphs and
figures whenever possible. We attempted to contact study authors
by using an open-ended request to obtain missing information or
for clarification when necessary.
We extracted information related to study methods, including
study design, study duration (overall length of follow-up in years)
and objectivity/reliability of primary outcome measurement (di-
agnostic methods and thresholds/definitions used and included,
and monitoring of diagnostic errors).
We recorded information on sponsoring/funding institutions and
manufacturers involved.
We extracted characteristics related to participants, including age
(mean or range or both) at start, caries severity at start (aver-
age DMFS/dmfs, DFS/dfs or other caries increment measure, for
sample analysed), background exposure to other fluoride sources
(toothpaste, water, etc), year study began, location where study
was conducted (country), settingwhere participants were recruited
(and setting of treatment) and total sample randomised (at base-
line) and analysed (at relevant final examination).
We extracted characteristics of the interventions, including mode
of application (how the intervention was delivered/supervision),
methods (technique/device) of application, before and after appli-
cation, fluoride active agents and concentrations used (in ppm F),
frequency and duration of application and amount applied. We
recorded information on what the fluoride mouthrinse was com-
pared with (no treatment or placebo), together with numbers for
each group. We have described these data in the Characteristics of
included studies table.
We recorded different ways of reporting caries increment (change
from baseline as measured by the DMF index) separately and/or
combined according to the components of the index chosen and
units measured (DMFT/S, or DFT/S, or DT/S, or FT/S), types
of tooth/surface considered (primary/permanent teeth/surfaces,
first molar teeth approximal surfaces, etc), diagnostic thresholds
used (cavitated/dentin lesions, non-cavitated incipient enamel le-
sions or both), methods of examination adopted (clinical or radio-
graphical, both or other), state of tooth eruption considered (teeth
erupted at baseline and/or erupting teeth (or surface) during the
trial) and approaches to account or not for reversals in caries in-
crement adopted (in a net caries increment or observed/crude in-
crement, respectively). In addition, we recorded caries increment
data at all reported time periods (at various follow-ups).
As we were aware that caries increment would be recorded dif-
ferently in different trials, we developed a set of a priori rules to
choose the main outcome data (D(M)FS) for analysis from each
study: DFS data would be chosen over DMFS data, and these
would be chosen over DS or FS; data for ’all surface types com-
bined’ would be chosen over data for ’specific types’ only; data for
’all erupted and erupting teeth combined’ would be chosen over
data for ’erupted’ only, and these over data for ’erupting’ only; data
from ’clinical and radiological examinations combined’ would be
chosen over data from ’clinical’ only, and these over ’radiological’
data only; data from ’clinical and FOTI examinations combined’
would be chosen over data from ’clinical’ examination only; data
for dentinal/cavitated caries lesions would be chosen over com-
bined data for dentinal/cavitated and for enamel/non-cavitated le-
sions, and these over enamel caries data only; net caries increment
data would be chosen over crude (observed) increment data; and
follow-up nearest to three years (often the one at the end of the
treatment period) would be chosen over all other lengths of fol-
low-up, unless otherwise stated. When no specification was pro-
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vided with regard to the methods of examination adopted, diag-
nostic thresholds used, groups of teeth and types of tooth eruption
recorded and approaches for reversals adopted, we assumed the
primary choices described above.
TheCharacteristics of included studies table provides a description
of allmain outcomedata reported fromeach study,with the chosen
primary outcome measure featured at the top. When assessments
of caries increments were made during a postintervention follow-
up period, we noted the length of time over which outcomes were
measured after the intervention ended. We also listed in this table
all other relevant outcomes identified as assessed in the trials.
Assessment of risk of bias in included studies
At least two review authors independently undertook assessment
of risk of bias in all included trials. We resolved disagreements
by discussion or by involvement of another review author. This
was carried out using the tool of The Cochrane Collaboration
for assessing risk of bias, as outlined in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011), but accord-
ing to predefined criteria that were adapted and refined for the
Cochrane topical fluoride review updates. We assessed eight do-
mains according to the tool, namely, sequence generation, alloca-
tion concealment, blinding of participants/personnel, blinding of
outcome assessment, incomplete outcome data, selective outcome
reporting, balance of baseline characteristics and freedom from
contamination or co-intervention. Each domain included one or
more specific entries in a ’Risk of bias’ table.Within each entry, we
described information reported in the study and assigned a judge-
ment related to risk of bias for that entry. When the study clearly
reported the methods used, we made a judgement of ’low risk of
bias’ or ’ high risk of bias’ as appropriate. Where trial methods
were unclear, we judged a domain as at ’unclear risk of bias’ until
further information becomes available.
After taking into account additional information provided by trial
authors, we assessed the overall risk of bias in included trials over
all eight domains. We categorised studies as being at overall:
• low risk of bias (plausible bias unlikely to seriously alter the
results: all eight domains assessed as at low risk of bias);
• unclear risk of bias (plausible bias that raises some doubt
about the results: at least one domain assessed as at unclear risk
of bias, but none at high risk of bias); or
• high risk of bias (plausible bias that seriously weakens
confidence in the results: at least one domain assessed as at high
risk of bias).
Measures of treatment effect
The chosen measure of treatment effect for the primary outcome,
caries increment, was the prevented fraction (PF), that is, mean in-
crement in control groupminus mean increment in treated group,
divided by mean increment in controls. For an outcome such as
caries increment, where discrete counts are considered to approx-
imate to a continuous scale and are treated as continuous data,
we considered this measure more appropriate than the mean dif-
ference or the standardised mean difference because it allows the
combination of different ways of measuring caries increment and
a meaningful investigation of heterogeneity between trials. It is
also simple to interpret.
For outcomes other than caries increment, we planned that we
would summarise continuous data as average mean differences
(MDs) in treatment effects along with their 95% confidence in-
tervals (95% CIs), or, if different scales were used to measure the
same outcome in different trials, standardised mean differences
(SMDs) and their 95% CIs. We analysed dichotomous outcome
data by calculating risk ratios (RRs) or, for adverse effects of fluo-
ride treatment, risk differences (RDs).
Unit of analysis issues
Trials with multiple treatment arms
In trials with more than one relevant intervention group and a
common control group, such as those comparing different active
fluoride agents or concentrations of fluoride ions against a placebo
group, we combined summary statistics (the number of children
analysed, mean caries increments and standard deviations) from
all relevant experimental groups (and from any relevant control
groups, if this was the case) to obtain a measure of treatment effect
(the PF). This enabled the inclusion of all relevant data in the pri-
mary meta-analysis, although it might have slightly compromised
the secondary investigations of dose response.
Cluster-randomised trials
When cluster-randomised trials did not report results adjusted for
clustering present in the data, we performed an approximately
correct analysis by estimating the design effect for such trials (
Higgins 2011) by using:
• the intraclass correlation coefficient (ICC) if reported;
• an ICC value of 0.05 obtained from a similar study
(Lawrence 2008; ICC = 0.045) to reduce the numbers in
intervention and control groups to their ’effective sample size’; or
• an ICC value of 0.1 already used for the cluster trial in the
original review to inflate the standard error of the PF by
multiplying it by the square root of the design effect.
The design effect is (1 + (M-1) * ICC) where M is the average
cluster size.
Dealing with missing data
We decided that when missing standard deviations for caries in-
crements could not be obtained by contacting the original re-
searchers, we would impute these values through linear regression
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of log standard deviations on log mean caries increments. This
is a suitable approach for caries prevention trials because, as they
follow an approximate Poisson distribution, caries increments are
closely related (similar) to their standard deviations (Van Rijkom
1998).
Assessment of heterogeneity
We assessed heterogeneity by inspecting a graphical display of es-
timated treatment effects from trials along with their 95% CIs
and by conducting formal tests of homogeneity undertaken be-
fore each meta-analysis (Thompson 1999). We quantified this by
using the I2 statistic and classified it according to the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
A rough guide to interpretation follows: 0% to 40% might not be
important, 30% to 60% may represent moderate heterogeneity,
50% to 90% may represent substantial heterogeneity and 75% to
100% may indicate very substantial (“considerable”) heterogene-
ity.
Assessment of reporting biases
Reporting bias can be assessed as within-study outcomes reporting
bias or as between-study publication bias.
Outcomes reporting bias (within-study reporting bias)
Within-study reporting bias (one of the eight ’risk of bias’ domains
listed above, as selective outcome reporting) would ideally be as-
sessed by comparing outcomes reported in the published report
against the study protocol. As this was not possible, we compared
the outcomes listed in the Methods section with reported results.
If results were mentioned but were not reported adequately in a
way that allowed analysis (e.g. only mentioned whether or not the
results were statistically significant), we sought information from
the authors of study reports. Otherwise, this would be judged as
“high risk” of bias. If information was insufficient to judge the risk
of bias, we judged the risk as unclear (Higgins 2011).
Publication bias (between-study reporting bias)
We generated funnel plots (plots of effect estimates versus the in-
verse of their standard errors) when we identified sufficient trials
(more than 10). Asymmetry of the funnel plot may indicate pub-
lication bias and other biases related to sample size, although this
may also represent a true relationship between trial size and size
of effect. We performed a formal investigation of the degree of
asymmetry by using the method proposed by Egger 1997.
Data synthesis
We conducted meta-analyses for the PFs as inverse variance
weighted averages in Review Manager 5.3 (RevMan 2014), where
the prevented fraction and standard error data [PF (SE)] were en-
tered by using the generic inverse variance (GIV) method. We
estimated variances using the formula presented in Dubey 1965,
whichwasmore suitable for use in aweighted average, and for large
sample sizes the approximation should be reasonable. Two previ-
ous reviews (Marinho 2013; Marinho 2015) noted that this for-
mula was inappropriate for studies with small increments, and that
the data from such studies were to be excluded from the analysis
in this review. We used random-effects meta-analyses throughout
and analysed primary and permanent teeth separately throughout.
We used random-effects models to calculate a pooled estimate of
effect for outcomes other than caries increment data.
Subgroup analysis and investigation of heterogeneity
We specified three potential sources of heterogeneity a priori, as
these formed part of the primary objectives of this review. We hy-
pothesised that the effect of fluoride mouthrinses on caries dif-
fers according to: (1) baseline levels of caries severity; (2) ex-
posure to other fluoride sources (in water, in toothpastes, etc);
and (3) frequency of application and fluoride concentration. We
examined the association of these factors with estimated effects
(D(M)FS PFs) by performing random-effectsmetaregression anal-
yses in Stata version 12.0 (Stata Corporation, College Station,
Texas, USA) using the ’Metareg’ command (Sharp 1998).
To allow such investigation, we dealt with relevant data as follows.
We calculated data on ’baseline levels of caries’ from the study sam-
ple analysed (final sample) unless otherwise stated, and we aver-
aged values among all relevant study groups. Data on ’background
exposure to other fluoride sources’ represented combined data on
use of fluoride toothpaste and consumption of fluoridated water
(or salt) and were grouped into two categories: one for studies that
were based on samples provided with non-fluoride toothpaste and
that were obtained from non-fluoridated areas (non-exposed), and
another for studies based on samples using fluoride toothpaste or
studies in fluoridated communities or both. We considered expo-
sure to water fluoridation when fluoride levels in water were stated
to be above 0.3 ppm F. Use of fluoride toothpaste reported for
30% or more of the study sample would indicate exposure to flu-
oridated toothpaste. When use or non-use of fluoride toothpaste
was not clearly indicated in studies carried out in high-income
countries, we assumed that fluoride toothpaste was widely used
from themiddle of the 1970s (Ripa 1989); we sought this informa-
tion from study authors (or obtained it from other sources) when
missing from studies carried out in other locations. When data
on the year a study had begun were not provided, we calculated a
’probable date’ by subtracting the duration of the study (in years)
plus one extra year, from the publication date of the study. We
have not categorised data on ’frequency of application’ and ’con-
centration applied’. We averaged concentrations in multiple-arm
studies over fluoride mouthrinse groups. We dealt with incom-
plete data for frequency of mouthrinsing as follows: In studies of
supervised daily rinse at school where participants were provided
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with mouthrinse for home use, we assumed rinsing frequency of
365 times a year if not precisely reported. We assumed rinsing fre-
quency of 320 times a year in studies of ’unsupervised’ daily rinse
at home (even if instructions to rinse more than once a day were
given); we assumed frequency of 160 times (days) a year when it
was not precisely reported in studies of supervised daily rinse at
school where children were not provided with any rinse for home
use; frequency of 30 times a year for weekly rinse at school and
frequency of 17 times a year for fortnightly rinse at school.
We investigated further potential sources of heterogeneity by
metaregression - for different types of control groups (placebo (PL)
or no treatment (NT), length of follow-up (years) and dropout
rate (%). These ’post hoc’ analyses were reported as such and find-
ings should be treated with caution.
Sensitivity analysis
For the main meta-analysis of D(M)FS prevented fraction, we
planned to undertake a sensitivity analysis including trials with
an overall assessment of low risk of bias, but we found no trials
satisfying this criterion. We undertook a sensitivity analysis ex-
cluding trials where we imputed missing standard deviations. We
performed a sensitivity analysis to take account of additional un-
certainty related to the cluster-randomised trial by Ruiken 1987,
and another excluding one trial (Spets-Happonen 1991) in which
a non-fluoride active agent was present in both fluoride and con-
trol groups (the trial was different in this way from all others). We
also undertook a sensitivity analysis excluding trials at high risk
of bias for allocation concealment, and another excluding trials at
high and unclear risk of bias for blinding of outcome assessment.
We performed these meta-analyses using a random-effects model.
Presentation of main results - Summary of findings
We used the GRADE (Grades of Recommendation, Assess-
ment, Development and Evaluation Working Group) approach (
gdt.guidelinedevelopment.org) to rate the overall ’quality of evi-
dence’ for our primary outcome and themost important secondary
outcomes in the main comparison. Summary of findings for the
main comparison provides outcome-specific information concern-
ing the overall quality of evidence from each included study in the
comparison, the magnitude of effect of the interventions exam-
ined and the sum of available data on all outcomes that we rate as
important to patient care and decision making.
The quality of evidence reflects the extent to which we are con-
fident that an estimate of effect is correct and apply this in our
interpretation of results. The four possible ratings are ’high’, ’mod-
erate’, ’low’ and ’very low’. A rating of ’high quality’ of evidence
implies that we are confident in our estimate of effect and believe
that further research is very unlikely to change our confidence in
the estimate of effect. A rating of ’very low quality’ quality implies
that any estimates of effect obtained are very uncertain.
The GRADE approach considers evidence fromRCTs that do not
have serious limitations as ’high’ quality. However, the quality of
evidence can be decreased by:
• study limitations (risk of bias);
• inconsistency;
• Indirectness of evidence;
• imprecision; and
• publication bias.
Depending on the seriousness of limitations, we downgraded the
quality of evidence by one or two levels for each aspect.
R E S U L T S
Description of studies
Results of the search
We have used the full search conducted on 22 April 2016 as de-
scribed in Searchmethods for identification of studies to construct
the PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses) flow chart shown in Figure 1.
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Figure 1. Study flow diagram from 2016 search
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For this update, we identified 1823 records through searches (from
electronic databases and other sources) and screened 1231 after
removing duplicates and records already linked to the review in
Archie. After discarding 1099 records as irrelevant, we assessed
132 full-text articles (including some available only as abstracts or
summary reports) as potentially eligible, and considered 126 for
inclusion in this review. Of these 126 reports:
• 62 reports were related to 37 included trials (including the
36 trials included in the original 2003 review);
• 63 reports were related to 50 excluded trials (including the
43 trials excluded in the original review); and
• one report was related to one study that awaits classification.
We found no reports of ongoing studies.
Included studies
See Characteristics of included studies table for details of each
study.
We included37 trials in the review.We treated the study conducted
by Horowitz 1971 as two independent trials (Horowitz 1971 and
Horowitz 1971a) because results for the two age groups in the
study have been reported separately as distinct studies. Also, these
completely distinct studies were published concomitantly by the
same author: Koch 1967, Koch 1967a and Koch 1967b. All 62
study reports were published between 1965 and 2005. The 36
previously included trialswere conducted between1962 and1994:
10 during the 1960s, 19 during the 1970s, six during the 1980s
and one in the 1990s. The 2016 update of this review found
another trial conducted in the early 2000s (Moberg Sköld 2005).
Thirteen trials were conducted in the USA, four in the UK, six in
Sweden, two in Denmark, two in Canada, two in New Zealand,
three in Brazil and one in each of the following countries: Finland
(Spets-Happonen 1991), The Netherlands (Ruiken 1987), South
Africa (van Wyk 1986), Chile (Molina 1987) and Puerto Rico
(Duany 1981). Fifteen studies had more than one publication,
and one of these studies had seven published reports (Koch 1967).
Eleven trials acknowledged assistance (e.g. product provision) and/
or financial support from fluoride mouthrinse manufacturers; 13
trials acknowledged support from non-commercial sources, and
16 trials provided no information on sources of funding.
Design and methods
All included studies used a parallel-group design, and one was
cluster randomised (Ruiken 1987). Sixteen studies had more than
one fluoride mouthrinse treatment group compared with a control
(multi-treatment studies); among these, one trial had two treat-
ment groups and two placebo control groups (Ringelberg 1979).
Six trials used a factorial design to investigate the effects of multi-
ple topical fluoride interventions (Ashley 1977; Blinkhorn 1983;
DePaola 1980; Koch 1967; Ringelberg 1979; Torell 1965). With
regard to type of control group used, five trials used a no treatment
control group (Craig 1981; Moberg Sköld 2005; Moreira 1981;
Ruiken 1987; Torell 1965), and the remaining 32 used a placebo
control group, of which two used tap water as ’placebo solution’
(Moreira 1972; Petersson 1998). Study duration (indicated by to-
tal length of follow-up as well as treatment duration) ranged from
two to three years among included trials; only three trials lasted
less than two years (1.6 years) (Horowitz 1971; Horowitz 1971a;
Radike 1973).
Participants
Studieswere large; only two trials allocated fewer than100 children
to relevant groups (Craig 1981; Spets-Happonen 1991). The total
number of children participating in the 37 included trials (given
by the sample analysed at the end of the trial periods) was 15,813,
and ranged from 95 in the smallest trial (Spets-Happonen 1991)
to 1238 in the largest trial (Ringelberg 1982), on average 427
participants per trial.
Investigators recruited all participants from school settings.
All included trials reported that participants were aged 14 or
younger at the start, with similar numbers of males and females
(where these data were reported). The age of children at the start
of trials ranged from five to 14 years (where these data were re-
ported); at least 18 trials included children who were 12 years old
at the start, and at least five trials included six-year-olds (but re-
ported no primary teeth caries data). Caries prevalence at base-
line (decayed, missing and filled surfaces (D(M)FS)), reported in
all but two studies, ranged from 0.94 (Horowitz 1971) to 14.6
D(M)FS (Koch 1967). With regard to ’background exposure to
other fluoride sources’, all but two studies reported whether or
not participants were exposed to water fluoridation: Four stud-
ies were conducted in fluoridated communities (Driscoll 1982;
Laswell 1975; Moreira 1981; Radike 1973), and 31 studies were
not. Of the 31 studies conducted in non-fluoridated areas, re-
searchers clearly reported no (or very low) background exposure
to fluoride toothpaste or to other fluoride sources in eight studies,
substantial exposure to fluoride toothpaste (over 95%) in seven
studies and exposure to other fluoride sources - varnish (Moberg
Sköld 2005) and tablets (Ruiken 1987) - in two studies; whether
or not participants were exposed to fluoride toothpaste had to be
assumed in 16 studies based on study location and year started, as
described above.
Interventions
All included trials reported supervised use of fluoride mouthrinse
in school programmes, and two trials also tested use of rinse at
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home (Spets-Happonen 1991; Torell 1965). Rinsing with sodium
fluoride (NaF) was tested in 33 trials, acidulated phosphate fluo-
ride (APF) in four trials (Finn 1975; Heifetz 1973; Laswell 1975;
Packer 1975), stannous fluoride (SnF2) in two (McConchie 1977;
Radike 1973) and sodium monofluorophosphate (SMFP), amine
fluoride (AmF) and ammonium fluoride (NH4F) each in a differ-
ent study (Bastos 1989; Ringelberg 1979 and DePaola 1977, re-
spectively). The fluoride concentration used in tested mouthrinses
ranged from 100 ppm F (0.02% NaF) to 3000 ppm F (0.66%
NaF), and frequency of application ranged from three to 330 times
a year, but these were unusually low and high concentrations and
frequencies. Eighteen studies used the concentration of 230 ppm
F (180 and 250 ppmF in a few studies), and 20 studies the concen-
tration of 900 ppm F (1000 ppm F in a few studies). It can be seen
that when rinsing was performed once a week or once every two
weeks, investigators employing 900 ppm F was usually used (17
trials). Conversely, when rinsing was performed once (or twice) a
day, the fluoride concentration used was 230 ppm F, or around
this concentration (13 trials). The only study (Duany 1981) where
information on rinsing frequency was not available is likely to have
used daily rinses for all three low concentrations of fluoride tested
(this was one of the four studies testing 100 ppm F rinsing solu-
tions). The most usual amounts of mouthrinse used per applica-
tion was 5 or 10 mL, and usual rinsing time was one or two min-
utes (these amounts and rinsing times were reported in 21 studies).
Four studies reported performance of some form of prior tooth
prophylaxis (brushing without paste or with a non-fluoride paste
before rinsing, which was not considered a separate intervention
on its own but as a possible part of the rinsing procedure) (Ashley
1977; Blinkhorn 1983; Craig 1981; Spets-Happonen 1991).
Outcome measures
Caries increment data
All but two of the 37 trials (Brandt 1972;DeLiefde 1989) reported
caries increment data (or data from which these could be derived)
at the tooth surface level (D(M)FS), and 13 trials reported caries
increment at the tooth level (D(M)FT) for permanent dentition;
no trial reported caries increment data for the primary dentition
[d(e/m)fs/d data]. With regard to components of the DMFS in-
dex used (and types of teeth/surfaces assessed), 20 trials reported
DMFS data (one trial for premolars and molars only, and 19 tri-
als for all tooth surface types), and 17 trials reported DFS data
(two trials for approximal surfaces of premolars and molars only,
and 15 trials for all tooth surface types). No choice had to be
made between DMFS or DFS data in any one trial. Sixteen trials
presented D(M)FS data at more than one follow-up time (which
ranged from 1.6 to three years); 27 trials reported follow-up of 2
or 3 years. Three trials also assessed D(M)FS increments during a
postintervention follow-up period.
Two studies did not include a visual examination to detect caries
(Moberg Sköld 2005; Petersson 1998) when caries was diagnosed
by X-rays only. In five studies where a visual examination was em-
ployed, investigators did not report use of a probe including tactile
criteria (Ashley 1977; Blinkhorn 1983; Brandt 1972; Rugg-Gunn
1973; Ruiken 1987). Twenty trials used X-rays in addition to vi-
sual examination for caries detection. Clinical (35 trials) and ra-
diographic (22 trials) examinations provided the definition of dif-
ferent levels or grades of caries lesions, which have been grouped
into two basic grades for each method of examination: NCA =
non-cavitated incipient enamel lesions clinically visible as white
spots or discoloured fissures; CA = lesions showing loss of enamel
continuity that can be recorded clinically (undermined enamel,
softened floor/walls) or showing frank cavitation; ER = any radi-
olucency in enamel/enamel-dentine junction; DR = radiolucency
into dentine. Eighteen trials presented results using the dentine
cavitation level of diagnosis for caries (CA/DR), and two trials
presented results using the enamel level (NCA/ER) (Ashley 1977;
Heifetz 1973). The 17 trials remaining did not report the diag-
nostic level/grade used for caries (14 trials), in which case CA/DR
was assumed, or reported both levels of diagnosis (Moberg Sköld
2005; Petersson 1998; Ruiken 1987), in which case CA/DR was
chosen where viable. Nineteen trials specified data on the state
of tooth eruption considered: seven trials reported data for teeth
erupted at baseline (although data were recorded on erupting and
erupted teeth in some), and 12 trials reported combined data for
erupting and erupted teeth.
Other outcome data
Five trials reporting caries increment also used other similar mea-
sures/indices - caries incidence/attack rate in permanent teeth/sur-
faces (Heidmann 1992; Koch 1967; Koch 1967a; Koch 1967b;
Moreira 1981). Three trials reported data on the proportion of
children developing new caries (Finn 1975; Heidmann 1992;
Torell 1965). One trial also reported data on caries progression
(Moberg Sköld 2005), but no trials have reported data on children
not remaining caries-free.
A few trials reported assessment of data on adverse effects, but
incompletely: stain score (Ringelberg 1979); proportion of chil-
dren with tooth staining (McConchie 1977; Radike 1973), with
incomplete data; signs of sensitivity (allergic reactions) in oral soft
tissue (Rugg-Gunn 1973), with the following statement in the
trial: “no cases of mucosal hypersensitivity after periodical exam-
inations of every subject”; any side effects (Bastos 1989; DePaola
1977; McConchie 1977), with incomplete or no useable data and
with the following statement in all three trials: “no adverse side
effects observed”. No trials reported adverse acute symptoms (nau-
sea/vomiting during treatment).
Four of the five non-placebo (no-treatment) control trials provided
data for unacceptability of the treatment regimen (as measured by
dropouts/exclusions) (Craig 1981; Moberg Sköld 2005; Moreira
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1981; Torell 1965).
Excluded studies
See Characteristics of excluded studies for a description of our
reasons for rejecting each study.
We excluded 50 trials for a variety of reasons. We have categorised
these as related to study design, intervention/comparison or out-
come, as given below, on the basis of the main or most obvious
reason(s) for exclusion.
Study design
• Not an RCT or quasi-RCT or unlikely to be so - 34 studies
(Arcieri 1981; Badersten 1975; Bohannan 1985a; Boyd 1985;
Bristow 1975; Chen 2010; Chikte 1996; Cichocka 1981; Clark
1985a; Corpus 1973; De Canton 1983; Disney 1989; Esteva
Canto 1991; Fernandez 1979; Hall 1964; Irmisch 1974; Ivanova
1990; Kani 1973; Kasakura 1966; Kunzel 1978; Louw 1995;
McCormick 1970; Mendonca 1995; Moungtin 1975; Nenyei
1971; Roberts 1948; Rodriguez Miro 1983; Shimada 1978;
Suntsov 1991; Torell 1969; Weisz 1960; Widenheim 1989;
Wilson 1978; Wycoff 1991).
• Open assessment stated or blinded outcome assessment not
stated or unlikely - 33 studies: four studies owing to lack of
blinding in outcome assessment (Brodeur 1989; Castellanos
1983; Mendonca 1995; Ramos 1995) and the other 29 studies
owing to other features that met the exclusion criteria (Arcieri
1981; Axelsson 1976; Badersten 1975; Birkeland 1973;
Bohannan 1985a; Chen 2010; Chikte 1996; Cichocka 1981;
Corpus 1973; DePaola 1967; Disney 1989; Esteva Canto 1991;
Fernandez 1979; Hall 1964; Irmisch 1974; Ivanova 1990; Kani
1973; Kasakura 1966; Kunzel 1978; Louw 1995; Morgan 1998;
Morozova 1983; Moungtin 1975; Nenyei 1971; Shimada 1978;
Suntsov 1991; Weisz 1960; Widenheim 1989; Wycoff 1991).
Intervention/comparison
• Other intervention or active agent applied with fluoride
mouthrinse - 16 studies: five studies owing to use of additional
intervention (Gray 1980; Heifetz 1979; Kitsugi 1978; Luoma
1978; Zickert 1982 ) and the other 11 studies owing to other
features that met the exclusion criteria (Axelsson 1976; Badersten
1975; Boyd 1985; Bristow 1975; De Canton 1983; DePaola
1967; Disney 1989; Irmisch 1974; Morgan 1998; Morozova
1983; Rodriguez Miro 1983).
• Fluoride rinse solution swallowed after rinsing - two studies
(Aasenden 1972; Frankl 1972).
Outcome
• Followed up for less than one year - we excluded three
studies on this basis (Birkeland 1973; Boyd 1985; Swerdloff
1969), but only one study solely on this basis (Swerdloff 1969).
We excluded no studies or the reason that the children/adolescent
population enrolled had been medically/dentally compromised.
Risk of bias in included studies
See Figure 2 and Figure 3 for a summary of the risk of bias of the
37 studies included in the review.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies (a plot of the distribution of judgements (low risk of bias, unclear risk of
bias and high risk of bias) across studies for each risk of bias item)
All included studies were published between one and four decades
ago, and ratings considered the overall context of those papers and
correspondencewith study authorswhere available.We considered
none of the included studies to be at low risk of bias overall. We
considered nine studies to be at unclear risk of bias (Ashley 1977;
Blinkhorn 1983; Gallagher 1974; Heidmann 1992;Heifetz 1982;
Petersson 1998; Poulsen 1984; Radike 1973; Rugg-Gunn 1973)
and the remaining 28 studies to be at high risk of bias.
Allocation
None of the studies were at low risk of selection bias overall, that
is, low risk of bias for both sequence generation and allocation
concealment. Most (23 studies) were at unclear risk of bias for
sequence generation and allocation concealment. We rated three
of the studies as having high risk of bias for both sequence gener-
ation and allocation concealment because researchers very likely
used a quasi-randomisation method (Bastos 1989; Moreira 1972;
Moreira 1981).
At least 20 studies had described attempting to do some form of
stratification by sex, age, dental age, caries status, number of ex-
aminers, etc. Five of these (Bastos 1989; Gallagher 1974; Moreira
1972; Moreira 1981; Ruiken 1987) did not use participants as the
unit of randomisation. Ruiken 1987 had stratified schools accord-
ing to their socioeconomic status and used the schools as a unit
of randomisation. Bastos 1989 had divided children “randomly”
between two examiners according to gender and age, and had ar-
ranged them in ascending order in terms of number of permanent
teeth present and caries status (DMFS); investigators then formed
these children into groups of four before assigning rinsing solu-
tions “at random”. Moreira 1972 and Moreira 1981 had used a
similar method, forming “homogeneous” groups of four and as-
signing interventions “randomly”. It seems very likely that inves-
tigators used a quasi-randomised method, and allocation conceal-
ment would not have been effective. Gallagher 1974 divided the
children in each class into two “teams” on the basis of caries status
and dental age, then used a flip of a coin to decide which team
received the intervention.
We considered eight studies to be at low risk of bias related to ran-
dom sequence generation (Ashley 1977; Craig 1981; Heidmann
1992;Heifetz 1982;Molina 1987; Radike 1973; Ringelberg 1979;
Torell 1965), but the adequacy of allocation concealment was un-
clear. In addition to the three studies mentioned above (Bastos
1989; Moreira 1972; Moreira 1981), another four studies were
likely to have used a quasi-randomised method for sequence gen-
eration. Three studies (Koch 1967; Koch 1967a; Koch 1967b) had
separated girls and boys into classes, arranged their names in al-
phabetical order and then assigned them to treatment or control in
alternation (quasi-randomisation). However, because all students
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were involved in the trial and the order of students appearing in
the class register cannot be changed, the risk of bias arising from
lack of concealment is low.Moberg Sköld 2005 had only described
randomising participants and did not provide details, but overall
descriptions in the report suggest that a quasi-randomised method
very likely was used.
Blinding
Performance bias
We considered five studies as having high risk of performance bias,
as a placebo group was not used (Craig 1981;Moberg Sköld 2005;
Moreira 1981; Ruiken 1987; Torell 1965) - the control group
did not use a mouthrinse (no treatment). Risk was unclear in
another six studies (Bastos 1989; Koch 1967; Koch 1967a; Koch
1967b; Moreira 1972; Petersson 1998); we are unclear whether
the “placebo” used was similar enough to maintain blinding. We
considered the rest of the studies as having low risk of performance
bias.
Detection bias
Only studies that indicated that outcomes assessors were blinded
were included in this review. Of all studies included, it was uncer-
tain if attempts to blind the examiners were adequate in eight stud-
ies: Five of these studies used no treatment as the control group
(Craig 1981; Moberg Sköld 2005; Moreira 1981; Ruiken 1987;
Torell 1965) and were at high risk of bias for participant/person-
nel blinding; three studies used a placebo control group (Finn
1975; Laswell 1975; Packer 1975) and indicated only blinding of
outcome assessment (examinations were done independently, or
X-rays were used). All studies described diagnostic methods used
(clinical or radiographic), but not all studies reported thresholds/
definitions used for caries and monitoring of diagnostic errors (see
’Notes’ in theCharacteristics of included studies table for method-
ological features assessed). We rated the remaining 29 studies as
having low risk of bias for outcome assessment.
Incomplete outcome data
The risk of attrition bias was high for most of the included studies
(25 trials). We considered only two out of 37 studies to be at low
risk of attrition bias (Craig 1981; Poulsen 1984). We considered
another 10 studies to be at unclear risk of bias (Ashley 1977;
Blinkhorn 1983; Gallagher 1974; Heidmann 1992;Heifetz 1982;
Koch 1967; Petersson 1998; Radike 1973; Rugg-Gunn 1973;
Torell 1965).
All the participants considered at the end of each study as a pro-
portion of all the participants present at start was 65.3% (13,622
analysed out of 20,854 randomised); this excludes six studies
with no data by group on participants randomised (Ashley 1977;
De Liefde 1989; DePaola 1980; Duany 1981; Petersson 1998;
Spets-Happonen 1991). We could not obtain dropout rates for
five of the 37 included studies (De Liefde 1989; DePaola 1980;
Duany 1981; Petersson 1998; Spets-Happonen 1991). We noted
considerable variation in dropout rates, ranging from 8% at three
years to 62% at 2.5 years. Reasons for exclusions (when given)
included moving away, absence for follow-up examinations and
refusal to participate or poor compliance. A few trials reported
numbers excluded according to reason for attrition.
Selective reporting
Ideally, we would have compared outcomes listed in each study
protocol against outcomes reported in the papers, but this was sel-
dom possible.Most of the studies in this review were published be-
fore the year 2000 and provided very little information. We com-
pared results reported in the studies against what was stated in the
Methods section and used clinical judgement to consider whether
studies had reported data as expected. We considered two studies
to be at high risk of selective reporting bias (Brandt 1972; De
Liefde 1989). Brandt 1972 reported only matched-pair analyses
data (94 pairs; data from more than a quarter of available partic-
ipants not analysed).. In our correspondence, the trial author ex-
plained that this was an attempt to correct the baseline imbalance
observed, but unfortunately, themethod of analysis broke the ran-
domisation, precluding inclusion of data in the meta-analysis. De
Liefde 1989 reported only results of combined non-randomised
and randomised groups (separate results for placebo group not
available, data could not be included for meta-analysis).
Seven other studies (Bastos 1989; DePaola 1977; Koch 1967;
McConchie 1977; Moberg Sköld 2005; Radike 1973; Ringelberg
1979) had unclear risk of bias, most often because of inadequate
reporting/non-reporting of adverse event data.
Other potential sources of bias
Baseline imbalance
We assessed whether imbalance of important prognostic factors
(baseline caries level) was evident between the arms of included
trials. We assessed 30 trials as having low risk of bias for this
domain.
We considered three studies to be at high risk of bias from baseline
imbalance. One trial did not report any baseline data (De Liefde
1989), whereas Brandt 1972 had described baseline imbalance in
caries level. Duany 1981 also observed baseline imbalance in caries
level.
We considered four studies to be at unclear risk of bias. DePaola
1980 described baseline data as “balanced” (for which randomi-
sation may have succeeded to produce nearly exact balance) but
did not report any of the actual values for baseline characteristics
(such as initial caries levels). A few trials reported some degree of
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imbalance (for characteristics considered most influential, usually
initial caries levels) and generally described this as not significant
or indicated that adjustment had resulted in trivial differences in
effect estimates (Koch 1967b; Laswell 1975; Rugg-Gunn 1973).
Contamination/co-intervention
We assessed 10 trials as having low risk of bias owing to freedom
from contamination. These trials provided information suggest-
ing no differences between groups in co-interventions that could
have affected observed outcomes, such as toothbrushing practices,
oral hygiene instructions, dental checkups/preventive treatments
or rinsing procedures. In the other studies, risk of bias was unclear,
as researchers provided no or not enough information.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings - fluoride mouthrinse compared with placebo or no
treatment for preventing caries in children and adolescents
Fluoride mouthrinses versus placebo or no treatment
Effects of fluoride mouthrinses on dental caries increment
The included studies reported the effects of fluoride mouthrinses
on dental caries increment (as measured by the DMF index) in
a variety of ways. Where appropriate and possible, we have com-
bined these to produce pooled estimates. We have reported the
prevented fraction (PF) results separately here for:
• decayed (missing) and filled surface prevented fraction
(D(M)FS PF) (Analysis 1.1; 35 trials); and
• decayed (missing) and filled teeth prevented fraction
(D(M)FT PF) (Analysis 1.2; 13 trials).
We could not present in this review estimates of the effects of flu-
oride mouthrinse on caries increment in deciduous teeth/surfaces
(as measured by the dmf index) as no study contributed data.
Two included studies (Brandt 1972; De Liefde 1989) did not
contribute data suitable for meta-analysis, although we have re-
tained them in the review as part of the qualitative data synthe-
sis (we have described their characteristics in the Characteristics
of included studies table). We have extracted data from the other
trials as appropriate to produce the pooled estimates, as described
in the Methods section.
Imputation of missing standard deviations
Standard deviations (SDs) of mean caries increment data were
missing in 12 of the 35 studies reporting D(M)FS data (Bastos
1989; DePaola 1977; Driscoll 1982; Finn 1975; Gallagher 1974;
Heidmann 1992; Laswell 1975;McConchie 1977; Moreira 1972;
Poulsen 1984; Ruiken 1987; van Wyk 1986). In the original ver-
sion of this review, we estimated unreported SDs from analysis of
the 179 available treatment arms for the series of topical fluoride
reviews with complete information (as of October 1999). This
resulted in a regression equation of log (SD caries increment) =
0.64 + 0.55*log (mean caries increment) (R2 = 77%).We used this
equation to estimate missing SDs frommean D(M)FS increments
for meta-analyses. Similarly, we used this same regression equation
to estimate missing SD data for three of the 13 trials reporting
D(M)FT data (Bastos 1989; Finn 1975; McConchie 1977).
Inflating standard errors for approximate analyses of cluster-
randomised trials
One cluster-randomised trial did not account for clustering of the
data in its reporting of results (Ruiken 1987). As we had already
incorporated this in the original review, accounting for clustering
through the inflated variance approach, we decided that the same
approach would be used and we would conduct sensitivity analy-
sis again to take account of additional uncertainty related to the
cluster-randomised trial. We inflated the variance of the prevented
fraction estimate by an amount equal to (1 + (m-1) * ICC), where
m is the average cluster size and ICC the intraclass correlation co-
efficient. A conservative value of 0.1 was used for the ICC because
we could not find an ICC from this or a similar trial at the time.
Effects on tooth surfaces of permanent dentition: D(M)FS
prevented fraction (PF)
For all 35 trials combined, the D(M)FS PF pooled estimate was
0.27 (95% confidence interval (CI), 0.23 to 0.30; P value <
0.0001), suggesting a large caries-preventive benefit from the use of
fluoride mouthrinse. The CIs are relatively narrow, and although
not substantial, heterogeneity in results could be observed statis-
tically (Chi2 = 58.43 on 34 degrees of freedom, P value = 0.006;
I2 = 42%; Analysis 1.1).
Metaregression and sensitivity analyses: D(M)FS PF
Univariate metaregression suggested no significant association be-
tween estimates of D(M)FS prevented fractions and prespecified
factors: baseline caries severity, background exposure tofluoridated
water, background exposure to fluoride toothpaste, background
exposure to any fluoride source, fluoride concentration and rinsing
frequency. We noted an association of ’total intensity of applica-
tion per year’ (frequency times concentration) with the prevented
fraction, but this became non-significant when we excluded from
the analysis the trial of DePaola 1977, a study with high influence
(an outlier).
Further univariate metaregression analyses on other characteristics
not specified a priori showed no significant association between es-
timates of D(M)FS prevented fractions and type of control group
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(placebo/no treatment), dropout rate or length of follow-up (du-
ration of study in years). We have not investigated other potential
effect modifiers (e.g. mode of mouthrinse use) because virtually
all trials were conducted in school settings under supervision.
We have presented the results of random-effects meta-analyses of
D(M)FS PFs (all trials) in Additional Table 1. We have provided
metaregression results for all potential effectmodifiers investigated
in Additional Table 2. It should be noted that we omitted the
influential study by DePaola 1977 from the analysis intensity of
application with prevented fraction. These metaregression results
must be interpreted with caution given the observational nature
of the comparisons and the large number of comparisons made.
To determine the potential influence of data imputation and ap-
proximation, we undertook a sensitivity analysis, restricting pool-
ing of trials to those that were fully reported and suitable for analy-
sis (23 trials). Results of this gave rise to a very similar D(M)FS PF
value to the one obtained as a result of the full meta-analysis (PF =
0.28, 95%CI 0.24 to 0.31), although a large reduction in the indi-
cator of heterogeneity (I2 = 19%) was evident. We also performed
a sensitivity analysis for the main meta-analysis of D(M)FS pre-
vented fraction to take account of additional uncertainty related
to the cluster-randomised trial by Ruiken 1987 after accounting
for clustering using the inflated variance approach. The D(M)FS
PF pooled estimate was 0.26 (95% CI 0.23 to 0.30; P value <
0.0001). These results are nearly identical to results of the anal-
ysis ignoring the cluster-randomised design because the estimate
for this trial is similar to the meta-analysis result, and altering its
weight has minimal effect.
We also performed sensitivity analyses excluding the three trials at
high risk of bias for allocation concealment (Bastos 1989; Moreira
1972; Moreira 1981) and excluding the eight trials at high or
unclear risk of bias for blinding of outcome assessment (Craig
1981; Finn 1975; Laswell 1975; Moberg Sköld 2005; Moreira
1981; Packer 1975; Ruiken 1987; Torell 1965). For allocation
concealment, results were equal to those of the full meta-analysis
(PF = 0.27, 95% CI 0.23 to 0.30) with some increase in the
indicator of heterogeneity (from 42% to 46%); for blind outcome
assessment, results showed similar PF values (PF = 0.26, 95% CI
0.22 to 0.30) and a somewhat increased indicator of heterogeneity
(from 42% to 48%).
We performed yet another sensitivity analysis by excluding one
trial (Spets-Happonen 1991) in which a non-fluoride active agent
was present in both fluoride and control groups, making the trial
different in this way from all others that had been included. The
D(M)FS PF pooled estimate resulting from exclusion of this trial
was identical to the analysis that includes it (PF = 0.27, 95% CI
0.23 to 0.30). This is a small trial that carries little weight and
had minimal effect in a meta-analysis that includes so many larger
studies.
Funnel plot and test for funnel plot asymmetry: D(M)FS PF
A funnel plot of the 35 included trials reporting D(M)FS PFs does
not look asymmetrical, and the weighted regression test for asym-
metry (Egger 1997) was not statistically significant (asymmetry
intercept: -0.69 (95% CI -1.89 to 0.50; P value = 0.24)). There-
fore, we found no evidence of bias when this method was used.
Effects on whole teeth of permanent dentition: D(M)FT PF
Thirteen trials reported data that allowed calculation of the
D(M)FT PF.We included all 13 studies in the analysis of D(M)FS
PF. Results of this analysis are similar to those reported above (for
D(M)FS PF).
The pooled estimate of D(M)FT PF was 0.23 (95% CI 0.18 to
0.29; P value < 0.0001), suggesting moderate to large benefit of
fluoride mouthrinse within relatively narrow CIs. Heterogeneity
between trials (Chi2 = 26.04 on 12 degrees of freedom, P value =
0.01; I² = 54%) was not substantial, although it was statistically
significant.
We have also presented results of the random-effects meta-analysis
of D(M)FT PFs (all 13 trials) in Additional Table 1.
Effects on primary tooth surfaces/teeth: d(e/m)fs/t PF
None of the included trials reported on caries increment in decid-
uous teeth/tooth surfaces (no data were available).
Effects of fluoride mouthrinse on other outcomes
A few trials report data for other relevant outcomes (see “Outcome
measures” under Description of studies). Some of these are simply
other measures/indices for dental caries increment in permanent
teeth/surfaces and require no further consideration. Three trials
reported on the proportion of children developing new caries. Re-
sults of meta-analyses for the proportion of children developing
new caries are presented below. The few trials that reported on
adverse effects give no useable (incomplete) data for analysis. Four
of the non-placebo controlled trials reported data for unaccept-
ability of treatment (as measured by dropouts in the no-treatment
control trials). We have described below results of meta-analyses
of these data.
Development of new caries: risk ratio
Three trials reported results on the proportion of children devel-
oping one or more new caries (Finn 1975;Heidmann 1992; Torell
1965). The pooled estimate (random-effects meta-analysis) of the
risk ratio was 0.77 (95% CI 0.46 to 1.29), with considerable het-
erogeneity in the results (Chi2= 54.59 on 2 degrees of freedom, P
value < 0.0001; I² = 96%).
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Not remaining caries-free
None of the trials reported data on the proportion of children not
remaining caries-free.
Tooth staining
The only trial reporting average stain scores per individual within
each group did not provide standard deviations (SDs), and data
could not be summarised as average mean differences (MDs) in
treatment effects with their 95% confidence intervals (Ringelberg
1979). Study authors reported a significant difference in stain score
from control (n = 44; mean score = 1.05) in the group using an
amine fluoride mouthrinse (n = 84; mean score = 3.57) and a non-
significant difference from control (n = 52; mean score = 0.31)
in the group using a sodium fluoride mouthrinse (n = 87; mean
score = 0.97), concluding that use of amine fluoride mouthrinse
resulted in the highest stain score.
Reporting on tooth staining was incomplete in two other trials,
where stannous fluoride mouthrinsing was tested against placebo
rinsing: In McConchie 1977, researchers stated that “some stain-
ing was observed in a very small number of children in the trial,
where approximately six children had tenacious staining that re-
quired a rubber cupprophylaxis carried out”, but they did not indi-
cate to which groups these children belonged. In Radike 1973, re-
searchers stated that “most of the participants who exhibited poor
oral hygiene had some amount of yellow pigmentation, somewhat
more noticeable in the children in the test group”.
Mucosal irritation/oral allergic reaction
One trial reported incompletely on oral soft tissue irritation/signs
of sensitivity (allergic reaction) to the rinse (Rugg-Gunn 1973);
these researchers described “no cases of mucosal hypersensitivity
after periodical examinations of every subject”.
Signs of acute toxicity
None of the studies reported adverse acute symptoms (nausea/
vomiting during treatment).
Unacceptability of treatment (dropouts/exclusions)
The pooled estimate of the risk ratio of dropping out from the
mouthrinse arm as opposed to the non-treatment arm in the four
non-placebo-controlled trials that reported dropouts (Craig 1981;
Moberg Sköld 2005; Moreira 1981; Torell 1965) was 1.33 (95%
CI 0.62 to 2.83). Heterogeneity was evident in these results (Chi
2 = 14.15 on 3 degrees of freedom, P value = 0.003; I² = 79%).
D I S C U S S I O N
Summary of main results
We have presented the key findings in Summary of findings for
the main comparison.
The main aim of this review was to estimate the effects on dental
caries of using fluoride mouthrinse compared with placebo or no
treatment in children. More than 15,800 children were included
in the 37 trials comparing a fluoride mouthrinse against a placebo
or no treatment. For almost all children, the fluoride rinse they
received was a sodium fluoride (NaF) formulation, provided in
supervised school-based mouthrinsing programmes, often on a
daily or weekly/fortnightly basis. Fluoride mouthrinsing at these
two rinse frequencies and twomain different strengths (230 ppmF
(fluoride concentration)/900ppmF) has proved a versatilemethod
of self applied topical fluoride use, and an effective method when
used regularly over time under supervision.
An average caries reduction in terms of decayed, missing and filled
tooth surfaces (DMFS) in permanent teeth of about 27% can be
expected from use of this method. The meta-analysis of the 35
studies assessing the effect of fluoride mouthrinse on the perma-
nent dentition suggests that this reduction falls within narrow con-
fidence intervals (23% to 30%).
A secondary aim of this review was to determine whether we could
find any relationship between the caries-preventive effectiveness
of fluoride mouthrinse and a number of factors, including the
initial level of caries severity, background exposure to fluoride and
fluoride concentration and frequency of use. We were unable to
detect a clear relationship between any of these factors and the
magnitude of the treatment effect in the metaregression analysis
performed in spite of substantial variation between trials in these
factors. This result should, however, be interpreted with caution.
Even ameta-analysis including 35 trials has limited power to detect
such relationships and, like all analyses of observational data, is
subject to the problem of potential confounding. In addition,
some factors such as ’background exposure to fluoride’ introduce
the problem of potential misclassification due to the poor quality
of reported data on exposure to fluoride other than in water. We
were forced to make several assumptions, for instance, classifying
’use of fluoride toothpaste’ for 16 of the studies on the basis of
the year when the study was conducted and its location. We were
also forced to treat this as a dichotomous variable (before/after
mid 1970s), although it is likely that use of fluoridated toothpaste
gradually increased during the 1960s, 1970s and 1980s. Similarly,
we grouped exposure tofluoride in toothpaste andfluoride inwater
into a single dichotomous variable, which is likely to group studies
whose participants had quite different levels of baseline exposure to
fluoride sources. These problems may bias any estimates of effect
towards the null hypothesis. Nevertheless, these results suggest
that fluoride mouthrinse may still be of benefit after the advent of
fluoride toothpaste, and in both fluoridated and non-fluoridated
areas.
We did observe a significantly greater treatment effect with
increased total intensity (frequency times concentration) of
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mouthrinse application. Although plausible, this relationship was
dependent on the inclusion of one study with particularly pow-
erful effects (DePaola 1977). After exclusion of this study from
the analysis, we noted no significant association with this factor. It
should be noted that in most studies where mouthrinse was per-
formed once a week (or once every two weeks), a rinse employing
higher fluoride concentrations (usually 900 ppm F) was used (16
trials). Conversely, in most studies where rinsing was performed
once (or twice) a day, a lower fluoride concentration (usually 230
ppm F) was used (13 trials). Moreover, in six multi-arm studies in-
vestigating both combinations of concentrations-frequencies (and
in seven studies testing the two main fluoride concentrations),
we averaged this intensity score over fluoride treatment groups to
combine study results, a decision that may have slightly affected
this particular investigation of heterogeneity (and that of dose re-
sponse). Nevertheless, looking specifically at the effectiveness of
the two most commonly used fluoride mouthrinse regimens in-
dicates that few choices may be available when the weaker (low
concentration) is used as a daily rinse and the stronger (high con-
centration) as a weekly or fortnightly rinse. This does not nec-
essarily imply that when both concentrations are used daily, or
both are used as weekly/fortnightly rinses, they will have a similar
effect. A weaker solution may well yield poorer results when used
less frequently. More robust investigations of these aspects of the
intervention require direct, head-to-head comparisons of different
fluoride concentrations, frequencies and intensities, which were
not within the scope of this review.
Overall completeness and applicability of
evidence
The evidence included in the review pertains to caries in chil-
dren and adolescents, where all studies that met the review’s in-
clusion criteria examined the caries-inhibiting effect of fluoride
mouthrinse used in supervised school-based schemes on perma-
nent teeth, with only two studies also looking at unsupervised
home use of rinse, and none of the studies reporting data on the
primary dentition. We found most of the evidence in the school
setting where children were supervised when rinsing, although the
evidence may be applicable to other settings where children use
mouthrinsing under supervision or not.
Although there is clear evidence that fluoride mouthrinses have
a caries-inhibiting effect, we found little information about the
effects of fluoride mouthrinses on other outcomes such as the pro-
portion of children developing new caries, or on the acceptability
of a fluoride rinsing regimen. We found little useful information
about possible adverse effects of the procedure, such as tooth stain-
ing or oral soft tissue irritation/allergic reactions, and none of the
studies reported on signs of acute toxicity. This scarcity of direct
evidence from clinical trials on relevant outcomes other than den-
tal caries makes it more difficult for clinicians and policymakers to
weigh the benefits of fluoride mouthrinse use in preventing caries
against possible shortcomings of the procedure, whether provided
in community dental health programmes or in the home environ-
ment.
The trials included in this review used a variety of fluoride rinsing
frequencies, agents and concentrations. In studies with more than
one relevant intervention group and a common control group,
such as those comparing different active fluoride agents or concen-
trations of fluoride ions, or rinsing frequencies, against a placebo
group, we combined summary statistics from the studies (num-
ber of children analysed, mean caries increments, standard devi-
ations) from all relevant intervention groups to obtain a measure
of treatment effect. This enabled the inclusion of all relevant data
in the primary meta-analyses assessing the caries-inhibiting effect
of fluoride mouthrinsing on children’s permanent tooth surfaces,
but it has limited a secondary investigation of dose response.
The trials included in this reviewwere conductedwith participants
who were at differing levels of caries risk, as evidenced by the
variability of caries increments in the control groups, and who
were based in different locations with variability in background
exposure to other sources of fluoride.
The caries increment prevented fraction appeared to be consis-
tent across different populations, levels of caries risk and expo-
sure to other fluoride sources. The absolute benefit from fluoride
mouthrinse will, of course, depend on the expected caries incre-
ment in the target population. When the expected caries incre-
ment is small, the absolute benefit of fluoride mouthrinse will
be small. Moreover, the Cochrane review (Marinho 2003b) that
evaluated the effects of all main topical fluoride interventions for
preventing caries in children and adolescents found evidence that
the relative effect of topical fluoride may be greater in those who
have higher baseline levels of caries.
An important issue in this review is whether the body of evidence,
which consists of older studies carried out in the 1960s and 1970s
mainly with participants who were probably not exposed to fluo-
ride toothpaste, is applicable today, when fluoridated toothpastes
are widely available and level of use is generally high. Among the
31 studies conducted in non-fluoridated areas, seven studies re-
ported substantial exposure to fluoride toothpaste (over 95%).
In this update, we included only one new study (Moberg Sköld
2005), which was carried out in Sweden in the early 2000s. The
prevented fractions (PFs) observed in this trial comparing various
rinsing frequencies against a no-treatment control group where
participants would have had lifetime use of fluoride toothpaste
pointed out a large effect, greater than the overall pooled result.
Again, the Cochrane review (Marinho 2003b) summarising all the
evidence on the effects of the main topical fluoride interventions
found no evidence that the effect of topical fluoride was dependent
on background exposure to other fluoride sources.
We have found little information about the adverse effects of fluo-
ride mouthrinse; only one randomised controlled trial (RCT) re-
ported data on tooth staining, concluding that use of amine flu-
oride mouthrinse resulted in a high stain score. Substantial infor-
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mation on a particular type of adverse effect (fluorosis) of topically
applied fluoride treatments (especially toothpaste) can be found in
a Cochrane review on topical fluoride and risk of fluorosis (Wong
2010).
Quality of the evidence
We used the GRADE (Grades of Recommendation, Assessment,
Development and Evaluation Working Group) approach to assess
the quality of evidence for fluoride mouth rinses versus placebo or
no treatment.
In terms of methodological limitations of the studies, we assessed
none of the trials included in this review as having low risk of bias;
most (28) were at high risk of bias. The domain most commonly
found to be at high risk of bias was incomplete outcome data (at-
trition bias), followed by random sequence generation and allo-
cation concealment (selection bias), and blinding of participants
and personnel (performance bias). Moreover, all but one of the
included studies were published before the year 2000, most in the
1970s and 1980s, and most papers provided little information on
topics considered important for assessment of bias. This meant
that many of the trials included in the review were at ’unclear’ risk
of bias. Most studies conducted supervised mouthrinsing in the
school setting - this was considered for indirectness, but down-
grading was considered unnecessary because the evidence may be
applicable to other settings where children use mouthrinsing un-
der supervision or not.
For the primary outcome, we downgraded the quality of evidence
on caries increment on permanent tooth surfaces (DMFS) tomod-
erate quality because of limitations in study design across the 35
trials (15,813 participants) contributing data to this meta-analy-
sis. The size of the treatment effect for the effectiveness outcomes
(caries increment) was clinically important. For the same reason,
the quality of evidence for the caries-preventive effect on perma-
nent teeth (DMFT increment) based on 13 trials (5105 partici-
pants) was alsomoderate; we are moderately confident in the effect
estimate - the true effect is likely to be close to the effect estimate,
but there is a possibility that it could be different.
Only three studies reported on developing one or more new caries
(1805 participants). It is unclear whether the other studies mea-
sured this outcome; therefore, we cannot rule out the possibility of
reporting bias. We also downgraded the quality of evidence owing
to high risk of bias in two of the three studies and owing to highly
inconsistent findings across studies. Therefore quality of evidence
for this outcome is very low. Our confidence in the effect estimate
is very limited, and further research is very likely to have an im-
portant impact and is likely to change this estimate.
The quality of the evidence for dropping out from the mouthrinse
as opposed to dropping out from the control condition (as an
indirect measure of treatment acceptability) was also very low.
The four studies (1700 participants) that contributed data to the
pooled results have serious limitations in their methods; all are at
high risk of bias. We downgraded further for imprecision because
of the small numbers of events andparticipants, which contributed
to the wide confidence intervals. Serious, unresolved heterogeneity
was also observed. Besides, it is unclear how this outcome is linked
to participants’ lack of acceptance of treatment.
The quality of the evidence on another two outcomes - risk of
tooth staining (three trials) and oral mucosal irritation (one trial) -
is very low, owing to very incomplete reporting and concerns about
risk of bias. Too little information was provided for assessment of
whether risk was increased with fluoridated mouthrinses.
Potential biases in the review process
We used a sensitive search strategy to identify trials for inclusion
in this review and placed no restrictions on publication status nor
language. We translated many references to determine whether or
not they included trials eligible for inclusion in this review.
Wemade a thorough attempt to investigate sources of heterogene-
ity in this review, examining factors related to participants and
interventions, as discussed above (Summary of main results), and
studymethodological/design quality.None of the a priori specified
factors discussed above (initial caries levels, background exposure
to fluoride, frequency of use, fluoride concentration) was clearly
related to heterogeneity. When we looked for any relationship be-
tween the caries-preventive effectiveness of fluoride rinse and a few
other factors posed post hoc (length of follow-up, prior prophy-
laxis, dropout rate, type of control group), we found no significant
associations. Even though the type of control group (placebo/no
treatment) might represent a strong indicator of study quality and
source of heterogeneity in the topical fluoride reviews (Marinho
2015), we did not observe a relationship between type of con-
trol group and prevented fraction in this review, possibly because
only five non-placebo-controlled trials were included. Moreover,
it should be pointed out that we observed a generally high attrition
rate across fluoride rinse trials (mean of 32%).Overall only 65%of
all participants at the start remained at the end of the studies, and
results were often based on compliant participants who actually
completed the study. Thus, the issue of longer-term compliance
should not be disregarded when such a procedure is administered.
We performed a sensitivity analysis for the main meta-analysis to
take account of additional uncertainty we may have about the
cluster-randomised trial by Ruiken 1987. This produced results
(pooled DMFS PF) virtually identical to those of the analysis ig-
noring the cluster-randomised design because the estimate for this
trial is similar to that for the meta-analysis result, and altering its
weight has minimal effect. We also performed sensitivity analyses
for the main meta-analysis to take into account the uncertainty
that we had about imputations for missing standard deviations
and for inclusion of trials at high risk of bias for allocation conceal-
ment and for blinding of outcome assessment. These sensitivity
analyses showed results that were very similar, albeit with some
variation in levels of heterogeneity, to those of the full DMFS PF
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meta-analysis. The unchanged sensitivity analysis result obtained
for the key domain of allocation concealment was possibly due
to the fact that this process was generally poorly described in the
included studies.
A degree of funnel plot asymmetry may be suggested by visual
inspection (Figure 4), but the Egger test provided no evidence of
a significant relationship between trial size and effect estimate.
Figure 4. Funnel plot of comparison: 1 Fluoride mouthrinse versus placebo or no treatment, outcome: 1.1
D(M)FS increment (PF) - nearest to 3 years (35 trials)
Agreements and disagreements with other
studies or reviews
The general directionof findings presented is in keepingwith those
of other reviews (e.g. Twetman 2004; Weyant 2013), which also
found evidence for the effectiveness of fluoride mouthrinse.
The estimate of caries reduction in this review remains similar to
that reported in the meta-analysis on the caries-preventive effect
of fluoride mouthrinses in Twetman 2004, which found a pooled
D(M)FS PF estimate of 29% (95% confidence interval (CI) 14%
to 53%) reduction in caries increment for children with no addi-
tional fluoride exposure, although trials including children with
no background fluoride exposure (pooled results combining both
subsets not reported) found a PF of 6% (95%CI 0% to 30%). It is
also similar to that reported in the most recently published meta-
analysis (Weyant 2013), where treatment effects for 900 ppm F
mouthrinse solutions only were presented as pooledD(M)FS stan-
dardised mean differences (SMDs), and a pooled estimate of -0.26
(95% CI -0.40 to -0.13) was obtained (owing to the character of
D(M)FS data, mean caries increments are closely related to their
standard deviations).
Nevertheless, there were substantial differences in selection crite-
ria and methods between these reviews, and consequently in the
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numbers and types of studies included. Of the 21 studies included
in D(M)FS PF meta-analyses in the review by Twetman 2004, we
did not include five in this review. We identified and included 16
additional studies in this review, including one published after the
Twetman 2004 review (Moberg Sköld 2005).
As for the other review (Weyant 2013), of the eight studies
included in its D(M)FS SMD meta-analysis of 900 ppm F
mouthrinses, we included seven in this review; in the trial that
did not meet the inclusion criteria for our review (Chikte 1996),
we found no indication of random or quasi-random allocation,
and blind outcome assessment, also not stated or indicated, was
unlikely. We identified 10 additional studies testing 900 ppm F
mouthrinses for inclusion in this review - all published before the
Weyant 2013 review.
This updated Cochrane review includes one additional RCT
(Moberg Sköld 2005) compared with the previous version (
Marinho 2003). This included trial is not included in the reviews
mentioned above (Twetman 2004; Weyant 2013).
The large body of evidence contained in this updated Cochrane
review provides the best available evidence of the effectiveness
of fluoride mouthrinses compared with placebo or no treatment
(the comparative effectiveness of topical-fluoride interventions is
addressed in another review in this series (Marinho 2004)).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review found that supervised regular use of fluoride
mouthrinse by children and adolescents is associated with a large
reduction in caries increment in permanent teeth (the quality of
evidence is moderate). Compared with control groups, daily and
weekly/fortnightly supervised rinse programmes result on average
in 26% (95% CI 13 % to 40% reduction) fewer decayed, missing
or filled permanent tooth surfaces. Most of the evidence is from
studies that evaluated use of fluoride mouthrinse supervised in a
school setting, but the findings may be applicable to children in
other settings with supervised/unsupervised rinsing, although the
size of the caries preventive effect is less clear.
We found no evidence that this relative effect was dependent on
baseline caries level nor exposure to other fluoride sources, fluoride
concentration and mouthrinsing frequency, although this result
should be interpreted with caution. A higher decayed (missing)
and filled surface (D(M)FS) prevented fraction was shown with
increased intensity of application (frequency times concentration).
This relationship was dependent on the inclusion of one study
with particularly powerful effects.
In line with the findings for permanent tooth surfaces, regular
mouthrinsing with fluoride results on average in 23% (95% CI,
18% to 29%; I² = 54%) fewer decayed,missing or filled permanent
teeth (moderate quality evidence).
Unfortunately, the review does not provide useful information on
the likelihood of significant side effects with the use of fluoride
mouthrinse, and information on acceptability is inconclusive.
The evidence seems applicable to current clinical practice. Al-
though the evidence base for fluoridemouthrinse is derivedmainly
from studies conducted when fluoridated toothpaste was not
widely available in the 1960s and 1970s, the eight trials from the
1980s and 1990s show no evidence of smaller treatment effects.
Implications for research
Wehave identified a large number of trials, but the reporting of the
trials included in this review is relatively poor, with many lacking
important methodological details. This is likely due in part to the
fact that most are relatively old. Many characteristics considered
crucial for excluding bias, such as clearly stated randomisation and
allocation concealment, have beenmore emphasised only in recent
years, after most of the mouthrinse trials were reported. However,
given the clarity of study results, additional randomised compar-
isons of fluoride mouthrinse and placebo alone would be difficult
to justify. Head-to-head comparisons of fluoride rinses and other
preventive strategies, and of different fluoride rinse application
features, may provide more useful information.
It is important that future trials include assessment of other rele-
vant outcomes such as potential adverse effects and those related to
acceptability of treatment. Planning and conducting an economic
analysis alongside the clinical trial could be considered. In addi-
tion, evaluation of possible differences in effect associated with flu-
oride rinse application features, such as frequency/concentration
of application, should be based on trials that directly compare such
features. Future trials should be well-designed RCTs (adequate se-
quence generation and allocation concealment methods, blinding
of participants and outcome assessors) reported according to the
Consolidated Standards of Reporting Trials (CONSORT) state-
ment (www.consort-statement.org). Researchers should use core
outcomes on assessment of caries and the impact of caries, which
may be available through the Core Outcome Measures in Effec-
tiveness Trials (COMET) initiative (www.comet-initiative.org).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ashley 1977
Methods Study design:4-armparallel-groupRCT(only 2 relevant armsused), placebo -controlled
Study duration: 2 years
Participants Participants randomised (numbers for relevant groups NR)
488 children analysed at 2 years (available at final examination)
Average age at start: 12 years
Surfaces affected at start: 9.4 DFS
Exposure to other fluoride: no
Year study began: 1973
Location: UK
Setting of recruitment and treatment: school
Interventions Comparison: FR + ptc vs PL + ptc
FR group: 0.02 % NaF, 100 ppm F
PL group: non-F rinse
School use/supervised, daily (160 rinses/y), 20 mL applied for 1 minute
Before application: Both groups had toothbrushing with non-fluoride toothpaste
Postop instruction: NR
Outcomes 2yNetDFS increment - (E+U)(NCA)cl+(ER)xr
Reported at 2 years’ follow-up
PF-DFS
MD-BL-DFS
MD-DFS
DFS (U)
Declaration of Interest No information provided
Funding Financial support for the study provided by the Warner Lambert Research Institute
Notes Clinical (V) caries assessment by 1 examiner (FOTI used); diagnostic threshold = NCA.
Radiographic assessment (postBW) by 1 examiner; diagnostic threshold = ER. State of
tooth eruptions included = E/U. Intraexaminer reproducibility checks for incremental
caries data (ICC for clinical 0.95, for radiographic 0.8); reversal rate between 12% and
7% of observed DFS increment in study groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a table of random numbers,
subjects were allocated within each school
to one of four study groups”
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Ashley 1977 (Continued)
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The study was organized on a
double-blind basis...”
“The placebo rinse preparation was identi-
cal to the active rinse, except that it did not
contain any fluoride”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The studywas organized on a dou-
ble-blind basis...”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
12% in 2 years (all groups)
Dropout by group: not reported
Reasons for losses: mainly due to moving
from the area
Comment: numbers lost not high, given
length of follow-up; differential loss be-
tween groups not assessable. It is unclear
whether reasons for missing outcome data
are acceptable and balanced. Caries data
used in the analysis pertain to participants
present at baseline and at final exams
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (E+U)(NCA)cl+(ER)xr,
reported at 2 years’ follow-up
PF-DFS
MD-BL-DFS
MD-DFS
DFS (U)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) re-
ported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 9.10 (6.75) FD, 9.79 (7.28) PL
DMFT: 5.71(3.44) FD, 6.06 (3.66) PL
DMFS: 10.47 (7.36) FD, 11.05 (7.98) PL
Age: 12.33 FD, 12.28 PL
Comment: initial caries appears balanced
between groups. Age also balanced
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
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Bastos 1989
Methods Study design: 4-arm parallel-group quasi-RCT (only 3 relevant arms used)**, “placebo”-
controlled
Study duration: 2.5 years
Participants Participants randomised: N = 766
420 children analysed at 2.5 years (after exclusions, available at final examination)
Age range at start: 9 to 12 years (average = 10)
Surfaces affected at start: 10.5 DMFS (from sample randomised)
Exposure to other fluoride: none assumed
Year study began: 1977
Location: Brazil
Setting of recruitment and treatment: school
Interventions Comparison: FR (2 groups) vs PL
FR group 1: 0.2% NaF, 900 ppm F
FR group 2: 0.7% SMFP, 900 ppm F
PL group: non-F rinse (aqueous 0.1% NaCl solution)
School use/supervised, weekly (32 rinses/y), 10 mL applied for 1 minute
Before application: NR
Postop instruction: no rinsing, eating or drinking for 1 hour
Outcomes 2.5yDMFS increment - (CA)(E)
Reported at 1, 1.5 and 2.5 years’ follow-up
DMFT (E/U)
O-DFS
BL-DFS
MD-DFS
DMFS (U)
AntDMFS
PostDMFS
Side effects (incomplete data)
Dropout
Declaration of Interest No information provided
Funding Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA. State of tooth
eruption included = E/U. Consistency of diagnosis assessed by duplicate examinations
annually. Reversals < 5% of DMFS increments in all groups and equally common
**Study group of sodium monofluorophosphate solution containing 4% of ethanol not
considered
Risk of bias
Bias Authors’ judgement Support for judgement
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Bastos 1989 (Continued)
Random sequence generation (selection
bias)
High risk Quotes from translation: “The children
were 9-12 year olds and were divided be-
tween the two examiners in equal numbers
according to gender and age but at random”
“For each examiner, and for each gender,
the children were ordered firstly in ascend-
ing order, according to the number of per-
manent teeth present, and secondly, ac-
cording to the number of DMFS. To each
group formed in this way, by lot, one of the
following rinsing solutions were given...”
“Then every set of four records (children) at
random were distributed into four groups.
In this way, comparability between the ex-
perimental groups was achieved. Then at
random, each group was assigned to one of
the four following rinsing solutions...”
Comment: unclear how this method of
randomisation could affect selection bias.
Method of sequence generation not de-
scribed - possibly a quasi method
Allocation concealment (selection bias) High risk Quotes from translation: “The children
were 9-12 year olds and were divided be-
tween the two examiners in equal numbers
according to gender and age but at random”
“For each examiner, and for each gender,
the children were ordered firstly in ascend-
ing order, according to the number of per-
manent teeth present, and secondly, ac-
cording to the number of DMFS. To each
group formed in this way, by lot, one of the
following rinsing solutions were given...”
“Then every set of four records (children) at
random were distributed into four groups.
In this way, comparability between the ex-
perimental groups was achieved. Then at
random, each group was assigned to one of
the four following rinsing solutions...”
Comment: method of sequence generation
not described - possibly a quasi-method
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes from translation:
“Group D: aqueous solution of sodium
chloride 0.1%(control)”
“Through the school year, themouthrinses,
prepared weekly at the dental school lab-
oratory, were put in plastic bottles, then
accommodated in separate boxes, accord-
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Bastos 1989 (Continued)
ing to the different rinsing solutions, which
were taken to the schools and given to the
classroom teachers who had been trained to
apply/supervise the procedures during the
time of the study. The names of the chil-
dren, who would use the bottles according
to the groups to which they belonged, fea-
tured in the lid of the boxes”
Comment: use of placebo described. Al-
though blinding of participants indicated,
study personnel (teachers carrying out the
procedure in the schools) were not blind to
group assignment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes from translation: “Two dentists not
involved in treatment conducted the ex-
ams”
“The examiners were not aware of the study
groups to which the children belonged” (in
thesis dissertation)
Comment: examiners likely to be unaware
of treatment group assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
45.17% in 2.5 years
Dropout by group: 116/256 FR1, 116/256
FR2, 114/254 PL
Reasons for losses: not reported, but exclu-
sions based on ‘statistical reasons’ (made at
random to keep groups of equal sizes)
Comment: numbers lost unduly high for
length of follow-up, and although no dif-
ferential losses occurred, the reason for
exclusion of data is unacceptable. Caries
data used in analysis pertain to participants
present at final examination (after exclu-
sions were made)
Selective reporting (reporting bias) Unclear risk Outcomes reported
DMFS increment - (CA)(E)
Reported at 1, 1.5 and 2.5 years’ follow-
up
DMFT (E/U)
O-DFS
BL-DFS
MD-DFS
DMFS (U)
AntDMFS
PostDMFS
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Bastos 1989 (Continued)
Side effects (incomplete data). Study re-
ported that “no adverse effects were ob-
served” but did not specify what adverse
effects were assessed or how they were as-
sessed
Comment: trial protocol not available (the-
sis available). All prespecified outcomes (in
Methods) were reported in the prespecified
way, but we noted some discrepancy be-
tween outcomes actually reported and re-
porting in Methods
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 10.43 FR1, 10.51 FR2, 10.54 PL
DMFT: 5.69 FR1, 5.67 FR2, 5.65 PL
Dental age: 19.08 FR1, 19.01 FR2, 19.13
PL
Comment: initial caries appears balanced
between groups. Dental age also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Blinkhorn 1983
Methods Study design: 4-armparallel-groupRCT (only 2 relevant arms used), placebo-controlled
Study duration: 3 years
Participants Participants randomised: N = 414
374 children analysed at 3 years (available at final examination)
Age range at start: 11 to 12 years
Surfaces affected at start: 8.6 DMFS
Exposure to other fluoride: no
Year study began: 1972
Location: UK
Setting of recruitment and treatment: school
Interventions Comparison: FR+ptc vs PL+ptc
FR group: 0.05% NaF, 230 ppm F
PL group: non-F rinse
School use/supervised, daily (160 rinses/y), for half minutes
Before application: toothbrushing with non-fluoride toothpaste in both groups
Postop instruction: NR
Outcomes 3yNetDFS increment - (E+U)(CA)cl+(DR)xr
Reported at 3 years’ follow-up
PF-DFS
MD-BL-DFS
MD-DFS
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Blinkhorn 1983 (Continued)
PostMD-DFS
DMFT (E/U)
Anterior DMFT
Posterior DMFT
DFS (U)
Dropout
Declaration of Interest No information provided
Funding This study was supported by a grant from Colgate-Palmolive
Notes Clinical (V) caries assessment by 1 examiner, diagnostic threshold = CA. Radiographic
assessment (1 postBW) by 1 examiner; diagnostic threshold = DR. State of tooth erup-
tion included = E/U. Intraexaminer reproducibility checks for incremental clinical and
radiographic caries data in 10% sample (ICC score 0.9)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The children were allocated to
four groups by stratified random sampling
at two levels: school and dental age...”
Quote from correspondence: “The alloca-
tion to groups was random...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk Quote from correspondence: “The alloca-
tion to groups was random with complete
concealment of treatment allocation”
Comment: not enough information pro-
vided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The trial was organised on a dou-
ble-blind basis, neither the children nor the
examiner being aware of who was receiving
test or control products”
“Control subjects used the equivalent den-
tifrice and rinse without fluoride”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The trial was organised on a dou-
ble-blind basis, neither the children nor the
examiner being aware of who was receiving
test or control products”
Comment: blind outcome assessment and
use of placebo described
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Blinkhorn 1983 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up: 9.
66% in 3 years
Dropout by group: 19/209 FR, 21/205 PL
Reasons for losses: left school (57), with-
drawn by parents (12), absent at final exam
(6) (for all 4 groups combined)
Comment: numbers lost not high for
length of follow-up, with no differential
losses between groups. It is unclear whether
reasons for losses are balanced between
groups Caries data used in the analysis per-
tain to participants present at final exami-
nation
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (E+U)(CA)cl+(DR)xr,
reported at 3 years’ follow-up
PF-DFS
MD-BL-DFS
MD-DFS
PostMD-DFS
DMFT (E/U)
Anterior DMFT
Posterior DMFT
DFS (U)
Comment: trial protocol not available. All
pre-specified outcomes (in Methods) were
reported in the pre-specified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 8.71(6.42) FR, 8.48(6.29) PL
DMFT: 5.30(3.58) FR, 5.26(3.47) PL
SAR: 93.00(19.75) FR, 93.61(20.43) PL
Comment: initial caries appears balanced
between groups (although DFS baseline
data NR). SAR also seems balanced
Free of contamination/co-intervention? Unclear risk No information provided
Brandt 1972
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 2 years
Participants Participants randomised: N = 314
246 children analysed at 2 years (after exclusions based on compliance, present at all
examinations)
Average age at start: 11.5 years
46Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Brandt 1972 (Continued)
Surfaces affected at start: 7.9 DMFS (for sample present at all examinations)
Exposure to other fluoride: none assumed
Year study began: 1969
Location: UK
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group: 0.2% NaF (900 ppm F)
PL group: non-F rinse
School use/supervised, twice a week (60 rinses/y), 10 mL applied for 1 minute
Prior to application: NR
Postop instruction: NR
Outcomes 2yDFS scores - (E+U)
Reported at 2 years’ follow-up
DMFS*
DMFT*
PostMD-DMFS
CFS
CFT
Dropout
*Reported match-pair rather than randomised results - could not be included in meta-
analysis. See ROB section
Declaration of Interest No information provided
Funding The study authors thank the pharmacy department of The London Hospital
Notes Clinical caries assessment, diagnostic thresholdNR. Radiographic assessment; diagnostic
threshold = NR. State of tooth eruption included = E/U. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...allocation to either study or con-
trol groups was done on a school house
basis, allocation to a house being done by
school administrative staff randomly”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The subjects rinsed with...NaF
for one minute or similarly with...NaCl if
they were in the control group”
“The solutions were coloured ...and la-
belled as solution A and solution B...and
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Brandt 1972 (Continued)
the formula for each was unknown to the
authors until the trial was completed”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The study was conducted as a 2
year CCT on a double-blind basis”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
21.66% in 2 years
Dropout by group: 28/153 (18.3%) FR,
40/161 (24.8%) PL
Reasons for losses: exclusions based on
compliance
Reasons for attrition described with num-
bers by group: change of residence (18, 12)
, absent at final examination (5, 7); plus ex-
clusions based on compliance, presence in
all examinations and for statistical analysis;
no differential group losses
Comment: numbers lost not unduly high
for length of follow-up, with no differential
losses between groups. Reasons for dropout
may not be acceptable or balanced between
groups. Caries data used in analysis pertain
to participants present at all examinations
Selective reporting (reporting bias) High risk Outcomes reported
DFS scores* - (E+U), reported at 2 years’
follow-up
DMFS*
DMFT*
PostMD-DMFS
CFS
CFT
Comment: trial protocol not available
*Only results of matched-pair analyses (94
pairs, rather than all participants) were re-
ported - study author explained that this
was due to baseline imbalance. No longer
RCT data; could not be included in meta-
analysis
Baseline characteristics balanced? High risk Prognostic factors reported
DMFS: 7.10 FR, 8.65 PL
Age: 11.5 FR, 11.5 PL
Comment: initial caries with some imbal-
ance between groups
48Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Brandt 1972 (Continued)
Free of contamination/co-intervention? Unclear risk No information provided
Craig 1981
Methods Study design: 3-arm parallel-group RCT (only 2 relevant arms used), non-placebo-
controlled
Study duration: 2 school years (21 months)
Participants Participants randomised: N = 109
97 children analysed at 2 years (available at final examination)
Age range at start: 11 to 12 years
Surfaces affected at start: 10.6 DFS
Exposure to other fluoride: toothpaste
Year study began: 1977
Location: New Zealand
Setting of recruitment and treatment: school
Interventions FR+ptc vs NT+ptc
FR group: 0.2% NaF (900 ppm F)
NT group: no intervention
School use/supervised, fortnightly (17 rinses/y), 10 mL applied for 2 minutes
Before application: prior professional prophylaxes with non-fluoride toothpaste in both
groups (+oral hygiene instructions)
Postop instruction: NR
Outcomes 2yDFS increment - (CA)
Reported at 1 and 2 years’ follow-up
O-DFS
MD-DFS
BL-DFS
Dropout
Declaration of Interest No information provided
Funding The study authors thank the Director General of Health (NZ) for approval to publish
the study report
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA. State of
tooth eruption included NR. Reproducibility checks for incremental clinical caries data
in 15% sample at each examination (reversal rate < 4% for both examiners)
Risk of bias
Bias Authors’ judgement Support for judgement
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Craig 1981 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “The children were then stratified
according to sex, age and caries experience
and allocated randomly to three groups”
Quote from correspondence: “We are sure
that a random number system was used to
allocate the children into groups after strat-
ification...”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quotes: “one test group received profes-
sional prophylaxes and the other grouppro-
phylaxes + fluoride rinses”
“...one of the examiners, ignorant of the
group to which the child belonged”
Comment: no placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “...one of the examiners, ignorant
of the group to which the child belonged”
Comment: blind outcome assessment re-
ported but no placebo described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Overall dropout for length of follow-up:
11.0% in 2 years
Dropout by group: 6/54 FR, 7/55 NT
Reasons for losses: leaving school (12 chil-
dren)
Comment: numbers lost not high, given
length of follow-up. No differential losses
between groups. Reason for losses accept-
able and balanced between groups Caries
data used in the analysis pertain to partici-
pants available at final examination
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (CA), reported at 1 and
2 years’ follow-up
O-DFS
MD-DFS
BL-DFS
Dropout
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 10.65(6.4) FR, 10.5(6.4) NT
Dental age: 21.2(5.7) FR, 21.4(5.0) NT
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Craig 1981 (Continued)
Comment: initial caries appears balanced
between groups. Dental age also balanced
Free of contamination/co-intervention? Unclear risk No information provided
De Liefde 1989
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 3 years
Participants Participants randomised: numbers NR
262 children analysed after 3 years (available at final examination)
Age range at start: 7 to 10 years (average = 8)
Surfaces affected at start: NR
Exposure to other fluoride: toothpaste assumed
Year study began: 1984
Location: New Zealand
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group: 0.2% NaF (900 ppm F)
PL group: non-F rinse
School use/supervised, fortnightly (17 rinses/y)
Before application: NR
Postop instruction: NR
Outcomes 2yDMFS final scores* - (CA)
Reported at 3 years’ follow-up
DMFT
*Only results of combined non-randomised and randomised groups reported (separate
results for placebo group not available, data could not be included in meta-analysis)
Declaration of Interest No information provided
Funding The study authors thank the permission of the Director General of Health (NZ) for
approval to publish the paper
Notes Clinical (VT) caries assessment by 1 examiner; diagnostic threshold = CA; state of tooth
eruption included NR; diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The high caries-risk children were
randomly divided into two groups...”
Comment: not enough information
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De Liefde 1989 (Continued)
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “...the other used a placebo rinse..
.”
“Mouth rinsing was conducted double-
blind, with the supervisor, the dental nurses
and the children being unaware of the com-
position of the mouth rinsing solution”
“...after examination and tentative treat-
ment planning by the dental nurses”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: as above
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
not reported
Dropout by group: not assessable
Reasons for losses: not reported
Reasons for attrition NR: any differential
group losses not assessable
Selective reporting (reporting bias) High risk Outcomes reported
DMFS (final) - (CA), reported at 3 years’
follow-up
DMFT
Comment: only results of combined non-
randomised and randomised groups re-
ported (separate results for placebo group
not available, data could not be included
for mea-analysis)
Baseline characteristics balanced? High risk Prognostic factors reported
No baseline characteristics/values reported
Free of contamination/co-intervention? Unclear risk No information provided
DePaola 1977
Methods Study design: 3-arm parallel group RCT, placebo-controlled
Study duration: 2 years
Participants Participants randomised: N = 614) (numbers randomised to each group NR)
475 children analysed at 2 years (available at final examination,whoparticipated through-
out)
Age range at start: 10 to 12 years (average = 11.7)
Surfaces affected at start: 6.1 DFS
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DePaola 1977 (Continued)
Exposure to other fluoride: some assumed***
Year study began: assumed in/before 1974
Location: USA
Setting of recruitment and treatment: schools in a non-fluoridated community
***History of prior exposure to systemic F was reported by nearly half of panel
Interventions Comparison: FR (2 groups) vs PL
FR group 1 (n = 159): 0.2% NH4F group = 1000 ppm F
FR group 2 (n = 158): 0.22% NaF group = 1000 ppm F
PL group (n = 158): distilled water, coloured and flavoured to simulate active agents
School use/supervised, daily (140 rinses/y), 5 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 2yNetDFS increment - (CA)cl+(ER)xr
Reported at 2 years’ follow-up
DFS (U)
Side effects (incomplete data)
Declaration of Interest No information provided
Funding Supported by NIDR Contract Number NIH 71-2379
Notes Clinical (VT) caries assessment, diagnostic threshold = CA; state of tooth eruption in-
cluded NR. Radiographic assessment (4 postBW); diagnostic threshold = ER; diagnostic
errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “After being randomly assigned to
one of three treatment groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “A double-blind clinical trial was
conducted...”
“The placebo agent consistent of distilled
water colored and flavored to simulate the
active agents”
Comment: described as double-blinded.
No descriptions on how personnel were
blinded, but this was probably carried out.
Use of placebo described
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DePaola 1977 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “A double-blind clinical trial was
conducted...”
“Subjects were examined clinically and by
radiography after 12 and 24 months with-
out reference to previous findings”
Comment: described as double-blinded
but method of blinding of outcome asses-
sor not reported. Probably low risk because
bitewing radiographs were used
Blind outcome assessment and use of
placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
22.64% in 2 years
Dropout by group: not assessable
Reasons for losses: “factors unrelated to the
study”
Comment: numbers lost not unduly high
for length of follow-up. Differential losses
not assessable. It is unclear whether reasons
for missing outcome data are acceptable
and balanced. Caries data used in the analy-
sis pertain to participants present through-
out the trial
Selective reporting (reporting bias) Unclear risk Outcomes reported
DFS increment - (CA) cl+xr, reported at
2 years’ follow-up
DFS (U)
Side effects (incomplete data): Study re-
ported that “no adverse effects were ob-
served” but did not specify what adverse
effects were assessed or how these were as-
sessed
Comment: trial protocol not available. Pre-
specified outcomes (in Methods) were re-
ported. However side effects data were in-
complete
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 6.26(5.09) FR1, 5.46(4.54) FR2, 6.
47(5.50) PL
No prior exposure to systemic fluoride: 85/
159 (53.5%)FR1, 92/158 (58.2%)81/158
(51.3%) PL
Comment: initial caries appears balanced
between groups
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DePaola 1977 (Continued)
Free of contamination/co-intervention? Unclear risk No information provided
DePaola 1980
Methods Study design: 4-armparallel-groupRCT (only 2 relevant arms used), placebo-controlled
Study duration: 2 years
Participants Participants randomised: numbers NR nor obtainable
271 children analysed at 2 years (after exclusions, present for both examinations)
Age range at start: 12 to 14 years (average = 13)
Surfaces affected at start: NR
Exposure to other fluoride: toothpaste assumed
Year study began: assumed in/before 1977
Location: USA
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group:NaF 0.05% (230 ppm F)
PL group: non-F rinse (disguised and colour coded)
School use/supervised, daily (140 rinses/y), 10 mL applied for 1 minute
Before application: no tooth cleaning performed
Postop instruction: NR
Outcomes 2yNetDFS increment - (CA)cl+xr
Reported at 1 and 2 years’ follow-up (and 1 year post treatment)
Declaration of Interest No information provided
Funding The study was supported by National Institute of Dental Research, Contract No. NOI-
DE42445
Notes Clinical (VT) caries assessment by 2 examiners; diagnostic threshold = CA; state of tooth
eruption included NR. Radiographic assessment (2 postBW) by 2 examiners; diagnostic
threshold NR; diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Subjects were randomly assigned
to 1 examiner and 1 of 4 treatment groups
at the time of the clinical examination”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
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DePaola 1980 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “A strict double-blind routine was
maintained throughout the course of the
investigation”
“The placebo and active rinses were dis-
guised and colour coding...”
“Supervisors had typed lists indicating the
agent code for each subject”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “A strict double-blind routine was
maintained throughout the course of the
investigation”
“Subjects always seen by the same examiner
and examined without reference to previ-
ous findings”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
not reported
Dropout by group: not reported
Reasons for losses: exclusions based on
compliance and presence at all exams
Comment: Reasons for missing outcome
data may be unacceptable, and It is unclear
whether these are balanced between groups
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (CA) cl+xr, reported at
1 and 2 years’ follow-up (and at 1 year
post treatment)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Unclear risk Prognostic factors: DFS, dental age and
age reported as “balanced” (values not re-
ported)
Free of contamination/co-intervention? Unclear risk No information provided
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Driscoll 1982
Methods Study design: 4-armparallel-groupRCT (only 3 relevant arms used), placebo-controlled
Study duration: 2.5 years
Participants Participants randomised: N = 966
524 children analysed at 2.5 years (present for entire trial period)
Average age at start: 12.8 years
Surfaces affected at start: 4.8 DMFS
Exposure to other fluoride: water (and toothpaste assumed)
Year study began: 1977
Location: USA
Setting of recruitment and treatment: school
Interventions Comparison: FR (2 groups) vs PL
NaF group 1: 230 ppm F, daily (160 rinses/y)
NaF group 2: 900 ppm F, weekly (30 rinses/y)
PL group: non-F rinse (0.1 NaCl)
School use/supervised, 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 2.5yNetDMFS increment
Reported at 1.5 and 2.5 years’ follow-up
O-DMFS
MD-DMFS
BL-DMFS
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners; diagnostic threshold NR. State of tooth
eruption included NR; differences between examiner assessments NS (but reproducibil-
ity assessment NR). Results presented separately by examiner (combined results consid-
ered)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The children were assigned ran-
domly, within each school, to one of three
groups”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
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Driscoll 1982 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “A control group of children fol-
lowed the procedure once a week using a
placebo mouthrinse”
“Those in group C (controls) rinsed their
mouths once every week in school with 10
ml of a placebo solution containing 0.1per-
cent sodium chloride”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The examiners were unaware of
any child’s group assignment, and did not
have access to records from the baseline ex-
amination”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
45.75% in 2.5 years
Dropout by group: 176/384 FR1, 133/298
FR2, 133/284 ‘PL’
Reasons for losses: moving out of the area/
school, voluntary withdrawal at request of
child or parent
Comment: Numbers lost were high, al-
though no differential loss occurred be-
tween groups. It is unclear whether 1 of
the reasons for missing outcome data (vol-
untary withdrawal) is acceptable and bal-
anced. Caries data used in the analysis per-
tain to participants present throughout the
trial
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment reported at 1.5 and 2.
5 years’ follow-up
O-DMFS
MD-DMFS
BL-DMFS
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 4.62 FR1, 4.76 FR2, 4.93 PL
Comment: initial caries apparently bal-
anced between groups
Free of contamination/co-intervention? Unclear risk No information provided
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Duany 1981
Methods Study design: 4-arm parallel-group RCT, placebo-controlled
Study duration: 3 years
Participants Participants randomised: numbers NR nor obtainable
936 children analysed at 3 years
Age range at start: not obtainable
Exposure to other fluoride: not obtainable
Surfaces affected at start: 7 DMFS
Year study began: assumed in/before 1977
Location: Puerto Rico
Setting of recruitment and treatment: school
Interventions FR (3 groups) vs PL
(NaF groups = 100 ppm F, 225 ppm F, 450 ppm F)
FR group 1: 0.02% NaF = 100 ppm F
FR group 2: 0.05% NaF = 225 ppm F
FR group 3: 0.10% NaF = 450 ppm F
PL group: non-F rinse
Before application: NR
Postop instruction: NR
Outcomes 3yDMFS increment
Declaration of Interest No information provided
Funding No information provided
Notes Other data NR nor obtainable
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The children were randomly as-
signed to one of four mouth rinse groups..
.”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “...one of four mouthrinse groups
(control, and three concentrations of
sodium fluoride) and were followed dou-
ble-blinded for three years...”
Comment: Study described use of a control
mouthrinse, the control is a mouthrinse
group that did not rinse with F and it is a
DB study
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Duany 1981 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “...one of four mouthrinse groups
(control, and three concentrations of
sodium fluoride) and were followed dou-
ble-blinded for three years...”
Comment: blind outcome assessment re-
ported, although unclear what procedures
were used, but use of placebo reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
not obtainable
Dropout by group: not obtainable
Reasons for losses: not obtainable
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? High risk Prognostic factors reported
DMFS: 7.39(8.52) FR1, 6.28(7.77) FR2,
6.79(7.07) FR3, 7.50(8.23) PL
Comment: initial caries appears not bal-
anced between groups
Free of contamination/co-intervention? Unclear risk No information provided
Finn 1975
Methods Study design: 3-arm parallel-group RCT, placebo-controlled
Study duration: 2 years
Participants Participants randomised: N = 820; numbers by group NR
453 children analysed at 2 years (present in all examinations)
Age range at start: 8 to 13 years (average = 11.7)
Surfaces affected at start: 6 DMFS
Exposure to other fluoride: no
Year study began: assumed in/before 1972
Location: USA
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
FR group 1: 0.02% neutral NaF solution (100 ppm F)
FR group 2: 0.04% neutral NaF solution (200 ppm F)
PL group: non-F rinse
School use/supervised, twice a day (330 rinses/y), 20 mL applied in 2 successive rinses
of 30 seconds each
Before application: NR
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Finn 1975 (Continued)
Postop instruction: NR
Outcomes 2yNetDFS increment - cl+xr
Reported at 2 years’ follow-up
DMFS
DMFT
Proportion of children with new DFS
Declaration of Interest No information provided
Funding The study was supported by a grant from the Warner-Lambert Company
Notes Clinical (VT) caries assessment by 1 examiner, diagnostic threshold NR. Radiographic
assessment (2-4 postBW+ 4 anterior) by 1 examiner; diagnostic threshold NR. State of
tooth eruption included NR. Diagnostic errors NR. Reversals ranged between 6% and
16% of observed DMFS increment in study groups for combined clinical and x-ray
findings, with rates higher in the test groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “On the basis of age and sex within
individual classrooms in each of the three
schools, the children were randomly as-
signed to one of three treatment regimen
groups”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “Children in regimen group 3 used
the placebomouthwash which was fluoride
free...”
“...the children entered the room, an-
nounced their name and colour code,
picked a colour-coded cup containing the
assigned mouthwash...”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quotes: “Children in regimen group 3 used
the placebomouthwash which was fluoride
free...”
“...the children entered the room, an-
nounced their name and colour code,
picked a colour-coded cup containing the
assigned mouthwash...”
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Finn 1975 (Continued)
“Radiographic findings were added later to
the clinical findings”
Comment: use of placebo described, but it
is unclear whether examiner was blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
44.76% in 2 years
Dropout by group: not assessable
Reasons for dropout: children transferred
to other schools, exclusion based on pres-
ence at all exams
Comment: numbers lost unduly high for
length of follow-up. Differential losses not
assessable. It is unclear whether reasons for
missing outcome data are acceptable and
balanced. Caries data used in the analysis
pertain to participants present at all exam-
inations
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - cl+xr, reported at 2
years’ follow-up
DMFS
DMFT
Proportion of children with new DFS
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFT: 3.67(2.81) FR1, 3.87(3.48) FR2,
3.60(2.90) PL
DMFS: 5.82(5.18) FR1, 6.17(6.67) FR2,
6.02(6.21) PL
Age: 11.8 FR1, 11.4 FR2, 11.8 PL
Gender: 75M, 75F (FR1), 70M, 72F (FR2)
, 71M, 89F (PL)
Comment: initial caries appears balanced
(although DFS baseline data NR). Other
characteristics also balanced
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste and appropriate
mouthrinse provided to all for home use
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Gallagher 1974
Methods Study design: 2-arm parallel group (quasi) RCT, “placebo” -controlled
Study duration: 3 years
Participants Participants randomised: N = 809
594 children analysed at 2 years (available at final examination)
Age range at start: 11 to 13 years
Surfaces affected at start: 7.3 DMFS (from sample randomised)
Exposure to other fluoride: none assumed
Year study began: 1970
Location: Canada
Dental treatment level (F/DMF): 42%
Setting of recruitment and treatment: school
Interventions FR vs PL
FR group:NaF = 1800 ppm F. 0.4% neutral NaF
PL group: sodium bicarbonate solution*
School use/supervised, weekly (30 rinses/y), applied for 1minute. Rinsingwas performed
once a week in the morning
Before application: NR
Postop instruction: Children were instructed not to swallow the solution and not to
eat or drink for 30 minutes after rinsing
*Test and control solutions look and taste similar
Outcomes 2yDMFS increment - (E+U)
Reported at 2 years’ follow-up
DMFT
DT
DF
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 1 examiner, diagnostic threshold NR. State of tooth
eruption included = E/U. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quotes: “...all children in the same class-
rooms were divided into two teams. The
criteria used for the division were DMFT
andDMFS, dental age and score for OHI”
“A flip of a coin decided which team would
be experimental and which team would be
controls”
Comment: unclear how method of ran-
63Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gallagher 1974 (Continued)
domisation used affected selection bias.
Coin flipping acceptable method of se-
quence generations but unclear how teams
were formed
Allocation concealment (selection bias) Unclear risk Quote: “A flip of a coin decidedwhich team
would be experimental andwhich teamwill
be controls”
Comment: Allocation was done after teams
were formed
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The solutions were mixed by the
dental staff. The solution used was 0.4%
neutral sodium fluoride, with 0.18 % fluo-
ride ion. The placebo consist of a solution
of sodiumbicarbonate. Both solutionswere
colourless and almost tasteless. Students act
as the monitors who dispense the solution,
collected the used cups, kept the time and
reminded each other about brushing”
Mouth rinsing was conducted in “teams”
Comment: blinding likely maintained be-
cause both types of solutions look and taste
similar
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “In asmuch as a double-blind study
was being accomplished, neither students
nor examiner knewwhether a student was a
member of the controls or the experimental
group”
Comment: likely to be at low risk for out-
come assessment blinding if blinding was
maintained for participants
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
26.58% in 2 years
Dropout by group: 108/414 FR, 107/395
PL
Reasons for losses: exclusion of persistent
swallowers, absence from school
Comment: numbers lost not unduly high,
given length of follow-up, with no differ-
ential losses between groups. It is unclear
whether reasons for missing outcome data
are acceptable and balanced. Caries data
used in the analysis pertain to participants
present at final exam
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Gallagher 1974 (Continued)
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (E+U), reported at 2
years’ follow-up
DMFT
DT
DF
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 7.19 FR, 7.37 PL
DMFT: 4.50 FR, 4.59 PL
DT: 2.36 FR, 2.49 PL
FT: 1.90 FR, 1.85 PL
Dental age: 18.53 FR, 18.64 PL
OHI: 1.44 FR, 1.47 PL
Comment: initial caries appears balanced
between groups. Other characteristics also
balanced
Free of contamination/co-intervention? Unclear risk No information provided
Heidmann 1992
Methods Study design: 2-arm parallel group RCT, placebo-controlled
Study duration: 3 years
Participants Number randomised: 1306 (numbers randomised to each group NR)
Number analysed: 1083 children at 3 years (present at final examination)
Age range at start: 6 to 12 years (average = 9)
Surfaces affected at start: 1.4 DMFS
Exposure to other fluoride: yes (toothpaste, “almost all sold toothpaste contains fluo-
ride”)**
Year study began: 1983
Location: Denmark
Setting of recruitment and treatment: school
**Both groups had been using FR before the study started
Interventions Comparison: FR vs PL
FR group (n = 538): 0.2% NaF (900 ppm F) - peppermint flavoured
PL group (n = 545): distilled water - peppermint flavoured
School use/supervised, fortnightly (17 rinses/y)
Before application: NR
Postop instruction: NR
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Heidmann 1992 (Continued)
Outcomes 3yCrude postDMFS increment - (CA)(E+U)cl
DMFS (U)
O-DMFS
MD-DMFS
BL-DMFS
CIR - xr
Proportion of children with new postMDDMFS
Declaration of Interest No information provided
Funding Danish Dental Association
Notes Clinical (VT) caries assessment by dentists at public dental service, diagnostic threshold
= CA. Radiographic assessment (2 postBW) by 1 examiner; diagnostic threshold = ER.
State of tooth eruption included=E/U.Reproducibility of diagnosis assessed by duplicate
radiographic examination of 10% random sample (kappa value 0.72)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...children from kindergarten
through 6th grade were stratified by school
and grade and randomly distributed into
two groups”
Quote from correspondence: “The ran-
domization was done using a table of ran-
dom numbers”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “...the children were allocated to
two groups: a fluoride group...and a water
(placebo) group”
“ both solutions were slightly flavoured
with peppermint. The solutions were cen-
trally prepared and distributed to the
schools in individual plastic cup labelled
with the child’s name and school class”
Comment: use of placebo described. Both
participants and personnel should be effec-
tively blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “two bitewings radiographs taken
using a standardised method”
“The examiner was unaware of the the
group to which the individual radiograph
belonged”
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Heidmann 1992 (Continued)
Comment: objective method used, blind-
ing stated. Blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
17.08% (223/1306) in 3 years
Dropout by group: not reported
Reasons for losses: not reported
Comment: numbers lost not high for
length of follow-up; differential losses be-
tween groups not assessable (study au-
thors were unable to provide the num-
bers randomised to each group (personal
correspondence)), but numbers analysed
seem balanced across groups. It is un-
clear whether reasons for missing outcome
data are acceptable and balanced. Caries
data used in analysis pertain to participants
present at final examination
Selective reporting (reporting bias) Low risk Outcomes reported: postDMFS (CA)
(E+U)cl, reported at 3 years’ follow-up
DMFS (U)
O-DMFS
MD-DMFS
BL-DMFS
CIR-xr
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 1.43 FR, 1.46 PL
SAR: 27.7 FR, 28.6 PL
Comment: initial caries appears balanced
between groups. SAR also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Heifetz 1973
Methods Study design: 3-arm parallel-group RCT; placebo-controlled
Study duration: 2 years
Participants Participants randomised: N = 947; numbers randomised to each group NR
413 children analysed at 2 years (after exclusions, present in all examinations)
Age range at start: 10 to 12 years
Surfaces affected at start: 10.8 DMFS
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Heifetz 1973 (Continued)
Exposure to other fluoride: none assumed
Year study began: 1969
Location: USA
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
FR group 1: APF 0.66% = 3000 ppm F
FR group 2: NaF 0.66% = 3000 ppm F
PL group: non-F rinse
School use/supervised, weekly (25 rinses/y), 8 mL applied twice (16 mL) for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 2yNetDMFS increment - (E+U) cl+(ER)xr
Reported at 1 and 2 years’ follow-up
Declaration of Interest No information provided
Funding All mouthwash solutions used in the study were commercially prepared by the Lorvic
Corp
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. Radiographic
assessment (5postBW)by 2 examiners; diagnostic threshold =ER. State of tooth eruption
included -E/U. Diagnostic errors NR (but examiners calibrated regularly). Reversals
rangedbetween5%and10%of observedDMFS increment in study groups for combined
clin+xr findings, with rates higher in the test groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The baseline records of the chil-
dren were stratified according to sex, dental
age... Within each stratum, each child was
assigned randomly to one of three study
groups”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “Group A rinsed their mouths in
school once aweekwith a placebo solution”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “The examiner did not know the
group to which any child was assigned”
“Group A rinsed their mouths in school
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Heifetz 1973 (Continued)
once a week with a placebo solution”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
56.39% in 2 years
Dropout by group: not reported
Reasons for losses: high transience of the
population, dissatisfaction with taste of the
rinses. Exclusion due to poor compliance
and lack of data for all examinations
Comment: numbers lost unduly high,
given length of follow-up. Differential
losses not assessable. Reasons for missing
outcome data (poor compliance) may be
unacceptable, and it is unclearwhether they
are balanced between groups. Caries data
used in the analysis pertain to participants
present at baseline and final exams
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment (E+U) cl+(ER) xr, re-
ported at 1 and 2 years’ follow-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 10.16(9.77) FR1, 11.38(10.60)
FR2, 10.81(8.69) PL
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
Heifetz 1982
Methods Study design: 3-arm parallel-group RCT, placebo -controlled
Study duration: 3 years
Participants Participants randomised: N = 912; numbers by group NR
598 children analysed at 3 years (present for entire trial period)
Age range at start: 10 to 12 years
Surfaces affected at start: 6.2 DMFS
Exposure to other fluoride: toothpaste
Year study began: 1976
Location: USA
Setting of recruitment and treatment: school
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Heifetz 1982 (Continued)
Interventions FR (2 groups) vs PL
FR group 1: 0.05% NaF 230 ppm F, daily (150 rinses/y)
FR group 2: 0.2% NaF 900 ppm F, weekly (30 rinses/y)
PL group: non-F rinse
School use/supervised, 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 3yNetDMFS increment - (CA)(E)clin
Reported at 1, 2 and 3 years’ follow-up
O-DMFS
MD-DMFS
BL-DMFS
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners; diagnostic threshold = CA (FOTI as-
sessment - loss of translucency on transillumination - for approximal surfaces). State of
tooth eruptions included = E; differences between examiner assessments NS (but repro-
ducibility assessment NR). Results presented separately by examiner(combined results
considered)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote from correspondence: “Using a
computer generated table of random num-
bers, the 912 subjects...were randomly as-
signed...”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “Group C (controls) rinsed once a
week with a placebo solution”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “The examiners were unaware of
any child’s group assignment, and did not
have access to records from the previous
examinations”
“Group C (controls) rinsed once a week
with a placebo solution”
Comment: blind outcome assessment and
use of placebo described
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Heifetz 1982 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
34.43% in 3 years
Dropout by group: not assessable
Reasons for losses: not assessable
Comment: numbers lost unduly high,
given length of follow-up. Differential
losses between groups not assessable. It is
unclear whether reasons for missing out-
come data are acceptable and balanced.
Caries data used in the analysis pertain to
participants present throughout the trial
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment (CA)(E)clin, reported
at 1, 2 and 3 years’ follow-up
O-DMFS
MD-DMFS
BL-DMFS
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 6.06(5.76) FR1, 5.98(5.70) FR2,
6.56(6.00) PL
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
Horowitz 1971
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 1.6 years
Participants Participants randomised: N = 493
256 children analysed at 1.6 years (present for entire trial period)
Age range at start: 6 to 7 years
Surfaces affected at start: 0.9 DMFS (sample available at end)
Exposure to other fluoride: none assumed
Year study began: 1967
Location: USA
Setting of recruitment and treatment: school
Interventions FR vs PL
FR group 1: 0.2% neutral NaF solution (900 ppm F)
PL group: non-F rinse solution
School use/supervised, weekly (30 rinses/y), 10 mL applied for 1 minute
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Horowitz 1971 (Continued)
Before application: NR
Postop instruction: NR
Outcomes 1.6yNetDMFS increment - (E+U)
Reported at 1 and 1.6 years’ follow-up
DMFT (E/U)
DMFS (U)
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. State of tooth
eruption included = E/U. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...according to dental age...sex and
previous caries experience of the children,
they were randomly assigned to one of the
two following study groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The control group rinsed with a
placebo”
“Amonthly rinsing for the controls seemed
to be a reasonable compromise. Because
the examiners for this study had no part in
administering treatments, a double-blind
method could be maintained strictly”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “The control group rinsed with a
placebo”
“Amonthly rinsing for the controls seemed
to be a reasonable compromise. Because
the examiners for this study had no part in
administering treatments, a double-blind
method could be maintained strictly”
Comment: blind outcome assessment and
use of placebo described
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Horowitz 1971 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
48.07% in 1.6 years
Dropout by group: 114/247 FR, 123/246
PL
Reasons for losses: transience of the schools’
neighbourhoods, exclusion due to absence
from any follow-up examination
Comments: numbers lost unduly high,
given length of follow-up, with no differen-
tial losses. It is unclear whether reasons for
missing outcome data are acceptable and
balanced. Caries data used in the analysis
pertain to participants present at all exams
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (E+U), reported at 1
and 1.6 years’ follow-up
DMFT (E/U)
DMFS (U)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 0.90 FR, 0.97 PL
DMFT: 0.73 FR, 0.75 PL
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
Horowitz 1971a
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 1.6 years
Participants Participants randomised: N = 381
208 children analysed at 1.6 years (present for entire trial period)
Age range at start: 10 to 11 years
Surfaces affected at start: 6.7 DMFS (sample available at end)
Exposure to other fluoride: none assumed
Year study began: 1967
Location: USA
Setting of recruitment and treatment: school
Interventions FR vs PL
FR group 1: 0.2% neutral NaF solution (900 ppm F)
PL group: non-F rinse solution
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Horowitz 1971a (Continued)
School use/supervised, weekly (30 rinses/y), 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 1.6yNetDMFS increment - (E+U)
Reported at 1 and 1.6 years’ follow-up
DMFT (E/U)
DMFS (U)
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. State of tooth
eruption included = E/U. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...according to dental age...sex and
previous caries experience of the children,
they were randomly assigned to one of the
two following study groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The control group rinsed with a
placebo”
“Amonthly rinsing for the controls seemed
to be a reasonable compromise. Because
the examiners for this study had no part in
administering treatments, a double-blind
method could be maintained strictly”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “The control group rinsed with a
placebo”
“Amonthly rinsing for the controls seemed
to be a reasonable compromise. Because
the examiners for this study had no part in
administering treatments, a double-blind
method could be maintained strictly”
Comment: blind outcome assessment and
use of placebo described
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Horowitz 1971a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
45.41% in 1.6 years
Dropout by group: 93/191 FR, 80/190 PL
Reasons for losses: transience of the schools’
neighbourhoods. Exclusions due to ab-
sence from any follow-up examination
Comments: numbers lost unduly high,
given length of follow-up, with almost dif-
ferential losses (51.31% FR, 42.11% PL)
. It is unclear whether reasons for missing
outcome data are acceptable and balanced.
Caries data used in the analysis pertain to
participants present at all exams
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (E+U), reported at 1
and 1.6 years’ follow-up
DMFT (E/U)
DMFS (U)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 6.97 FR, 6.48 PL
DMFT: 3.59 FR, 3.44 PL
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
Koch 1967
Methods Study design: 2-arm parallel-group RCT, ”placebo“-controlled
Study duration: 3 years
Participants Participants randomised: N = 217
167 children analysed at 3 years (present for entire trial period)
Age range at start: 9 to 11 years (average = 10)
Surfaces affected at start: 14.5 DFS
Exposure to other fluoride: no
Year study began: 1962
Location: Sweden
Setting of recruitment and treatment: school
Interventions Comparison: FR vs ’PL’
FR group: 0.5% NaF (2250 ppm F)
’PL’ group: non-F rinse (distilled water)
75Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Koch 1967 (Continued)
School use/supervised, fortnightly (17 rinses/y), 10 mL applied for 2 minutes
Before application: NR
Postop instruction: NR
Outcomes 3yDFS increment - (CA)(E)cl
Reported at 1 and 3 years’ follow-up (and at 2 years post treatment)
DFT
O-DFS
MD-DFS
BL-DFS
CAR (annual)
Secondary caries
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 1 examiner; diagnostic threshold = CA; radiographic
assessment (2 postBW) used as an aid but not reported; state of tooth eruption included
= E.
Intraexaminer reproducibility checks for DFS in 10% sample (ICC over 0.98); reversals
very small in both groups and equally common
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quotes: ”The children were randomly as-
signed to test and control groups“
“The children selected to be exposed to an
experimental measure were divided into 2
groups by assigning every other child in the
class register to one group; the remainder to
the other group. In these alphabetical regis-
ter the boys and the girls were entered sep-
arately. In this way, both groups comprised
an equal number of boys and girls”
Comment: not randomised. Alternation
used to allocate into groups
Allocation concealment (selection bias) Low risk Comment: The non-random method (al-
ternation) used for sequence generation
would not allow for allocation conceal-
ment. However, because every child in the
class was assigned according to the ordering
in the class register (alphabetically), lack of
allocation concealment could not influence
assignment of participants
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Koch 1967 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes: “In the present investigation,
which was carried out with control groups,
the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“...fluoride solution in test group and dis-
tilled water in control group”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Comment: Effectiveness of distilled water
as a placebo is unclear. Moreover, partici-
pants were assigned in alternation, which
makes it easier to guess
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “In the present investigation,
which was carried out with control groups,
.the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Radiographic examination conducted
Comment: radiographic assessment used.
Unclear whether examiners were effectively
blinded but likely to be low risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
23.04% in 3 years
Dropout by group: 24/109 (22%) FR, 26/
108 (24%) PL
Reasons for losses: not reported
Comment: numbers lost not unduly high,
given length of follow-up, and no differen-
tial loss evident between groups. It is un-
clear whether reasons for missing outcome
data are acceptable and balanced. Caries
data used in the analysis pertain to partici-
pants present throughout the trial
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Koch 1967 (Continued)
Selective reporting (reporting bias) Unclear risk Outcomes reported
DFS increment - (CA) (E)cl, reported at
1 and 3 years’ follow-up (and at 2 years
post treatment)
DFT
O-DFS
MD-DFS
BL-DFS
CAR (annual)
Secondary caries
Comment: trial protocol available. Pre-
specified outcomes were reported. How-
ever side effects data were incomplete
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 14.36(7.47) FR, 14.93(8.47) PL
DFT: 9.38(4.15) FR, 9.45(4.26) PL
SAR: 67.82(19.82) FR, 64.30(16.85) PL
TAR: 9.06(3.60) FR, 8.41(2.99) PL
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (SAR, TAR) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Koch 1967a
Methods Study design: 2-arm parallel-group RCT, “placebo”-controlled
Study duration: 3 years
Participants Participants randomised: N = 344
251 children analysed at 3 years (present for entire trial period)
Age range at start: 6 to 8 years (average = 7)
Surfaces affected at start: 5.6 DFS
Exposure to other fluoride: none assumed
Year study began: 1962
Location: Sweden
Setting of recruitment and treatment: school
Interventions Comparison: FR vs ’PL’
FR group: 0.5% NaF (2250 ppm F)
PL group: non-F rinse (distilled water)
School clinic/supervised, 3 times a year (3 rinses/y), 10 mL applied for 2 minutes
Before application: NR
Postop instruction: NR
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Koch 1967a (Continued)
Outcomes 3yDFS increment - (CA)(E)cl
Reported at 1 and 3 years’ follow-up
DFT
CAR (annual)
Secondary caries
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 4 examiners; diagnostic threshold = CA; radiographic
assessment (2 postBW) used as an aid but not reported; state of tooth eruption included
= E. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quotes: “The children were randomly as-
signed to test and control groups”
“The children selected to be exposed to an
experimental measure were divided into 2
groups by assigning every other child in the
class register to one group; the remainder to
the other group. In these alphabetical regis-
ter the boys and the girls were entered sep-
arately. In this way, both groups comprised
an equal number of boys and girls“
”The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Comment: not randomised. Alternation
used to allocate into groups
Allocation concealment (selection bias) Low risk Comment: The non-random method (al-
ternation) used for sequence generation
would not allow for allocation conceal-
ment. However, because each child in the
class was assigned according to the order in
the class register (alphabetically), lack of al-
location concealment could not influence
assignment of participants
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Koch 1967a (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes: “In the present investigation,
which was carried out with control groups,
the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“...fluoride solution in test group and dis-
tilled water in control group”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “In the present investigation,
which was carried out with control groups,
.the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Radiographic examination conducted
Comment: radiographic assessment used.
Unclear whether examiners were effectively
blinded but likely to be low risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
27.03% in 3 years
Dropout by group: 55/172 (32%) FR, 38/
172 (22%) PL
Reasons for losses: not reported
Comment: Numbers lost were not high,
given length of follow-up, although differ-
ential losses evident between groups. It is
unclear whether reasons for missing out-
come data are acceptable and balanced.
Caries data used in the analysis pertain to
participants present throughout the trial
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (CA)(E)cl, reported at
1 and 3 years’ follow-up
DFT
CAR (annual)
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Koch 1967a (Continued)
Secondary caries
Comment: trial protocol available. All pre-
specified outcomes were reported in the
prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 5.52(3.14) FR, 5.63(3.12) PL
DFT: 3.40(1.62) FR, 3.64(1.85) PL
SAR: 32.45(10.39) FR, 33.34(11.23) PL
TAR: 5.15(2.27) FR, 5.16(2.66) PL
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (SAR, TAR) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Koch 1967b
Methods Study design: 2-arm parallel-group RCT, “placebo”-controlled
Study duration: 2 years
Participants Participants randomised: N = 392
251 children analysed at 2 years (present for entire trial period)
Age range at start: 7 to 11 years
Surfaces affected at start: 7 DFS
Exposure to other fluoride: none assumed
Year study began: 1962
Location: Sweden
Setting of recruitment and treatment: school
Interventions Comparison: FR vs ’PL’
FR group: 0.05% NaF (230 ppm F)
PL group: non-F rinse (tap water)
School clinic/supervised, 3 times a year (3 rinses/y), 10 mL applied for 2 minutes
Before application: NR
Postop instruction: NR
Outcomes 2yDFS increment - (CA)(E)cl
Reported at 2 years’ follow-up
DFT
CAR (annual)
Secondary caries
Dropout
Declaration of Interest No information provided
Funding No information provided
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Koch 1967b (Continued)
Notes Clinical (VT) caries assessment by 2 examiners; diagnostic threshold = CA; radiographic
assessment (2 postBW) used as an aid but not reported; state of tooth eruption included
= E. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quotes: “The children were randomly as-
signed to test and control groups”
“The children selected to be exposed to an
experimental measure were divided into 2
groups by assigning every other child in the
class register to one group; the remainder to
the other group. In these alphabetical regis-
ter the boys and the girls were entered sep-
arately. In this way, both groups comprised
an equal number of boys and girls“
”The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Comment: not randomised. Alternation
used to allocate into groups
Allocation concealment (selection bias) Low risk Comment: The non-random method (al-
ternation) used for sequence generation
would not allow for allocation conceal-
ment. However, because each child in the
class was assigned according to ordering in
the class register (alphabetically), lack of al-
location concealment could not influence
assignment of participants
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes: “In the present investigation,
which was carried out with control groups,
the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“...fluoride solution for test group and tap
water for control group”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
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Koch 1967b (Continued)
the ‘green’ one”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “In the present investigation,
which was carried out with control groups,
the double-blind method was used”
“The examiner did not know to which
group the children belonged”
“The terms test group and control group
were never used, for it was not known until
after the investigation which group was a
test or a control group. The groups were
therefore referred to as the ‘yellow’ one and
the ‘green’ one”
Radiographic examination conducted
Comment: radiographic assessment used.
Unclear whether examiners were effectively
blinded but likely to be low risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
35.97% in 2 years
Dropout by group: 82/196 (42%) FR, 59/
196 (30%) PL
Reasons for losses: not reported
Comment: Numbers lost were high, given
length of follow-up, and showed differ-
ential losses between groups. It is unclear
whether reasons for missing outcome data
are acceptable and balanced. Caries data
used in the analysis pertain to participants
present throughout the trial
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (CA)(E)cl, reported at
2 years’ follow-up
DFT
CAR (annual)
Secondary caries
Comment: trial protocol available. All pre-
specified outcomes were reported in the
prespecified way
Baseline characteristics balanced? Unclear risk Prognostic factors reported
DFS: 6.89(3.10) FR, 7.01(3.63) PL
DFT: 4.82(1.71) FR, 4.86(2.11) PL
SAR: 51.75(13.88) FR, 53.20(16.04) PL
TAR: 8.54(2.88) FR, 8.85(3.29) PL
Comment: initial caries appears balanced
between groups. Other baseline character-
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Koch 1967b (Continued)
istics (SAR, TAR) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Laswell 1975
Methods Study design: 3-arm parallel-group RCT, placebo-controlled
Study duration: 2.4 years
Participants Participants randomised: N = 575
343 children analysed at 2.4 years (after exclusions, present for entire trial period)
Average age at start: 8.6 years
Surfaces affected at start: 3 DMFS
Exposure to other fluoride: water
Year study began: assumed in/before 1971
Location: USA
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
APF group 1: 200 ppm F, daily (160 rinses/y)
APF group 2: 1000 ppm F, weekly (30 rinses/y)
School use/supervised
Before application: NR
Postop instruction: NR
Outcomes 2.4yDFS increment - (E+U)
Reported at 2.4 years’ follow-up
DMFS (U)
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA. State of tooth
eruption included = E/U. Diagnostic errors NR (results from only 1 examiner reported)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The subjects were randomly as-
signed to three groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
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Laswell 1975 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “One group received a daily placebo
mouthwash...”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quotes: “The examinations were accom-
plished by 2 examiners working indepen-
dently”
“One group received a daily placebo
mouthwash...”
Comment: use of placebo described, but It
is unclear whether examiners were blinded,
although examinationswere done indepen-
dently
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
40.35% in 2.4 years
Dropout by group: 75/181 FR1, 84/204
FR2, 73/190 PL
Reasons for losses: exclusions based on
presence at exams and compliance
Comment: numbers lost unduly high for
length of follow-up with no differential loss
between groups. It is unclear whether rea-
sons formissing outcomedata are balanced,
and theymay not be acceptable. Caries data
used in the analysis pertain to participants
present at all exams with more than 75%
compliance
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (E+U), reported at 2.4
years’ follow-up
DMFS (U)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Unclear risk Prognostic factors reported
DMFS: 2.57 FR1, 3.25 FR2, 3.20 PL
Age: 8.7 FR1, 8.6 FR2, 8.5 PL
Comment: initial caries appears balanced
between groups. Age also balanced
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
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McConchie 1977
Methods Study design: 3-arm parallel-group RCT, placebo-controlled
Study duration: 2 years (+ 1 year post-intervention period)
Participants Participants randomised: N = 1202; numbers randomized to each group NR
743 children analysed at 2 years (available at final examination)
Average age at start: 10 years
Surfaces affected at start: 6.2 DFS
Exposure to other fluoride: no
Year study began: 1970
Location: Canada
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
FR group 1: 0.08% SnF2 = 200 ppm F
FR group 2: 0.04% SnF2 = 100 ppm F
PL group: non-F rinse
School use/supervised, daily (160 rinses/y), 20 mL applied in 2 successive rinses 30
seconds each
Before application: NR
Postop instruction: NR
Outcomes 2yNetDFS increment - (E+U)cl+xr
Reported at 2 years’ follow-up (and at 1 year post treatment)
DMFS
DMFT
Increments standardised to 28 teeth and 122 surfaces (E/U)
Children with tooth staining/pigmentation, lack of acceptance of the taste, side effects
(incomplete data)
Declaration of Interest No information provided
Funding The study was supported by a grant from the Warner-Lambert Company
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. Radiographic
assessment (postBW) by 2 examiners; diagnostic threshold NR. State of tooth eruption
included = E/U. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “They were divided by basis of ran-
dom numbers into three groups selected in
such a manner that the sex, age and pre-
vious caries experience of each group were
closely similar”
Comment: not enough information pro-
vided
86Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
McConchie 1977 (Continued)
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “Two of the groups rinsed with the
two strengths of the solution and the third
rinsed with a placebo”
“The three tablets...resembled each other
in colour and taste”
“The status of each group was not known
to anyone actively involved in the study”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “Two of the groups rinsed with the
two strengths of the solution and the third
rinsed with a placebo”
“The three tablets dissolved in cups...re-
sembled each other in colour and taste”
“The status of each group was not known
to anyone actively involved in the study”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
38.19% in 2 years
Dropout by group: not assessable
Reason for losses: movement out of the
schools, administrative difficulties, absen-
teeism. Exclusions based on compliance
Comment: numbers lost unduly high for
length of follow-up. Differential losses not
assessable. It is unclear whether reasons for
losses are balanced, and they may not be
acceptable. Caries data used in the analysis
pertain to participants present at final ex-
amination
Selective reporting (reporting bias) Unclear risk Outcomes reported
DFS increment - (E+U)cl+xr, reported
at 2 years’ follow-up (and at 1 year post
treatment)
DMFS
DMFT
Increments standardised to 28 teeth and
122 surfaces (E/U)
Children with tooth staining/pigmenta-
tion, lack of acceptance of the taste, side
effects (incomplete data)
Comment: trial protocol not available. Pre-
specified outcomes were reported. How-
ever side effects data were incomplete
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McConchie 1977 (Continued)
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 6.19 FR1, 6.39 FR2, 6.12 PL
DMFT: 3.50 FR1, 3.67 FR2, 3.55 PL
SAR: 63.59 FR1, 63.54 FR2, 62.73 PL
TAR: 13.53 FR1, 13.45 FR2, 13.32 PL
Comment: initial caries appears balanced.
Other baseline characteristics (SAR, TAR,
age) also balanced
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
Moberg Sköld 2005
Methods Study design: 5-arm parallel-group RCT (quasi), non-placebo-controlled
Study duration: 3 years
Participants Year study began: 1999
Location: Sweden, 1 city
Setting of recruitment and treatment: school
Numbers randomised: 788 children (“randomly selected”)
Numbers analysed: 622 children at 3 years (after exclusions, present for both examina-
tions)
Age: all 13 years old
Surfaces affected: 1.6 MD-DFS (SD = 2.8)
Background exposure to other fluoride: yes (100% reported F toothpaste used twice
a day, 100% reported F varnish applied annually at checkups, but no F in water - “0.1
ppm F”)
Interventions Comparison: FR (4 groups) vs NT
FR group 1: 0.2% NaF, 900 ppm F, 6 rinses/y (initial 3 school days every semester)
FR group 2: 0.2% NaF, 900 ppm F, 12 rinses/y (initial 3 and last 3 school days every
semester)
FR group 3: 0..2%NaF, 900 ppm F, 27 rinses/y (3 consecutive school days everymonth)
FR group 4: 0.2% NaF, 900 ppm F, 20 rinses/y (2 school days (fortnightly) during
semesters)
NT group: no intervention
School use/supervised, 20 mL applied for 1 minute
Before application: no toothbrushing before rinsing
Postop instruction: Refrain from eating and drinking for 1 hour afterwards
Outcomes 3-year postMD-DFS incidence - (E)(DR/ER)xr
Reported at 3 years’ follow-up
DS
FS
Caries progression
Dropout
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Moberg Sköld 2005 (Continued)
Declaration of Interest No information provided
Funding Supported by Swedish Patent Revenue Fund for Research in Preventive Dentistry and
the Sigge Perssons & Alice Nybergs Foundation
Notes Radiographic caries assessment (4 postBW) by 2 examiners; diagnostic threshold = DR
and ER; intraexaminer K statistics/kappa values - 0.94 and 0.88 for all scores and for
carious surfaces scores only, respectively, interexaminer valuesNR. State of tooth eruption
included = E
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “... Adolescents of five different
secondary schools in Mölndal were ran-
domised into five different groups (every
school included had five classes within the
age group)”
Comment: method unclear, quasi-method
likely
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Group 5 (control group) did not
rinse”
Comment: no placebo described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Two of the authors (E.B. and U.
M.S.) read the radiographs simultaneously,
using a
light desk and a magnifying viewer. A con-
sensus of each code was reached. The au-
thors did not know towhich group the ado-
lescents belonged”
Comment: blind outcome assessment re-
ported, but no placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
166/788 (21%) in 3 years [but 88/788
(11%) in 3 years if no exclusions were per-
formedbased on compliancewith interven-
tion*]
Dropout by group 46/173 (17%) FR1, 29/
162 (18%) FR2, 30/184 (16%) FR3, 61/
175 (35%) FR4, 0/94 NT
Reasons for losses: excluded because of
fewer rinses than stipulated, refused to
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Moberg Sköld 2005 (Continued)
rinse, changed class, school, or moved out
from area, missed radiograph or poor ra-
diograph quality
*78 participants were not included in the
analysis, on a ’non-adherence’ basis, be-
cause they rinsed less than stipulated = 62,
or refused to rinse = 16); it is not clear if
they had the 3-year follow-up examination
Comment: numbers lost high for length
of follow-up (FR 4), differential losses be-
tween NT and FR groups and among FR
groups. Caries data used in analysis pertain
to participants present at initial and final
examinations
Selective reporting (reporting bias) Unclear risk Outcomes reported
DFS incidence - (DR/ER)xr at 3 years’
follow-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported; however, although caries preva-
lence data are fully reported by group (at
varying levels of diagnosis) at baseline and
at follow-up, not all caries incidence/incre-
ment data are fully reported/tabulated by
group and diagnostic threshold
Baseline characteristics balanced? Low risk Prognostic factors reported
Post MD-DFS (MD-DFSa+DeS) = 1.68
FR1, 1.44 FR2, 1.79 FR3, 1.75 FR4, 1.45
NT
MD-DS, MD-FS
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Low risk Quote: “All participants attended dental
clinics for regular check-ups once a year and
they were given prophylactic treatment. ..
.It is custom in Sweden’s dental clinics to
treat all children and adolescents with F
varnish at their yearly check-ups and it is
standard to brush one’s teeth with F tooth-
paste twice a day”
Comment: no indicationof inadvertent ap-
plication of the intervention to people in
the control group (no apparent contamina-
tion) or of any additional treatment given
to 1 of the groups differentially (no risk of
co-intervention)
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Molina 1987
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 2.5 years
Participants Participants: N= 767
295 children analysed at 2.5 years (available at final examination)
Age range at start: 5 to 13 years
Surfaces affected at start: 4.3 DMFS
Exposure to other fluoride: data not obtained for toothpaste or water
Year study began: 1983
Location: Chile
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group (n = 145): 0.2% NaF group = 900 ppm F
PL group (n = 150): non-F rinse (no details described)
School use/supervised, applied weekly (30 rinses/y)
Before application: NR
Postop instruction: NR
Outcomes 2.5yDMFS increment
Reported at 2.5 years’ follow-up
DMFT
Dropout
Declaration of Interest No information provided
Funding The investigation was financed by the Faculty of Dentistry University of Chile, Labora-
torio Chile, Indus Lever and Manufacturas de Cepillos Duralon Ltd
Notes Clinical (VT) caries assessment, diagnostic threshold NR. State of tooth eruption in-
cluded NR. Consistency of diagnosis assessed by duplicate examinations annually. Di-
agnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote from translation: “In each school,
children were divided at random by the
statisticians...”
Comment: A random method was likely
used
Allocation concealment (selection bias) Unclear risk Method was not specified
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes from translation: “The study was
conducted double-blind”
“..and placebo for the control group”
Blind outcome assessment and use of
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Molina 1987 (Continued)
placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes from translation: “The study was
conducted double-blind”
“..and placebo for the control group”
Blind outcome assessment and use of
placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
61.54% in 2.5 years
Reasons for losses: moved away because of
earthquake in the area (1985Chilean earth-
quake)
Comment: numbers lost very high, al-
though no differential loss evident between
groups (dropout by group: 225/370 FR,
247/397 PL). Caries data used in analysis
pertain to participants present at final ex-
aminations
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment, reported at 2.5 years’
follow-up
DMFT
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 4.38 FR, 4.22 PL
DMFT: 2.93 FR, 2.72 PL
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
Moreira 1972
Methods Study design: 5-arm parallel-group quasi-RCT (only 4 relevant arms used, the NT
control group not used), ”placebo“-controlled
Study duration: 2 years
Participants Participants randomised (N = 330)
200 children analysed at 2 years (after exclusions, available at final examination)
Age range at start: 6.5 to 7.5 years
Surfaces affected at start: 4.6 DMFS (from sample randomised)
Exposure to other fluoride: none assumed
Year study began: 1968
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Moreira 1972 (Continued)
Location: Brazil
Setting of recruitment and treatment: school
Interventions Comparison: FR (3 groups) vs ’PL’
FR group 1: 0.1% NaF, 450 ppm F, 3 times a week (80 rinses/y)
FR group 2: 0.1% NaF, 450 ppm F, weekly (28 rinses/y)
FR group 3: 0.1% NaF, 450 ppm F, fortnightly (14 rinses/y)
’PL’ group: tap water, 3 times a week (80 rinses/y)
School use/supervised, 25 mL applied for 30 seconds
Before application: Rinsing with water (tap = drinking water) was carried out first, in
all 4 groups, for 30 seconds (followed by another rinse with water in the ’PL’ group and
rinse with F solution in the treatment groups, as described above)
Postop instruction: NR
Outcomes 2yDMFS increment
Reported at 1 and 2 years’ follow-up
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment, diagnostic threshold NR. State of tooth eruption in-
cluded NR. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote from translation: “For this study, we
constituted a control group and four ex-
perimental groups numbered 1 to 4, tak-
ing into consideration: approximate num-
bers of children of school age, previous
experience of caries and permanent teeth
erupted”
Comment: not enough information pro-
vided
Quote from correspondence: “In order
to obtain ’homogeneous’ groups, children
were ordered and pre-stratified by gender,
age, number of permanent teeth present,
and by level of DMF, and in this way each
one of the groups was formed”
Comment: method unclear, quasi-method
likely
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Moreira 1972 (Continued)
Allocation concealment (selection bias) High risk Comment: no concealment of allocation
indicated/likely
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes: “Group V- children who rinsed
with clean water, three times a week”
“...study was conducted double-blind...”
Comment: double-blinding and use of
’placebo’ reported, but methods not de-
scribed. It was unclear whether the
’placebo’ could be distinguished from the
active treatment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote from correspondence: “The re-
searcher/examiner did not know to which
group the children belonged, and the chil-
dren were also blind to group assignment”
Comment: likely to be low risk because
blind outcome assessment and use of
’placebo’ described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
39.02% (130/330) in 2 years
Dropout by group: 32/82FR1, 35/85 FR2,
32/82 FR3, 31/81 PL
Reasons for losses: exclusions based on ‘sta-
tistical reasons’ (made at random to keep
groups of equal sizes)
Comment: Numbers lost were high, given
length of follow-up, and it is unclear
whether differential losses were noted be-
tween groups (because the numbers above
were produced after ’statistical’ exclusions
to keep groups of equal sizes). Reason
for missing outcome data is unacceptable.
Caries data used in analysis pertain to par-
ticipants present at final examination (after
exclusions)
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment, reported at 1 and 2
years’ follow-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 4.58 FR1, 4.60 FR2, 4.62 FR3, 4.
66 ‘PL’
Age: 7 FR1, 7 FR2, 7 FR3, 7 ‘PL’
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Moreira 1972 (Continued)
Dental age: 8.1 FR1, 8.1 FR2, 8.3 FR3, 8.
3 ‘PL’
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (dental age, age) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Moreira 1981
Methods Study design: 2-arm parallel-group RCT (quasi), non-placebo-controlled
Study duration: 2.5 years
Participants Participants randomised: N = 230
164 children analysed at 2.5 years (available at final examination)
Age range at start: 7 to 8 years
Surfaces affected at start: 1.4 DMFS
Exposure to other fluoride: water
Year study began: 1974
Location: Brazil
Setting of recruitment and treatment: school
Interventions Comparison: FR vs NT
FR group: 0.2% NaF (900 ppm F)
NT group: no intervention
School use/supervised, weekly (30 rinses/y), 20 mL applied, for 30 seconds
Before application: rinsing with drinking water for 30 seconds
Postop instruction: no eating or drinking for 30 minutes
Outcomes 2.5yDMFS increment
Reported at 2.5 years’ follow-up
CAR
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 1 examiner, diagnostic threshold NR. State of tooth
eruption included NR. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote from translation: “...children were
divided at random into 2 groups”
Comment: not enough information pro-
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Moreira 1981 (Continued)
vided
Quote from correspondence: “In order
to obtain ’homogeneous’ groups, children
were ordered and pre-stratified by gender,
age, number of permanent teeth present,
and by level of DMF, and then, they were
distributed ’at random’, to form each one
of the groups”
Comment: method unclear, quasi-method
likely
Allocation concealment (selection bias) High risk Quote from correspondence: “In order
to obtain ’homogeneous’ groups, children
were ordered and pre-stratified by gender,
age, number of permanent teeth present,
and by level of DMF, and then, they were
distributed ’at random’, to form each one
of the groups”
Comment: no concealment of allocation
indicated/likely
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote from translation: “... received no
treatment and served as control”
Comment: no placebo used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quotes from translation: “... received no
treatment and served as control”
“The clinical examinationswere performed
by a single examiner without prior knowl-
edge whether the child belonged to the ex-
perimental group or control”
Comment: blind outcome assessment de-
scribed, but no placebo used
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
28.7% (66/230) in 2.5 years
Dropout by group: 42/115FR, 24/115NT
Reasons for losses: not reported
Comment: Numbers lost were not high for
length of follow-up but showed differential
loss between groups (36.52% FR, 20.87%
NT). It is unclear whether reasons for miss-
ing data are acceptable. Caries data used in
analysis pertain to participants present at
final examinations
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment, reported at 2.5 years’
follow-up
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Moreira 1981 (Continued)
CAR
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostics factors reported
DMFS: 1.4(1.61) FR, 1.4(1.72) NT
TAR: 8.3 FR, 8.3 NT
Dental age: 9.6 FR, 9.5 NT
Comment: initial caries appears balanced
between groups. Dental age, TAR also bal-
anced
Free of contamination/co-intervention? Unclear risk No information provided
Packer 1975
Methods Study design: 3-arm parallel-group RCT, placebo controlled
Study duration: 2.4 years
Participants Participants randomised: N = 464
285 children analysed at 2.4 years (after exclusions, present for entire trial period)
Average age at start: 8.7 years
Surfaces affected at start: 6.6 DMFS
Exposure to other fluoride: no
Year study began: assumed in/before 1971
Location: USA
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
APF group 1: 200 ppm F, daily (160 rinses/y)
APF group 2: 1000 ppm F, weekly (30 rinses/y)
School use/supervised
Before application: NR
Postop instruction: NR
Outcomes 2.4yNetDMFS increment - (CA) (E+U)
Reported at 2.4 years’ follow-up
DMFS (U)
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA. State of tooth
eruption included = E/U. Diagnostic errors NR (results from only 1 examiner reported)
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Packer 1975 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The subjects were randomly as-
signed into three groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “One group received a daily placebo
mouthwash...”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quotes: “The examinations were accom-
plished by 2 examiners working indepen-
dently”
“One group received a daily placebo
mouthwash...”
Comment: use of placebo described, but It
is unclear whether examiners were blinded,
although examinationswere done indepen-
dently
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
38.58% in 2.4 years
Dropout by group: 62/142 FR1, 56/164
FR2, 61/158 PL
Reasons for losses: exclusion due to absence
from more than 25% of examinations and
compliance
Comment: numbers lost unduly high for
length of follow-up, with some differential
loss between groups (43.66%FR1, 34.15%
FR2, 38.61%PL). It is unclearwhether rea-
sons formissing outcomedata are balanced,
and theymay not be acceptable. Caries data
used in the analysis pertain to participants
present at all exams with more than 75%
compliance
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (E+U), reported at 2.
4 years’ follow-up
DMFS (U)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
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Packer 1975 (Continued)
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 6.47(4.65) FR1, 6.80(4.60) FR2
6.48(4.98) PL
Age: 8.7 FR1, 8.6 FR2, 8.6 PL
Comment: initial caries appears balanced
between groups. Age also balanced
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
Petersson 1998
Methods Study design: 2-arm parallel-group RCT, “placebo”-controlled
Study duration: 3 years
Participants Participants randomised: numbers NR nor obtainable
139 children analysed at 3 years
Average age at start: 13 years
Mean surfaces affected at start: 1.3 DFS
Background exposure to other fluoride: assumed yes (toothpaste) - The tap water
contained a very low level of fluoride: 0.01 ppm F
Year study began: assumed in/before 1994
Location: Sweden
Setting of recruitment and treatment: school
Interventions Comparison: FR vs ’PL’
FR group (n = 69): 0.045% NaF, 200 ppm F
’PL’ group (n = 70): tap water (no F = 0.01 ppm F)
School use/supervised, for 3 days every 6 months (6 rinses/y), 10 mL applied
Before application: NR
Postop instruction: NR
Outcomes 3ypostMD-DFS increment - (DR/ER)xr
Reported at 3 years’ follow-up
Declaration of Interest No information provided
Funding The study was supported by the County Council of Halland, Sweden
Notes Radiographic assessment (4 postBW) by 1 examiner; diagnostic threshold = DR and ER.
Diagnostic errors NR. State of tooth eruption included NR
Risk of bias
Bias Authors’ judgement Support for judgement
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Petersson 1998 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quotes: “A test group was randomly sam-
pled...”
“...school children were sampled into two
groups...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quotes: “...In the control group, the chil-
dren rinsed with tap water...”
“The study was designed so that the sub-
jects did not know whether their rinsing
solution contained fluoride or not”
“The same prophylactic information was
given to the teenagers during the rinsing
procedures in both groups, and the same
staff members.. organised the rinsing pro-
cedures in the test as well as control groups
through the whole study periods”
Comment: use of ‘placebo’ described (no
description of whether the mouthrinse is
identical in appearance or taste to tapwater.
Staff did not seem to be blinded)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “the detection and recording of
caries and filled surfaces from the bitewing
radiographs were performed by one of the
authors who was specially trained for the
purposed and did not know the origin of
the radiographs analysed”
Comment: likely to be low risk because
blind outcome assessment and use of
‘placebo’ described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Numbers randomised not
reported. Dropout rate NR nor obtainable.
Reasons for attrition NR. Any differential
group losses not assessable
Selective reporting (reporting bias) Low risk Outcomes reported
PostMD-DFS, reported at 3 years’ fol-
low-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
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Petersson 1998 (Continued)
Baseline characteristics balanced? Low risk Prognostic factors reported
PostMDDFS: 1.35 (1.58) FR, 1.16 (1.55)
‘PL’
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Low risk Quote: “Similar preventive programs were
applied to the two groups during the ex-
perimental period”
Comment: sufficient indication of overall
prevention of contamination/co-interven-
tion
Poulsen 1984
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 3 years
Participants Participants randomised: N = 398
Number analysed: 365 children analysed at 3 years (available at final examination)
Age range at start: 7 to 10 years (average = 9)
Surfaces affected at start: 3.6 DMFS
Exposure to other fluoride: yes ( toothpaste). Area has low fluoride content in water
(0.5 ppm in most parts)
Year study began: 1979
Location: Denmark
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group (n = 207): 0.2% NaF(900 ppm F)
PL group (n = 191): water, with flavouring solution added
School use/supervised, fortnightly (19 rinses/y), 10 mL applied
Before application: NR
Postop instruction: NR
Outcomes 3yNetDMFS increment - (CA)(E)cl
Reported at 3 years’ follow-up
DMFS (U)
O-DMFS
MD-DMFS
BL-DMFS
PostMDDMFS
Dropout
Declaration of Interest No information provided
Funding Supported by a grant from Colgate Palmolive Inc., Copenhagen
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Poulsen 1984 (Continued)
Notes Clinical (VT) caries assessment by dentists at public dental service, diagnostic threshold
= CA. Radiographic assessment (2 postBW) by 1 examiner; diagnostic threshold = DR.
State of tooth eruption included (E/U). Reproducibility of diagnosis assessed by duplicate
radiographic examination of 10% random sample (kappa value 0.72)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The children were stratified ac-
cording to school and age and subsequently
randomly allocated to two groups”
Quote from correspondence: “Themethod
of randomisation is not mentioned in the
protocol”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: ”...flavouring solution .... were
added“
”The children, the dental examiners and
the dental assistants did not know which
group the children belonged to“
“Both placebo and fluoride solutions were
poured into small plastic cups at the den-
tal school and each cup labelled with the
child’s name, school and grade”
Comment: adequate efforts to ensure that
water was an effective placebo, and steps
taken to ensure blinding; use of a placebo
described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “....the examiners .... did not know
to which group the children belonged”
“Caries was recorded on the radiographs
when the lesion had reached the amelo-
dentinal junction”
Comment: Examiner did not know treat-
ment assignment; definitions and objective
outcome measures used (bitewing radio-
graphs)
Comment: blind outcome assessment and
use of a placebo described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Overall dropout for length of follow-up: 8.
29% in 3 years
Dropout by group: 16/207 FR, 17/191 PL
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Poulsen 1984 (Continued)
Reasons for losses: not reported
Comment: numbers lost not unduly high,
given length of follow-up, with no differ-
ential losses between groups. It is unclear
whether reasons for missing outcome data
are acceptable and balanced. Caries data
used in the analysis pertain to participants
who completed the trial
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (CA)(E)cl, reported
at 3 years’ follow-up
DMFS (U)
O-DMFS
MD-DMFS
BL-DMFS
PostMDDMFS
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 3.56 (2.92) FR, 3.7 (2.49) PL
Mean age (months): 106.66(10.52) FR,
108.43(10.70) PL
Erupted surfaces: 56.86(17.66) FR, 57.34
(15.86) PL
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (erupted surfaces, age) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Radike 1973
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 2 school years (1.6 years)
Participants Participants randomised: N = 890
726 children analysed at 1.6 years (available at final examination)
Age range at start: 8 to 13 years (average = 10.4)
Surfaces affected at start: 4.9 DMFS
Exposure to other fluoride: water
Year study began: assumed in/before 1970
Location: USA
Setting of recruitment and treatment: school
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Radike 1973 (Continued)
Interventions Comparison: FR vs PL
FR group: 0.1% SnF2, 240 ppm F
PL group: non-F rinse
School use/supervised, daily (160 rinses/y), 60 mL applied in 3 successive rinses of 10,
30 and 30 seconds each
Before application: NR
Postop instruction: NR
Outcomes 1.6yDMFS increment - cl+xr
Reported at 8 months’ and 1.6 years’ follow-up
DMFT
Children with tooth staining/pigmentation (incomplete data)
Dropout
Declaration of Interest No information provided
Funding Sponsors of the study were US Airforce School of Aerospace Medicine under contract
no. F41609-68-C-0025, and Procter and Gamble Co
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. Radiographic
assessment (4 postBW) by 2 examiners; diagnostic threshold NR. State of tooth eruption
included NR. Diagnostic errors NR. Results of 1 examiner chosen (findings of both
examiners consistent throughout)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “At the time of the first examina-
tion, the children were grouped by sex,
age...Within these groupings, adjacent sub-
ject entries were assigned to test or control
groups by random permutations of two”
Comment: block randomisation done
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “Neither the participants nor the
examiners were aware of the assignments
throughout the test”
“The test and the placebomouthrinseswere
used by the children in school classrooms
under direct supervision of the teachers”
“the mouthrinses were simple in composi-
tion and similar in appearance and taste...
SnF2 was added to the test rinse; nothing
was added to the other rinse”
“into red or green cups according to the
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Radike 1973 (Continued)
color assigned”
“red-green coding used throughout the
study”
Comment: use of placebo reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “Neither the participants nor the
examiners were aware of the assignments
throughout the test”
“each child was sent to the two examiners
in a random order for clinical VT exami-
nation, and radiographs were read at a later
date by each examiner”
Comment: blind outcome assessment and
use of placebo reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
18.43% in 1.6 years
Dropout by group: 92/440 FR, 72/450 PL
Reasons for losses: not reported
Comment: numbers lost not unduly high,
given length of follow-up, with no differen-
tial losses evident between groups. It is un-
clear whether reasons for missing outcome
data are acceptable and balanced. Caries
data used in the analysis pertain to partici-
pants present at final examination
Selective reporting (reporting bias) Unclear risk Outcomes reported
DMFS increment - cl+xr, reported at 8
months’ and 1.6 years’ follow-up
DMFT
Children with tooth staining/pigmenta-
tion (incomplete data)
Comment: trial protocol not available. Pre-
specified outcomes were reported. How-
ever side effects data were incomplete
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 4.90(4.03) FR, 4.80(4.51) PL
DMFT: 3.22(2.18) FR, 3.06(2.47) PL
Age: 10.38 FR, 10.39 PL
Gender: 165 M 183 F (FR), 187 M, 191 F
(PL)
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (age, gender) also balanced
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Radike 1973 (Continued)
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
Ringelberg 1979
Methods Study design: 6-arm parallel-group RCT (4 relevant arms used), placebo-controlled
Study duration: 2.5 years
Participants Participants randomised: N = 878
527 children analysed at 2.5 years (available at final examination)
Average age at start: 11 years
Surfaces affected at start: 4.3 DMFS
Exposure to other fluoride: no
Year study began: 1973
Location: USA
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL (2 groups)
FR group 1: AmF 250 ppm F
FR group 2: NaF 250 ppm F
PL group 1: non-F rinse
PL group 2: non-F rinse
School use/supervised, daily (150 rinses/y), 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 2.5yNetDMFS increment - (CA)cl + (DR)xr
Reported at 2.5 years’ follow-up
DMFT
Stain score
Dropout
Declaration of Interest No information provided
Funding Investigation supported by the US National Caries Program under contract no. N01-
DE-32427 (product formulations by Procter and Gamble Co. and Menley and James
Laboratories)
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA. Radiographic
assessment (5 BW) by 2 examiners; diagnostic threshold = DR. State of tooth eruption
included NR. Reversal rate between 4% and 9% of observed caries increment in groups
Risk of bias
Bias Authors’ judgement Support for judgement
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Ringelberg 1979 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “The baseline examinations were
stratified by race and sex within each
school, and ordered by increasing DMFT.
Study group assignments were made by
random permutations of seven within each
stratum”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The placebo preparations were all
fully formulated like their active fluoride
ingredient, but did not have the specific
active fluoride ingredient”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “A double-blind design was used;
neither examiner nor subjects were aware
of the type of treatment received”
“The placebo preparations were all fully
formulated like their active fluoride ingre-
dient, but did not have the specific active
fluoride ingredient”
Comment: blinded outcome assessment
and use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
39.98% in 2.5 years
Dropout by group: 131/293 FR1, 110/289
FR2, 92/147 PL1 94/149 PL2
Reasons for losses: not reported
Comment: Numbers lost were high, given
length of follow-up, with differential losses
evident between groups: 44.71% FR1, 38.
06% FR2, 37.42% PL1, 36.91% PL2 Rea-
sons for missing outcome data are not re-
ported. Caries data used in the analysis per-
tain to participants at final exam
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (CA) cl + (DR) xr,
reported at 2.5 years’ follow-up
DMFT
Stain score
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
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Ringelberg 1979 (Continued)
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 3.90(0.34) FR1, 4.30(0.41) PL1,
4.36(0.43) FR2, 4.95(0.54) PL2
DMFT: 2.30(0.17) FR1, 2.49(0.20) PL1,
2.36(0.20) FR2, 2.72(0.28) PL2
Comment: initial caries appears slightly
imbalanced.
Free of contamination/co-intervention? Low risk Non-fluoride toothpaste provided to all for
home use (no rinse provided)
Ringelberg 1982
Methods Study design: 5-arm parallel-group RCT, placebo-controlled
Study duration: 2 years
Participants Participants randomised: N = 2014
1238 children analysed at 2 years (available at final examination)
Average age at start: 12.5 years
Surfaces affected at start: 4.7 DMFS
Exposure to other fluoride: toothpaste assumed
Year study began: in/before 1979
Location: USA
Setting of recruitment and treatment: school
Interventions FR (4 groups) vs PL
NaF group 1: 230 ppm F, daily (160 rinses/y)
NaF group 2: 900 ppm F, daily (160 rinses/y)
NaF group 3: 230 ppm F, weekly (30 rinses/y)
NaF group 4: 900 ppm F, weekly (30 rinses/y)
School use/supervised, 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 2yNetDMFS increment
Reported at 1.5 and 2.5 years’ follow-up
PostMD-DFS
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold NR. Radiographic
assessment by 2 examiners; diagnostic threshold NR. State of tooth eruption included
NR. Diagnostic errors NR
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Ringelberg 1982 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The participants were then allo-
cated to study groups by random permuta-
tions of five after stratification by sex and
race within each school...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “Group C rinsed weekly with a
placebo solution containing 0.1% NaCl”
“The examiners were not aware of group
assignments and did not consult baseline
findings during the incremental exam”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “Group C rinsed weekly with a
placebo solution containing 0.1% NaCl”
“The examiners were not aware of group
assignments and did not consult baseline
findings during the incremental exam”
Comment: blind outcome assessment and
use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
38.53% in 2 years
Dropout by group: 186/421 FR1, 158/415
FR2, 153/397 FR3, 144/397 FR4, 135/
384 PL
Reasons for losses: “migratory” nature of
community, changing schools
Comment: Numbers lost were unduly
high, given length of follow-up, with no
differential loss evident between groups
[44.18%(FR1), 38.01%(FR2), 38.53%
(FR3), 36.27%(FR4), 35.16%(PL)]. Rea-
sons for missing outcome data are accept-
able. Caries data used in analysis pertain to
participants present at final examinations
Selective reporting (reporting bias) Unclear risk Outcomes reported
DMFS increment, reported at 1.5 and 2.
5 years’ follow-up
PosMD-DFS
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Ringelberg 1982 (Continued)
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 4.71 FR1, 5.17 FR2, 4.75 FR3, 4.
11 FR4, 4.93 PL
Comment: Initial caries shows some imbal-
ance, but adjustment made no difference
in results - “A covariance analysis utilizing
baseline as the covariant, however failed to
change the results of the tests”
Free of contamination/co-intervention? Unclear risk No information provided
Rugg-Gunn 1973
Methods Study design: 2-arm parallel-group RCT, placebo-controlled
Study duration: 2 school years (1.6 years)
Participants Participants randomised: N = 491
434 children analysed at 3 years (available at final examination)
Age range at start: 10 to 11 years
Surfaces affected at start: 8.8 DMFS
Exposure to other fluoride: no (only 14 children, 8 control, 6 test claimed dentifrice
use)
Year study began: assumed in/before 1969
Location: UK
Setting of recruitment and treatment: school
Interventions Comparison: FR vs PL
FR group: 0.05% NaF (230 ppm F)
PL group: non-F rinse
School use/supervised, daily (160 rinses/y), 7.5 mL applied for 2 minutes
Before application: NR
Postop instruction: NR
Outcomes 3yNetDMFS increment - (E+U)(CA)cl+(DR)xr
Reported at 1, 2 and 3 years’ follow-up
DMFT (E/U)
PF-DMFS
FS-DMFS
AntMD-DMFS
PostMD-DMFS
DMFS (U)
Signs of sensitivity in oral mucosa
Dropout
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Rugg-Gunn 1973 (Continued)
Declaration of Interest No information provided
Funding The project was financed by a grant from Colgate-Palmolive Ltd
Notes Clinical (V) caries assessment by 1 examiner, diagnostic threshold = CA/NCA. Radio-
graphic assessment (2postBW) by 1 examiner; diagnostic threshold = ER. State of tooth
eruption included = E/U. Intraexaminer reproducibility checks for incremental caries
data in 10% sample (ICC score 0.9 for DMFS)
Reversal rate 4% and 7% of observed DMFS increment in control and study groups,
respectively
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quotes: “248 were allocated to the test and
243 to the control group”
“Control and test subjects were arranged
randomly within the same school classes”
“The distribution of subjects into test and
control groups was undertaken using strat-
ified random sampling”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “The trialswas organised on a dou-
ble-blind basis, neither the subjects not the
investigators being aware who was receiv-
ing test or control rinses”
“...the control rinse was similar in taste and
appearance to test rinse except for the omis-
sion of sodium fluoride”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “The trialswas organised on a dou-
ble-blind basis, neither the subjects not the
investigators being aware who was receiv-
ing test or control rinses”
“...the control rinse was similar except for
the omission of sodium fluoride”
Comment: blinded outcome assessment
and use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
11.6% in 3 years
Dropout by group: 26/248(10.5%) FR,
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Rugg-Gunn 1973 (Continued)
31/243(12.7%) PL
Reasons for losses: difficulty with rinsing
(1),moved away from area or absent at final
examination (56)
Comment: numbers lost not high, given
length of follow-up, with no differential
loss evident between groups. It is unclear
whether reasons for missing outcome data
are balanced between groups. Caries data
used in the analysis pertain to participants
present at the final examination
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment (E+U)(CA)cl + (DR)
xr, reported at 1, 2 and 3 years’ follow-
up
DMFT (E/U)
PF-DMFS
FS-DMFS
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Unclear risk Prognostic factors reported
DMFS: 8.74(5.49) FR, 8.88(5.44) PL
DMFT: 5.55(3.04) FR, 5.58(3.06) PL
Gender: 123 M, 99 F (FR), 121 M, 91 F
(PL)
Fluoride dentifrice use: 6 FR, 8 PL
Comment: initial caries appears balanced
between groups. Other baseline character-
istics (gender, exposure to fluoride tooth-
paste) also balanced
Free of contamination/co-intervention? Unclear risk No information provided
Ruiken 1987
Methods Study design: 2-arm cluster-randomised trial, non-placebo-controlled
Study duration: 3 years
Participants Number randomised: 501 children were “examined at baseline”, 29 schools were ran-
domised, number of children per group NR
207 children analysed at 3 years (present at final examination, for which readable x-rays
were available)
Average age at start: 8 years
Surfaces affected at start: 2.7 DFS
Exposure to other fluoride: yes (toothpaste, tablets)
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Ruiken 1987 (Continued)
Year study began: 1981
Location: The Netherlands
Setting of recruitment and treatment: elementary schools, The Hague
Interventions Comparison: FR vs NT
FR group: 0.2% neutral NaF (900 ppm F)
NT group: no intervention
School use/supervised, weekly (30 rinses/y), 10 mL applied for 1 minute
Before application: NR
Postop instruction: NR
Outcomes 3yNetDFS increment (mean converted from median) - (CA/NCA)cl+(DR/ER)xr
Reported at 3 years’ follow-up
Declaration of Interest No information provided
Funding Supported by a grant from Het Praeventiefonds
Notes Clinical (V) caries assessment by 2 examiners; diagnostic threshold = CA/NCA; state
of tooth eruption included NR. Radiographic assessment (2 postBW) by 2 examiners;
diagnostic threshold = DR/ER; partial recording. Diagnostic errors NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “A sample of 29 schools stratified
according to SES and randomly assigned to
two groups was selected”
Comment: not enough information pro-
vided about sequence generation
Allocation concealment (selection bias) Unclear risk Comment: no information about alloca-
tion concealment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “One group of schools (14) per-
formed rinsing and the other group (15)
served as controls”
Comment: Control group had no treat-
ment. No placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “The radiographs were interpreted
by the same investigators without reference
to the clinical examination data”
Comment: Clinical and radiographic ex-
ams were done independently. Randomi-
sation was by school. It was unclear
whether examiners would have known
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Ruiken 1987 (Continued)
which assignment/school the radiographs
were from. Blinded outcome assessment in-
dicated but no placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall drop-out for length of follow-up
(reported for individuals within clusters
only): 58.7% (207/501) in 3 years
Drop-outs by group: not reported
Main reasons for losses/attrition: “natural
losses”, and results reported only for chil-
dren with readable radiographs
Comment: unclear whether recruitment of
children was done before clusters (schools)
had been randomised. Numbers lost un-
duly high for length of follow-up; differ-
ential losses between groups not assessable.
Reason formissing outcomedata unaccept-
able. Caries data used in analysis pertain
to participants with readable radiographs
present at final examination
(and analysis done at individual level within
clusters does not take clustering into ac-
count)
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - cl+xr, reported at 3
years
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 2.8 FR, 2.6 PL
Age: 8 years (both groups combined)
Erupted surfaces: 38.3 (both groups com-
bined).
Comment: initial caries appears balanced
between groups (for individuals within
clusters). Other characteristics (erupted
surfaces, age) described as ’balanced’
Free of contamination/co-intervention? Unclear risk No information provided
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Spets-Happonen 1991
Methods Study design: 4-armparallel-groupRCT (only 2 relevant arms used), placebo-controlled
Study duration: 3 years
Participants Participants randomised: numbers NR
95 children analysed at 3 years (available at final examination)
Average age at start: 11 years
Surfaces affected at start: 5.8 DMFS (from 1 year sample)
Exposure to other fluoride: varnish once a year (toothpaste assumed)
Year study began: 1985
Location: Finland
Setting of recruitment and treatment: school and school/home
Interventions FR(Chlor)+ptc vs PL(Chlor)+ptc**
FR group: 0.04% NaF (180 ppm F)
PL group: non-F rinse
School use/supervised, 5 days every 3 weeks (115 rinses/y), 5 mL applied for 1 minute.
Same schedule recommended for evening rinse at home (but no instruction for use of
toothpaste given)
Before application: prior toothbrushing without toothpaste in both groups (done at
school, recommended for home)
Postop instruction: not to eat or drink after rinse
**Chlorhexidine present in both fluoride and non-fluoride mouthrinse (thus, other out-
comes, such as tooth staining, not relevant for the comparison of interest)
Outcomes 3yDMFS increment - (CA)cl+(DR)xr
Reported at 3 years’ follow-up
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 2 examiners; diagnostic threshold = CA (FOTI as-
sessment - loss of translucency on transillumination - for approximal surfaces of ante-
rior teeth); state of tooth eruption included NR. Radiographic assessment; diagnostic
threshold = DR ; kappa 0.7 and 0.79 for interexaminer and intraexaminer reliability
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The subjects were randomly di-
vided into 4 groups”
Comment: not enough information given
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: “All rinsing solutions were used
and other study procedures performed on
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Spets-Happonen 1991 (Continued)
a double-blind basis...”
“All rinsing solutions had same buffered
pH”
“Group CX rinsing with chlorhexidine so-
lution...Group CXF with chlorhexidine-
fluoride solution”
“The examiners did not know which group
the children belonged to”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quotes: “All rinsing solutions were used
and other study procedures performed on
a double-blind basis...”
“The examiners did not know which group
the children belonged to”
Comment: blinded outcome assessment
and use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
17.3% (42/243) in 3 years (all groups)
Dropout by group: not assessable, but
“greatest proportion of dropouts in the flu-
oride group”
Reasons for losses: not reported
Comment: numbers lost not unduly high
for length of follow-up, but differential
losses between groups not assessable. Rea-
son for missing outcome data not reported.
Caries data used in analysis pertain to par-
ticipants available at final examination
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (CA) cl+(DR)xr, re-
ported at 3 years’ follow-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 5.0(3.7) FR, 6.6(4.4) PL
Gender (% Boys): 50 FR, 50 PL
Comment: initial caries appears imbal-
anced, but “adjustment made no difference
in the results”. Gender balanced
Free of contamination/co-intervention? Unclear risk No information provided
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Torell 1965
Methods Study design: 9-arm parallel-group RCT (only 3 relevant arms used), non-placebo-
controlled
Study duration: 2 school years
Participants Participants randomised: N = 597
494 children analysed at 2 years (available at final examination)
Average age at start: 10 years
Surfaces affected at start: 14.7 DMFS (from sample randomised)
Exposure to other fluoride: none assumed
Year study began: 1962
Location: Sweden
Setting of recruitment and treatment: school and home/school
Interventions FR (2 groups) vs NT
FR group 1: 0.05%NaF (230 ppm F), 10 mL applied daily (320 rinses/y), unsupervised
at home (instructed to be done after toothbrushing every evening)
FR group2: 0.2%NaF (900 ppmF), 10mL applied fortnightly (17 rinses/y), supervised
at school
NT group: no intervention
Before application: NR
Postop instruction: NR
Outcomes 2yDMFS increment - (CA)cl+(DR)xr
Reported at 1 and 2 years’ follow-up
MD-DMFS
FS
Proportion of children with new carious lesions - (U)xr
Dropout
Declaration of Interest No information provided
Funding Financial support from the Swedish Medical Research Council, the City of Goteborg,
the County of Stockholm and theNational Board of Health, partial support (toothpastes
in the trial) by Procter and Gamble Co
Notes Clinical (VT) caries assessment by 2 examiners, diagnostic threshold = CA; radiographic
assessment (BW) by 2 examiners; diagnostic threshold = DR. State of tooth eruption
included NR. Interexaminer and intraexaminer reproducibility checks done for clinical
caries in 4% and 2% of sample, respectively; duplicate examination of x-ray records
done, and any discrepancies discussed before final diagnosis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The groups were randomly consti-
tuted and randomly assigned to the test dif-
ferent test methods, according to a system
worked out with the assistance of statisti-
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Torell 1965 (Continued)
cians...”
Comment: It is likely a random method
was used
Allocation concealment (selection bias) Unclear risk Method not specified
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “The study was a blind test as the
examination charts did not refer to the
treatment or to the code number of the
groups”
Comment: no placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “The study was a blind test as the
examination charts did not refer to the
treatment or to the code number of the
groups”
Comment: blinded outcome assessment
but no placebo described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Overall dropout for length of follow-up:
17.25% in 2 years
Dropout by group: 30/190 FR1, 39/211
FR2, 34/196 NT
Reasons for losses: changing school, mov-
ing away, appearance of new caries, un-
pleasant taste and objectionable pigmenta-
tion (not reported by group)
Comment: Numbers lost were not unduly
high for the length of follow-up, with no
differential losses. It is unclear whether rea-
sons for missing outcome data are accept-
able and balanced. Caries data used in anal-
ysis pertain to participants present at final
examinations
Selective reporting (reporting bias) Low risk Outcomes reported
DMFS increment - (CA)cl+(DR)xr, re-
ported at 1 and 2 years’ follow-up
MD-DMFS
FS
Proportion of children with new carious le-
sions (U) xr
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DMFS: 14.4(7.30) FR1, 15.2(8.57) FR2,
14.5(7.42) NT
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Torell 1965 (Continued)
MD-DMFS: 3.54 FR1, 3.97 FR2, 3.59
NT
Comment: initial caries appears balanced
between groups
Free of contamination/co-intervention? Unclear risk No information provided
van Wyk 1986
Methods Study design: 3-arm parallel-group RCT, placebo-controlled
Study duration: 3 years
Participants Participants randomised: N = 925
569 children analysed at 3 years (available at final examination)
Age range at start: 12 to 13 years
Surfaces affected at start: 8.4 DFS
Exposure to other fluoride: no
Year study began: 1981
Location: South Africa
Setting of recruitment and treatment: school
Interventions FR (2 groups) vs PL
FR group 1: 0.2% neutral NaF solution (900 ppm F)
FR group 2: 0.05% neutral NaF solution (230 ppm F)
PL group: non-F rinse solution
School use/supervised, weekly (30 rinses/y), 10 mL applied for 1 minute
Before application: NR
Postop instruction: children instructed not to eat or drink for at least 1/2 hour after
rinsing
Outcomes 3yNetDFS increment - (CA)cl
Reported at 1, 2 and 3 years’ follow-up
Dropout
Declaration of Interest No information provided
Funding No information provided
Notes Clinical (VT) caries assessment by 1 examiner, diagnostic threshold = CA. State of tooth
eruption included NR. Intraexaminer reproducibility checks for incremental caries data
in 40% sample (ICC score 0.91)
Risk of bias
Bias Authors’ judgement Support for judgement
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van Wyk 1986 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “...participants were randomly as-
signed to one of 3 rinsing groups”
“Boys and girls were separately, randomly
allocated to one of the three colours...”
Comment: not enough information pro-
vided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quotes: ”The trial was conducted on adou-
ble-blind basis. Boys and girls...were not in-
formed of the meaning of the colour code.
Nor was the examiner allowed to know to
which colour code a subject belonged”
“The solutions were indistinguishable in
taste”
Comment: use of placebo described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: as above
Comment: blinded outcome assessment
and use of placebo described
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall dropout for length of follow-up:
38.49% in 3 years
Dropout by group: 124/309 FR1, 114/306
FR2, 118/310 PL
Reasons for losses: “main reasons were:
scholastic failure and changing of schools”
Comment: numbers lost unduly high for
length of follow-up, with no differential
losses between groups. Reasons for missing
outcome data are acceptable and balanced.
Caries data used in analysis pertain to par-
ticipants present at final examinations
Selective reporting (reporting bias) Low risk Outcomes reported
DFS increment - (CA) cl reported at 1, 2
and 3 years’ follow-up
Comment: trial protocol not available. All
prespecified outcomes (in Methods) were
reported in the prespecified way
Baseline characteristics balanced? Low risk Prognostic factors reported
DFS: 8.7(6.6) FR1, 8.2(5.8) FR2, 8.4(6.5)
PL
Gender: 89 M, 96 F (FR1), 90 M , 102 F
(FR2), 93M, 99 F (PL)
Comment: initial caries appears balanced
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van Wyk 1986 (Continued)
between groups. Gender also balanced
Free of contamination/co-intervention? Low risk Quote from correspondence: “We ensured
that a child did not change the rinse during
the study”
Comment: overall prevention of contami-
nation/co-intervention indicated
Dropout rate based only on groups relevant to the review, on relevant follow-ups, unless otherwise stated. Baseline caries experience
averaged among relevant study arms, and based on the study sample analysed at the end of the study period (final sample), unless
otherwise stated. Age range (average age when reported) at the time the study started based on all study participants (or on groups
relevant to the review when data were available).
1stm = first permanent molar; AmF = amine fluoride; APF = acidulated phosphate fluoride; CA = lesions showing loss of enamel
continuity that can be recorded clinically (undermined enamel, softened floor/walls) or showing frank cavitation; CAR = caries attack
rate; CFS = caries-free surfaces; CFT= caries-free teeth; Chlor = chlorhexidine diguclonate; CIR = caries incidence rate; cl = clinical
examination; d(e)ft/s = decayed (extracted) and filled deciduous teeth or surface; dmft/s = decayed, missing (or extracted) and filled
deciduous teeth or surface; D(M)FS/T = decayed (missing) and filled permanent surfaces or teeth; DR = radiolucency into dentin; E
= teeth erupted at baseline; ER = any radiolucency in enamel/enamel-dentin junction; F = fluoride; FR = fluoride mouthrinse; ICC
= intraclass correlation co-efficient (for interrater reliability); M = missing permanent teeth; MD = mesio and distal surfaces; N =
numbers; Na = sodium; NaF = sodium fluoride; NCA = non-cavitated enamel lesions visible as white spots or discoloured fissures;
NH4F = ammonium fluoride; NR = not reported; NS = not significant; NT = no treatment control; O = occlusal surfaces; PF = pit
and fissure surfaces; PL = placebo mouthrinse; post BW = posterior bite-wing x-ray assessment; ppm F = parts per million of fluoride;
ptc = prior tooth-cleaning performed with or without a non-fluoride paste; RCT = randomised controlled trial; SMFP = sodium
monofluorophosphate; SnF2 = stannous fluoride; U = teeth unerupted at baseline; VT = visual-tactile assessment; xr = radiographic
examination.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aasenden 1972 Fluoride solution swallowed after rinsing (even though no systemic effect should be anticipated for this age
group)
Arcieri 1981 Random or quasi-random allocation not stated. Blind outcome assessment not stated
Axelsson 1976 Additional fluoride-based intervention associated with fluoride mouthrinse. Blind outcome assessment not
stated
Badersten 1975 Additional non-fluoride-based intervention associated with fluoride mouthrinse. Random or quasi-random
allocation not stated or indicated. Blind outcome assessment not stated or indicated
Birkeland 1973 No relevant outcome reported. Blind outcome assessment not stated. Length of follow-up of less than 1
year/school year (6 months)
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(Continued)
Bohannan 1985a Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
Boyd 1985 Additional fluoride-based intervention associatedwith fluoridemouthrinse. Clearly not randomised or quasi-
randomised (systematic process of assignment). Length of follow-up of less than 1 year/school year
Bristow 1975 Additional interventions associated with fluoride mouthrinse. Not a randomised or quasi-randomised trial
(only 2 clusters (schools) selected, each assigned to 1 of the 2 study groups)
Brodeur 1989 Open outcome assessment
Castellanos 1983 Open outcome assessment reported after contacting study author
Chen 2010 Open outcome assessment. Not a randomised or quasi-randomised trial (selection of 2 clusters only, each
assigned to 1 of the 2 groups)
Chikte 1996 Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
Cichocka 1981 No random or quasi-random allocation used (selected group comparisons). Blind outcome assessment not
stated and unlikely
Clark 1985a Clearly not randomised or quasi-randomised (concurrent control group taken from another study)
Corpus 1973 Clearly not randomised or quasi-randomised (systematic allocation according to participants’ characteristics)
. Blind outcome assessment not stated or indicated
De Canton 1983 Additional fluoride-based and non-fluoride-based interventions associated with fluoride mouthrinse. Ran-
dom or quasi-random allocation not stated
DePaola 1967 Additional fluoride-based intervention associated with fluoride mouthrinse. Blind outcome assessment not
stated
Disney 1989 Additional non-fluoride-based intervention associated with fluoride mouthrinse. Random or quasi-random
allocation not stated or indicated. Blind outcome assessment not stated or indicated
Esteva Canto 1991 Clearly not randomised or quasi-randomised (systematic group assignment). Blind outcome assessment not
stated and unlikely
Fernandez 1979 Open outcome assessment. Random or quasi-random allocation not stated or indicated
Frankl 1972 Fluoride solution swallowed after rinsing (even though no systemic effect should be anticipated for this age
group)
Gray 1980 Additional fluoride-based intervention associated with fluoride mouthrinse
Hall 1964 Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
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(Continued)
Heifetz 1979 Additional fluoride-based intervention associated with fluoride mouthrinse
Note - inappropriate ’placebo’ used
Irmisch 1974 Additional active agent associated with fluoride in mouthrinse. Random or quasi-random allocation not
stated or indicated. Blind outcome assessment not stated and unlikely
Ivanova 1990 Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
Kani 1973 Random or quasi-random allocation not stated. Blind outcome assessment not stated
Kasakura 1966 Random or quasi-random allocation not stated. Blind outcome assessment not stated and unlikely
Kitsugi 1978 Additional intervention associated with fluoride mouthrinse
Kunzel 1978 Not a randomised or quasi-randomised trial. Only 2 clusters (schools) selected, each assigned to 1 of the 2
study groups. Blind outcome assessment not stated and unlikely
Louw 1995 Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
Luoma 1978 Additional fluoride-based intervention associated with fluoride mouthrinse
McCormick 1970 Random or quasi-random allocation not stated
Note - only post-treatment effects reported
Mendonca 1995 Open outcome assessment reported after contacting study author
Morgan 1998 Additional non-fluoride-based intervention associated with fluoride mouthrinse. Blind outcome assessment
not stated
Morozova 1983 Additional intervention associated with fluoride mouthrinse. Random or quasi-random allocation not stated
or indicated. Blind outcome assessment not stated and unlikely
Moungtin 1975 Random or quasi-random allocation not stated or indicated. Outcome assessment not blind
Nenyei 1971 Random or quasi-random allocation not stated or indicated. Outcome assessment not blind
Ramos 1995 Open outcome assessment
Roberts 1948 Clearly not randomised or quasi-randomised (concurrent control group selected by matching procedure)
Rodriguez Miro 1983 Additional active agent associated with fluoride in mouthrinse. Not a randomised or quasi-randomised trial
- only 3 clusters (school classes), each assigned to 1 of the 3 interventions compared
Shimada 1978 Not a randomised or quasi-randomised trial - only 3 clusters (schools), each assigned to 1 of the 3 study
groups (method of assignment not stated). Outcome assessment not blinded
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(Continued)
Suntsov 1991 Random or quasi-random allocation not stated or indicated. Blind outcome assessment not stated and
unlikely
Note - only post-treatment effects reported
Swerdloff 1969 Length of follow-up of less than 1 year/school year
Torell 1969 Random or quasi-random allocation not stated or indicated
Note - unclear study duration
Weisz 1960 Clearly not randomised or quasi-randomised (concurrent control group taken from a different population)
. Open outcome assessment
Widenheim 1989 Clearly not randomised or quasi-randomised (concurrent control group taken from a different population)
. Open outcome assessment
Wilson 1978 Random or quasi-random allocation not stated
Note - abstract only; full text not obtainable; insufficient information available to include in review
Wycoff 1991 Clearly not randomised or quasi-randomised (systematic assignment of a few clusters to interventions). Blind
outcome assessment not stated and unlikely
Note - abstract only, full text not available/obtainable
Zickert 1982 Additional fluoride-based intervention associated with fluoride mouthrinse
Characteristics of studies awaiting assessment [ordered by study ID]
Kawall 1981
Methods
Participants
Interventions
Outcomes
Notes Additional information for this study report still missing
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D A T A A N D A N A L Y S E S
Comparison 1. Fluoride mouthrinse versus placebo or no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 D(M)FS increment (PF) -
nearest to 3 years (35 trials)
35 15305 Prevented Fraction (Random, 95% CI) 0.27 [0.23, 0.30]
2 D(M)FT increment (PF) -
nearest to 3 years (13 trials)
13 5105 Prevented Fraction (Random, 95% CI) 0.23 [0.18, 0.29]
3 Developing 1 or more new caries
(3 trials)
3 1805 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.46, 1.29]
4 Lack of acceptability of
treatment as measured by
leaving study early (4 trials)
4 1700 Risk Ratio (M-H, Random, 95% CI) 1.33 [0.62, 2.83]
Analysis 1.1. Comparison 1 Fluoride mouthrinse versus placebo or no treatment, Outcome 1 D(M)FS
increment (PF) - nearest to 3 years (35 trials).
Review: Fluoride mouthrinses for preventing dental caries in children and adolescents
Comparison: 1 Fluoride mouthrinse versus placebo or no treatment
Outcome: 1 D(M)FS increment (PF) - nearest to 3 years (35 trials)
Study or subgroup Fluoride Mouthrinse
Placebo/No
Treatment
Prevented
Fraction
(SE)
Prevented
Fraction Weight
Prevented
Fraction
N N IV,Random,95% CI IV,Random,95% CI
Ashley 1977 245 243 0.142602 (0.066092) 3.6 % 0.14 [ 0.01, 0.27 ]
Bastos 1989 280 140 0.282942 (0.053275) 4.4 % 0.28 [ 0.18, 0.39 ]
Blinkhorn 1983 190 184 0.2448 (0.069351) 3.4 % 0.24 [ 0.11, 0.38 ]
Craig 1981 49 48 0.316602 (0.182383) 0.8 % 0.32 [ -0.04, 0.67 ]
DePaola 1977 317 158 0.415894 (0.047721) 4.8 % 0.42 [ 0.32, 0.51 ]
DePaola 1980 129 142 0.216246 (0.084451) 2.7 % 0.22 [ 0.05, 0.38 ]
Driscoll 1982 373 151 0.375 (0.085352) 2.7 % 0.38 [ 0.21, 0.54 ]
Duany 1981 711 225 0.129382 (0.09169) 2.4 % 0.13 [ -0.05, 0.31 ]
Finn 1975 292 161 0.167336 (0.064681) 3.7 % 0.17 [ 0.04, 0.29 ]
-1 -0.5 0 0.5 1
Favours placebo/NT Favours fluoride rinse
(Continued . . . )
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Study or subgroup Fluoride Mouthrinse
Placebo/No
Treatment
Prevented
Fraction
(SE)
Prevented
Fraction Weight
Prevented
Fraction
N N IV,Random,95% CI IV,Random,95% CI
Gallagher 1974 306 288 0.141638 (0.045701) 5.0 % 0.14 [ 0.05, 0.23 ]
Heidmann 1992 538 545 0.054054 (0.12645) 1.5 % 0.05 [ -0.19, 0.30 ]
Heifetz 1973 259 154 0.322709 (0.063681) 3.7 % 0.32 [ 0.20, 0.45 ]
Heifetz 1982 394 204 0.35049 (0.077071) 3.0 % 0.35 [ 0.20, 0.50 ]
Horowitz 1971 133 123 0.162791 (0.17164) 0.9 % 0.16 [ -0.17, 0.50 ]
Horowitz 1971a 98 110 0.434932 (0.123182) 1.6 % 0.43 [ 0.19, 0.68 ]
Koch 1967 85 82 0.233729 (0.051929) 4.5 % 0.23 [ 0.13, 0.34 ]
Koch 1967a 117 134 0.253247 (0.08114) 2.8 % 0.25 [ 0.09, 0.41 ]
Koch 1967b 114 137 0.022312 (0.117779) 1.7 % 0.02 [ -0.21, 0.25 ]
Laswell 1975 226 117 0.351852 (0.121507) 1.6 % 0.35 [ 0.11, 0.59 ]
McConchie 1977 496 247 0.178571 (0.057012) 4.2 % 0.18 [ 0.07, 0.29 ]
Moberg Sko¨ld 2005 528 94 0.446541 (0.105614) 2.0 % 0.45 [ 0.24, 0.65 ]
Molina 1987 145 150 0.302734 (0.071395) 3.3 % 0.30 [ 0.16, 0.44 ]
Moreira 1972 150 50 0.167742 (0.11592) 1.7 % 0.17 [ -0.06, 0.39 ]
Moreira 1981 73 91 0.25 (0.086014) 2.6 % 0.25 [ 0.08, 0.42 ]
Packer 1975 188 97 0.349739 (0.149581) 1.1 % 0.35 [ 0.06, 0.64 ]
Petersson 1998 69 70 0.143302 (0.225475) 0.5 % 0.14 [ -0.30, 0.59 ]
Poulsen 1984 191 174 0.120567 (0.112779) 1.8 % 0.12 [ -0.10, 0.34 ]
Radike 1973 348 378 0.331126 (0.056087) 4.2 % 0.33 [ 0.22, 0.44 ]
Ringelberg 1979 341 186 0.229373 (0.081595) 2.8 % 0.23 [ 0.07, 0.39 ]
Ringelberg 1982 989 249 0.221557 (0.083431) 2.7 % 0.22 [ 0.06, 0.39 ]
Rugg-Gunn 1973 222 212 0.357143 (0.04436) 5.1 % 0.36 [ 0.27, 0.44 ]
Ruiken 1987 129 78 0.327744 (0.084548) 2.7 % 0.33 [ 0.16, 0.49 ]
Spets-Happonen 1991 44 51 0.264706 (0.221113) 0.6 % 0.26 [ -0.17, 0.70 ]
Torell 1965 332 162 0.347305 (0.044652) 5.1 % 0.35 [ 0.26, 0.43 ]
van Wyk 1986 377 192 0.298667 (0.050557) 4.6 % 0.30 [ 0.20, 0.40 ]
Total (95% CI) 9478 5827 100.0 % 0.27 [ 0.23, 0.30 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 58.43, df = 34 (P = 0.01); I2 =42%
Test for overall effect: Z = 15.47 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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126Fluoride mouthrinses for preventing dental caries in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Fluoride mouthrinse versus placebo or no treatment, Outcome 2 D(M)FT
increment (PF) - nearest to 3 years (13 trials).
Review: Fluoride mouthrinses for preventing dental caries in children and adolescents
Comparison: 1 Fluoride mouthrinse versus placebo or no treatment
Outcome: 2 D(M)FT increment (PF) - nearest to 3 years (13 trials)
Study or subgroup Fluoride Mouthrinse
Placebo/No
Treatment
Prevented
Fraction
(SE)
Prevented
Fraction Weight
Prevented
Fraction
N N IV,Random,95% CI IV,Random,95% CI
Bastos 1989 280 140 0.342048 (0.069845) 8.7 % 0.34 [ 0.21, 0.48 ]
Blinkhorn 1983 190 184 0.245014 (0.063186) 9.4 % 0.25 [ 0.12, 0.37 ]
Finn 1975 292 161 0.217799 (0.079035) 7.7 % 0.22 [ 0.06, 0.37 ]
Horowitz 1971 133 123 0.25 (0.167568) 2.7 % 0.25 [ -0.08, 0.58 ]
Horowitz 1971a 98 110 0.515337 (0.128074) 4.2 % 0.52 [ 0.26, 0.77 ]
Koch 1967 85 82 0.110583 (0.049171) 11.2 % 0.11 [ 0.01, 0.21 ]
Koch 1967a 117 134 0.125424 (0.112584) 5.0 % 0.13 [ -0.10, 0.35 ]
Koch 1967b 114 137 -0.04317 (0.127269) 4.2 % -0.04 [ -0.29, 0.21 ]
McConchie 1977 496 247 0.179487 (0.074938) 8.1 % 0.18 [ 0.03, 0.33 ]
Molina 1987 145 150 0.257053 (0.075132) 8.1 % 0.26 [ 0.11, 0.40 ]
Radike 1973 348 378 0.308458 (0.057146) 10.2 % 0.31 [ 0.20, 0.42 ]
Ringelberg 1979 341 186 0.177515 (0.075264) 8.1 % 0.18 [ 0.03, 0.33 ]
Rugg-Gunn 1973 222 212 0.316271 (0.041029) 12.3 % 0.32 [ 0.24, 0.40 ]
Total (95% CI) 2861 2244 100.0 % 0.23 [ 0.18, 0.29 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 26.04, df = 12 (P = 0.01); I2 =54%
Test for overall effect: Z = 7.69 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 1.3. Comparison 1 Fluoride mouthrinse versus placebo or no treatment, Outcome 3 Developing 1
or more new caries (3 trials).
Review: Fluoride mouthrinses for preventing dental caries in children and adolescents
Comparison: 1 Fluoride mouthrinse versus placebo or no treatment
Outcome: 3 Developing 1 or more new caries (3 trials)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Torell 1965 51/332 46/162 30.5 % 0.54 [ 0.38, 0.77 ]
Heidmann 1992 134/426 162/432 34.0 % 0.84 [ 0.70, 1.01 ]
Finn 1975 278/292 157/161 35.5 % 0.98 [ 0.94, 1.01 ]
Total (95% CI) 1050 755 100.0 % 0.77 [ 0.46, 1.29 ]
Total events: 463 (Treatment), 365 (Control)
Heterogeneity: Tau2 = 0.19; Chi2 = 54.59, df = 2 (P<0.00001); I2 =96%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours F mouthrinse Favours Placebo/NT
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Analysis 1.4. Comparison 1 Fluoride mouthrinse versus placebo or no treatment, Outcome 4 Lack of
acceptability of treatment as measured by leaving study early (4 trials).
Review: Fluoride mouthrinses for preventing dental caries in children and adolescents
Comparison: 1 Fluoride mouthrinse versus placebo or no treatment
Outcome: 4 Lack of acceptability of treatment as measured by leaving study early (4 trials)
Study or subgroup Fluoride mouthrinse NT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Craig 1981 5/54 7/55 21.9 % 0.73 [ 0.25, 2.15 ]
Torell 1965 69/401 34/196 36.3 % 0.99 [ 0.68, 1.44 ]
Moreira 1981 42/115 24/91 35.5 % 1.38 [ 0.91, 2.11 ]
Moberg Sko¨ld 2005 166/694 0/94 6.3 % 45.52 [ 2.86, 724.72 ]
Total (95% CI) 1264 436 100.0 % 1.33 [ 0.62, 2.83 ]
Total events: 282 (Fluoride mouthrinse), 65 (NT)
Heterogeneity: Tau2 = 0.38; Chi2 = 14.15, df = 3 (P = 0.003); I2 =79%
Test for overall effect: Z = 0.73 (P = 0.46)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours F mouthrinse Favours NT
A D D I T I O N A L T A B L E S
Table 1. Meta-analyses of prevented fractions: D(M)FS and D(M)FT
Analysis Number of studies RE PF estimate 95% CI Meta-analysis P value Heterogeneity test
D(M)FS - all studies 35 27% 23% to 30% P value < 0.0001 Chi2 = 58.43 (34 df ); P
value = 0.006; I² = 42%
D(M)FT - all stud-
ies
13 23% 18% to 29% P value < 0.0001 Chi2 = 26.04 (12 df ); P
value = 0.011; I² = 54%
D(M)FS = decayed (missing) and filled permanent surfaces
D(M)FT = decayed (missing) and filled permanent teeth
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Table 2. Random-effects metaregression analyses of prevented fractions: D(M)FS
Characteristic Number of studies Slope estimate 95% CI Slope interpretation P value
Mean baseline caries 34 0.2% (-0.8% to 1.3%) Increase in PF per unit
increase in mean base-
line caries
0.7
Fluoridated water
area
33 6.6% (-4.8% to 17.9%) Higher PF in presence
of water fluoridation
0.3
Fluoride dentifrice
use
33 4.8% (-3.2% to 12%) Higher PF in presence
of fluoride dentifrice
use
0.2
Background
fluorides
33 5.8% (-1.5% to 13.1%) Higher PF in presence
of background fluoride
0.12
Rinsing frequency 34 0.4% (-4.3% to 5.0%) Increase in PF per 100
extra applications/y
0.9
Fluoride concentra-
tion in solution
35 1.1% (-3.9% to 6.0%) Increase in PF per
1000 ppm F
0.7
Intensity (frequency
times
concentration)
33 (excludes De-
Paola 1977)
8.3% (-14% to 31%) Increase in PF equiva-
lent to doubling from
100 to 200 applica-
tions and increasing by
1000 ppm F
0.5
Control group 35 8.2% (-2.0% to 18.4%) Higher PF for no treat-
ment compared with
placebo
0.11
Dropout 32 0.4% (-2.1% to 2.9%) Increase in PF per 10
dropouts
0.7
Length of follow-up 35 1.1% (-6.2% to 8.5%) Increase in PF per extra
year of follow-up
0.8
D(M)FS = decayed (missing) and filled permanent surfaces
PF = prevented fraction
ppm F = parts per million of fluoride
y = year
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A P P E N D I C E S
Appendix 1. Cochrane Oral Health’s Trials Register search strategy
1 (carie* or carious or DMF):ti,ab
2 ((dental or tooth or teeth or enamel or dentin*) and (decay* or cavit* or deminerali* or reminerali* or “white spot*”)):ti,ab
3 #1 or #2
4 (fluorid* or fluor or “PPM F” or PPMF or APF or NAF or “Sodium F” or “Amine F” or SNF2 or “Stannous F” or “phosphat* F” or
“acidulat* F” or “phosphat* fluor*” or fluorphosphat* or “amin* fluor*” or “sodium fluor*” or “stannous fluor*” or SMFP or MFP or
monofluor*):ti,ab
5 (mouthwash* or mouthrins* or “mouth wash*” or “mouth rins*”):ti,ab
6 ((FluoriGard or Duraphat or Endekay or Act or Swirl or “Wisdom step by step” or Dentimint or AloeDent or Listerine) and (rins*
or wash*)):ti,ab.
7 (oral next (rins* or wash*)):ti,ab
8 #5 or #6 or #7
9 (#3 and #4 and #8) AND (INREGISTER)
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
#1 [mh “Tooth demineralization”]
#2 (carie* or carious or DMF)
#3 ((dental or tooth or teeth or enamel or dentin*) and (decay* or cavit* or deminerali* or reminerali* or “white spot*”))
#4 {or #1-#3}
#5 [mh Fluorides]
#6 (fluorid* or fluor or “PPM F” or PPMF or APF or NAF or “Sodium F” or “Amine F” or SNF2 or “Stannous F” or “phosphat* F”
or “acidulat* F” or “phosphat* fluor*” or fluorphosphat* or “amin* fluor*” or “sodium fluor*” or “stannous fluor*” or SMFP or MFP
or monofluor*)
#7 #5 or #6
#8 [mh Mouthwashes]
#9 (mouthwash* or mouthrins* or “mouth wash*” or “mouth rins*”)
#10 ((FluoriGard or Duraphat or Endekay or Act or Swirl or “Wisdom step by step” or Dentimint or AloeDent or Listerine) and (rins*
or wash*))
#11 (oral next (rins* or wash*))
Appendix 3. MEDLINE Ovid search strategy
1. exp Tooth demineralization/
2. (carie$ or carious or DMF).ti,ab.
3. ((dental or tooth or teeth or enamel or dentin$) and (decay$ or cavit$ or deminerali$ or reminerali$ or “white spot$”)).ti,ab.
4. or/1-3
5. exp Fluorides/
6. (fluorid$ or fluor or “PPM F” or PPMF or APF or NAF or “Sodium F” or “Amine F” or SNF2 or “Stannous F” or “phosphat$ F” or
“acidulat$ F” or “phosphat$ fluor$” or fluorphosphat$ or “amin$ fluor$” or “sodium fluor$” or “stannous fluor$” or SMFP or MFP
or monofluor$).ti,ab.
7. 5 or 6
8. Mouthwashes/
9. (mouthwash$ or mouthrins$ or “mouth wash$” or “mouth rins$”).ti,ab.
10. ((FluoriGard or Duraphat or Endekay or Act or Swirl or “Wisdom step by step” or Dentimint or AloeDent or Listerine) and (rins$
or wash$)).ti,ab.
11. (oral adj (rins$ or wash$)).ti,ab.
12. or/8-11
13. 4 and 7 and 12
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The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomized trials in
MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of The Cochrane
Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011] (Higgins 2011).
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
Appendix 4. Embase Ovid search strategy
1. Dental caries/
2. (carie$ or carious or DMF).ti,ab.
3. ((dental or tooth or teeth or enamel or dentin$) and (decay$ or cavit$ or deminerali$ or reminerali$ or “white spot$”)).ti,ab.
4. or/1-3
5. exp Fluoride/
6. (fluorid$ or fluor or “PPM F” or PPMF or APF or NAF or “Sodium F” or “Amine F” or SNF2 or “Stannous F” or “phosphat$ F” or
“acidulat$ F” or “phosphat$ fluor$” or fluorphosphat$ or “amin$ fluor$” or “sodium fluor$” or “stannous fluor$” or SMFP or MFP
or monofluor$).ti,ab.
7. 5 or 6
8. Mouthwash/
9. (mouthwash$ or mouthrins$ or “mouth wash$” or “mouth rins$”).ti,ab.
10. ((FluoriGard or Duraphat or Endekay or Act or Swirl or “Wisdom step by step” or Dentimint or AloeDent or Listerine) and (rins$
or wash$)).ti,ab.
11. (oral adj (rins$ or wash$)).ti,ab.
12. or/8-11
13. 4 and 7 and 12
The above subject search was linked to Cochrane Oral Health’s filter for identifying RCTs in Embase Ovid:
1. random$.ti,ab.
2. factorial$.ti,ab.
3. (crossover$ or cross over$ or cross-over$).ti,ab.
4. placebo$.ti,ab.
5. (doubl$ adj blind$).ti,ab.
6. (singl$ adj blind$).ti,ab.
7. assign$.ti,ab.
8. allocat$.ti,ab.
9. volunteer$.ti,ab.
10. CROSSOVER PROCEDURE.sh.
11. DOUBLE-BLIND PROCEDURE.sh.
12. RANDOMIZED CONTROLLED TRIAL.sh.
13. SINGLE BLIND PROCEDURE.sh.
14. or/1-13
15. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
16. 14 NOT 15
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Appendix 5. CINAHL EBSCO search strategy
S12 S3 and S6 and S11
S11 S7 or S8 or S9 or S10
S10 (oral n1 (rins$ or wash$))
S9 ((FluoriGard or Duraphat or Endekay or Act or Swirl or “Wisdom step by step” or Dentimint or AloeDent or Listerine) and (rins$
or wash$))
S8 (mouthwash* or mouthrins* or “mouth wash*” or “mouth rins*”)
S7 (MH “Mouthwashes+”)
S6 S4 or S5
S5 (fluoride* or fluor or “PPM F” or PPMF or APF or NAF or “Sodium F” or “Amine F” or SNF2 or “Stannous F” or “phosphat*
F” or “acidulat* F” or “acidulat* fluor*” or “phosphat* fluor*” or fluorphosphat* or “amin* fluor*” or “sodium* fluor*” or “stannous*
fluor*” or SMFP or MFP or monofluor*)
S4 (MH “Fluorides+”)
S3 S1 or S2
S2 (carie* or caries or carious or DMF* or cavit* or deminerali* or reminerali* or “white spot”*)
S1 (MH “Tooth demineralization+”)
Appendix 6. LILACS BIREME and BBO BIREME search strategy
(Mh Fluorides or fluoride$ or fluoruro$ or fluoreto$) [Words] and (Mh Dental caries or carie$ or carious) [Words] and (Mh Mouth-
washes or mouthwash$ or mouthrins$ or “mouth wash$” or “mouth rins$” or “antisépticos bucal$” or “antissépticos bucais”)
Appendix 7. Proquest Dissertations and Theses search strategy
all(fluoride) AND all(mouthwash* or mouthrins*) AND all(caries or carious or decay)
Appendix 8. Web of Science Conference Proceedings search strategy
#4 #1 and #2 and #3
#3 TS=(fluoride* or “PPM F” or “PPMF” or “APF” or “NAF” or “sodium F” or “amine F” or “SNF2” or “stannous F” or acidulat*
or “phosphat* fluorid*” or “fluorophosphat* sodium fluorid*” or “amine* fluorid*” or“stannous* fluorid*” or SMFP or “MFP” or
monofluor*)
#2 TS=(mouthwash* or mouthrins*)
#1 TS=(deminerali* or caries or carious or DMF* or fissure* or decay* or cavit* or “white spot*”)
Appendix 9. US National Institutes of Health Trials Register (ClinicalTrials.gov) and the World
Health Organization International Clinical Trials Registry Platform search strategy
fluoride mouthrinse
fluoride mouthwash
WH A T ’ S N E W
Last assessed as up-to-date: 22 April 2016.
Date Event Description
10 May 2016 New citation required but conclusions have not changed One new study included. Substantial update with some
new methods but conclusions unchanged
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(Continued)
22 April 2016 New search has been performed Updated search. One new included study. Risk of bias
assessment carried out for all included studies. Quality
of the evidence assessed using GRADE. ’Summary of
findings’ table added
H I S T O R Y
Protocol first published: Issue 3, 2000
Review first published: Issue 3, 2003
Date Event Description
27 August 2008 Amended Converted to new review format
C O N T R I B U T I O N S O F A U T H O R S
For the 2016 update, all members of the new review team decided on the updated methods to be used for this review. Valeria Marinho
(VM) and Lee Yee Chong (LYC) undertook study selection, data extraction, ’Risk of bias’ assessments and analyses. Tanya Walsh (TW)
and HelenWorthington (HW) provided advice when consulted throughout the update and undertook some of the extra analyses. VM
and LYC prepared the full review, and all review authors were active in its revision and approval.
For the original review, all four review authors contributed to the development of the protocol. VM wrote the protocol, conducted
searches, selected studies and extracted data. Julian Higgins duplicated study selection and data extraction in a sample of studies, and
Stuart Logan and Aubrey Sheiham were consulted when necessary. VM entered and analysed the data in consultation with Julian
Higgins. VM prepared the full review, and all review authors were active in its revision and approval.
D E C L A R A T I O N S O F I N T E R E S T
Valeria CC Marinho: none known. Valeria Marinho is an editor with Cochrane Oral Health.
Helen Worthington: none known. Helen Worthington is a Co-ordinating editor with Cochrane Oral Health.
Tanya Walsh: none known. Tanya Walsh is an editor with Cochrane Oral Health.
Lee Yee Chong: none known.
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S O U R C E S O F S U P P O R T
Internal sources
• Department of Epidemiology and Public Health (UCL), UK.
• Systematic Reviews Training Unit, Institute of Child Health (UCL), UK.
• Medical Research Council, UK.
External sources
• CAPES - Ministry of Education, Brazil.
• National Institute for Health Research (NIHR), UK.
This project was supported by the NIHR, via Cochrane Infrastructure funding to Cochrane Oral Health. The views and opinions
expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or
the Department of Health.
• Cochrane Oral Health Global Alliance, Other.
The production of our reviews is partly funded by our Global Alliance partners (http://oralhealth.cochrane.org/partnerships-
alliances): British Association for the Study of Community Dentistry, UK; British Association of Oral Surgeons, UK; British
Orthodontic Society, UK; British Society of Paediatric Dentistry, UK; British Society of Periodontology, UK; Canadian Dental
Hygienists Association, Canada; Mayo Clinic, USA; National Center for Dental Hygiene Research & Practice, USA; New York
University College of Dentistry, USA; NHS Education for Scotland (NES); and Royal College of Surgeons of Edinburgh, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the 2016 update, we further defined outcomes for clarity. We also trimmed the list of outcomes to those more relevant to patients.
Information on use of healthcare service resources (such as visits to dental care units, length of dental treatment time) was not available
from the studies and will no longer be collected. These data have limited applicability across settings.
Other changes implemented in this update are the addition of a full ‘Risk of bias’ assessment and the development of a ‘Summary of
findings’ table for the primary outcomes in the review.
Finally, we made changes to the measures of effect used for the meta-analysis of some secondary outcomes, as well as changes to some
of the investigations of heterogeneity performed through metaregression and subgroup analyses and to investigations of sensitivity
analyses, including changes to the way a few co-variates were analysed in each. We have reported these changes and the rationale for
them in relevant sections of the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Dental Caries [∗prevention & control]; Dentition, Permanent; Fluorides [∗administration & dosage]; Mouthwashes [∗administration
& dosage]; Randomized Controlled Trials as Topic
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MeSH check words
Adolescent; Child; Humans
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